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§ 1. INTRODUCTION 
1.1. CYCLIC PEPTIDES 
 
Cyclic peptides and peptidomimetics represent large and yet underexploited class of molecules 
for drug discovery. Cyclic peptides are present in hormones, antibiotics and toxins. Because of 
their reduced conformational freedom (compared to their linear precursors), cyclic peptides 
exhibit improved metabolic stability and binding affinity to their molecular targets. They are 
more resistant to enzymatic hydrolysis1-3 and show an increased receptor selectivity and 
bioavailability4 and are frequently endowed with biological activity.5,6 These properties have 
inspired researchers to synthesize and screen large libraries of natural cyclic peptides to meet 
other medical needs and serve as biomedical research tools. 
Two main classes of cyclic peptides can be described: in the frist one, heterodetic compounds, 
disulfide, ester or thioester bonds take place in the structure and connect amino acidic residues 
to each other.7 In the second class, called homodetic, every amino acid is bonded exclusively 
through amide bond. 
 
1.1.1. Synthesis of cyclic peptides 
 
Due to the growing interest that cyclic peptides have generated, intense efforts have been 
invested in developing efficient methods for peptide cyclizations.8 
There are four ways in which amino acids can cyclize in homodetic compounds (Figure 1). 
Head-to-tail, where condensation reaction happens between C- and N-termini, head-to-side 
chain, side chain-to-tail and side chain-to-side chain where the formation of amide bond 
involves the functional groups of the side chain of one or more residues that condensate with 
C-terminus, N-terminus or with each other. 
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 Figure 1. The four possible ways a peptide can be constrained in a macrocycle.9 
 
Synthesis of cyclic peptides, in particular head-to-tail cyclisation, represents however a 
significant synthetic challenge. Most condensation methods usually used for linear peptides are 
applicable for ring closure. Anyway, cyclization requires particular conditions. For instance, 
high dilution is still the main route applicable to minimize unwanted intermolecular processes 
such as oligo- and polymerizations, making the peptide more prone to intramolecular reaction. 
Selection of coupling reagents plays a very important role in the good outcome of the reaction, 
but the ring size is the main factor that governs the success of a macrocyclization.  
Large peptides containing more than ten amino acids usually don’t present difficulties and 
cyclize easily with good yields because intramolecular hydrogen bonds lower the free energy 
of loop closure.10 
Smaller peptides, instead, can often be troublesome if not impossible, to cyclize; tri-, tetra-, and 
pentapeptides show the tendency to dimerization, trimerization and C-terminal epimerization.11 
In particular, pentapeptides tend to form dimers in solution that are hold together by hydrogen 
bonds in an antiparallel sheet-like conformation, and cyclodimerize.12  
The success or failure of macrocyclization relies on the ability of a linear precursor to 
conformationally pre-organize its reactive ends bringing them close to each other before ring 
closure.13-17 Such pre-arrangement results in fewer by-products from intermolecular processes. 
Over the years, various strategies for directing macrocyclizations using conformational pre-
organization have been developed and reviewed.18 These strategies can be devided in two 
groups: 
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1) ‘internal’ conformational elements, which include covalent modifications of the peptide 
chain to facilitate the union of its ends, and  
1) ‘external’ conformational elements, which involve the use of molecular scaffolds that 
are neither covalently attached to the peptide, nor consumed during the course of the 
ring closure.  
 
1) Internal conformational elements. The cyclization process is favoured when both termini 
of a linear precursor in the transition state have the least amount of strain. Daidone and Smith 
concluded that the loop-closure kinetics in the longer peptides (more than 10 amino acids) is 
determined by the formation of intra-peptide hydrogen bonds and transient β-sheet structure.10 
Intramolecular hydrogen bonds were found to lower the free energy of loop closure for longer 
peptides. The absence of intra-peptide hydrogen bonds for the shorter peptides provided 
evidence of intrinsic stiffness of the short polypeptide chains. 
To help bring the ends of a linear peptide together, the secondary protein structures, particularly 
reverse turns have been taken into account.19 An elegant way of achieving a minimal end-to-
end distance is to introduce a cis-amide bond in the middle of the peptide chain, thus forming 
a motif analogous to a β-turn. This can be done, for example, by introducing proline in the 
sequence. 
The incorporation of other D-amino acids into all-L peptides is also known to pursue turn-
inducing effects.20 For two hexapeptides that differ only in α-carbon configuration at the 
terminal residues, cyclization is favoured for the diastereomer that contains both a D- and an L-
residue at its termini.21 The presence of both D and L residues in the termini of linear precursor22 
is usually necessary to obtain cyclic product in particular for small (penta- and hexa-) peptides 
presumably because of less steric clashes among the side chains. 
N-Methyl amino acids have a similar stereochemical impact on the backbone of peptides to that 
of proline. They have the potential to introduce cis-amide bonds into peptide sequences and are 
well suited to induce β-turns.23,24 
2) External conformational elements. External templates for assisting macrocyclization 
operate on the basis of a site-isolation mechanism. Polymeric scaffolds can create reaction 
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cavities large enough for only one linear peptide molecule to enter and cyclize at a time. In this 
way peptide is isolated from the bulk solution and these internal cavities significantly decrease 
the probability of cyclooligomerization. Van Maarseveen and co-workers have applied this 
strategy through the development of carbosilane dendrimeric carbodiimides25 (Scheme 1). The 
authors demonstrated that these dendrimeric carbodiimides could cyclize seven-membered bis-
lactams (homodiketopiperazines), which are difficult to obtain through traditional lactamization 
methods. 
 
 
Scheme 1. Carbosilane dendrimeric carbodiimides to cyclize homodiketopiperazines through site-
isolation mechanism.9 
 
Successful or inefficient cyclization depends also on the type of amino acid residues of the 
linear sequence. This sequence-dependent effect of cyclization often makes it neccesary to 
devise investigations to find adequate conditions that enable the formation of target cyclic 
structures. 
One example that confirmes previuosly mentioned facts is the attempt of Schmidt and Langner 
to synthesize cyclo-[Pro-Val-Pro-Tyr], a known tyrosinase inhibitor. They were unable to 
prepare the all-L-isomer. Instead, 31% of the C-terminal epimerization product cyclo-[Pro-Val-
Pro-D-Tyr] was obtained from the corresponding pentafluorophenyl (Pfp) ester. The authors 
also investigated all possible ring closures of the all-L-cyclic pentapeptide cyclo-[Pro-Ala-Ala-
Phe-Leu] through Pfp ester activation, and observed a strong sequence dependence for 
successful cyclization. Only cyclization of H-Phe-Leu-Pro-Ala-Ala-OH resulted in the 
formation of the monomeric cyclic species with 21% yield (Figure 2). This example 
demonstrates the difficulties in a retrosynthetic analysis of a cyclic peptides. The ring 
disconnection must be chosen carefully and several guidelines have been developed to aid in 
this.26 
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Figure 2. All possible ring disconnections of cyclo-[Pro-Ala-Ala-Phe-Leu] showing the isolated yields of 
the combined cyclomono- and/or dimerization through Pfp ester activation.9 
 
It is also known that sequences rich in Arg, Lys and Thr as well as those that contain Arg-His-
Ser motif next to the N-terminal are very difficult to cyclize. 
In the next few pages the most significant cyclization methods will be reported. 
 
a) Metal-ion assisted cyclization 
Tendency of peptide macrocycle to form stable complex with metal ions, found in natural 
compounds like gramicidin, valinomycin and anatamanide inspired the attempt to use metal 
ions to facilitate cyclisation. For instance, Beck and co-workers27 used two un-activated 
dipeptide methyl esters coordinated to a metal center (Pd, Ni, Cu) allowing nucleophilic attack 
under basic condition of amino group to the carboxyl group to get the cyclic product. This 
reaction does not require high dilution, protection or activation (Scheme 2). 
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Scheme 2. Transition metal-mediated cyclodimerization. 
Ye and co-workers later proposed that alkali metal ions28 bind carbonyl groups, starting from 
C-terminus (Scheme 7), forcing the peptide to acquire a strong turn structure that bring C-
terminus close to N-terminus allowing condensation reaction to occur.29,30 
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Scheme 3. Alkali metal ion assisted cyclisation 
 
Various coupling reagents were used and proposed for cyclisation reactions, despite the fact 
that reagents usually used in linear synthesis could be also employed. A strong reactivity of the 
activated precursor is usually required because of disfavored intramolecular reaction due to the 
pre-cyclisation fashion the molecule must have. But on the other hand, an over activated peptide 
could cause epimerization and polymerization side-reactions. 
Coupling reagents such as DCC paired with HOBt usually lead to very slow reactions causing 
high level of epimerization of C-terminus.31-33 Other, commonly used coupling reagent for 
cyclisation, diphenylphosphoryl azide (DPPA), 2-(1H-benzotriazole-1-yl)-1,1,3,3 
tetramethylaminium tetrafluoroborate34 (TBTU) and (benzotriazol-1-
yloxy)tris(dimethylamino)phosphonium hexafluorophosphate35 (BOP)  provide a fast 
cyclization36 but still epimerization was observed at not negligible levels. Application of 
coupling reagents derived from 1-hydroxy-7-azabenzotriazole37 (HOAt) such as O-(7-
azabenzotriazol-1-yl)-1,1,3,3-bis(tetramethylene)uronium hexafluorophosphate38 (HApyU), 
(7-azabenzotriazol-1-yloxy)trispyrrolidinophosphonium hexafluorophosphate38 (PyAOP) and 
N-[(dimethylamino)-H-1,2,3-triazolo[4,5]pyridin-1-yl-methylene]-N-methyl-methanaminium 
hexafluorophosphate38  (HATU) have shown advantages over the corresponding HOBt-based 
reagents for solution and solid-phase peptide synthesis about both, speed and maintenance of 
chiral integrity.38 
Among all 3-(diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one39 (DEPBT) (Figure 3), 
due to its notable resistance to racemization and high yields noticed in peptide bond formation, 
is an useful tool for the synthesis of complex natural products40, 41 and cyclisation reaction.30 
This coupling reagent was used in the previously mentioned example (Scheme 3). 
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Figure 3. Structure of DEPBT. 
 
b) Solid phase peptide synthesis (SPPS) 
Cyclization of peptides on a solid support may be an interesting choice for removing the 
eventuality of side-reaction like polymerization facilitating also purification process as 
coupling reagents and by-products can be simply washed away. The linear precursor is most 
commonly anchored to the support through the side chain of a trifunctional amino acid. 
Anchoring a reactive molecule to an insoluble polymer can create a pseudodilution 
phenomenon. 
 
c) Lactamization  
Amblard and co-workers42 reported a synthetic strategy to obtain penta- and hexacyclopeptides 
trying to overcome the entropic penalty of peptide’s macrocyclization. A N-Boc protected 
depsipeptide of serine was firstly synthetized through SPPS, then cyclized in solution with high 
dilution strategy and BOP as the coupling reagent, taking advantage of the greater flexibility of 
depsipeptides compared to linear ones.  After the removal of Boc from the serine residue, and 
under basic conditions, the O-to-N migration occurred leading to a ring contraction as showed 
in Scheme 4. However, it was observed by the same authors that the acyl migration step did not 
proceed in the case of a more conformationally constrained tetrapeptide derivative.  
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Scheme 4. Ring-contraction strategy involving an O-to-N acyl transfer. 
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Another ring-contraction method involving lactones was developed by Meutermans, Smythe 
and co-workers and was applied to the head-to-tail cyclization of a pentapeptide.43 A 
salicylaldehyde-derived auxiliary was attached to the N-terminus of the peptide chain through 
reductive amination. Activation of the C-terminus initially results in the cyclization to form the 
more accessible lactone. This brings the N-terminus into close proximity to the C-terminus and 
facilitates an O-to-N acyl transfer (Scheme 5). 2-hydroxy-6-nitrobenzyl (HnB) was chosen as 
the auxiliary because it is photo-labile and can be removed after macrocyclization. 
 
 
Scheme 5. A photo-labile auxiliary used in a ring-contraction strategy.9 
 
d) Azide-alkyne cycloadditions 
The incorporation of heterocycles into the backbone of cyclic peptides is growing in interest, 
especially from a medicinal chemistry perspective. The 1,2,3-triazole is both 
thermodynamically and physiologically stable. Depending on its substitution pattern it can 
serve as an effective isostere for a trans- or cis-amide bond. This heterocycle is readily obtained 
through a 1,3-dipolar cycloaddition between an N-terminal azide and a C-terminal alkyne 
(Scheme 6).44  
 
 
Scheme 6. A click-mediated macrocyclization.9 
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e) Sulfur-mediated cyclizations 
Inspired by the prevalent role imidazole plays in the catalyzing the hydrolysis and transfer of 
activated acyl groups, Houghten and co-workers45 have developed a method for the head-to-
tail synthesis of cyclic peptides by the direct aminolysis of peptide thioesters in the presence of 
imidazole (Scheme 7). Imidazole acts as nucleophilic catalyst, attacking the carbonyl group of 
the thioester to form a reactive acyl imidazolyl intermediate, which is subsequently intercepted 
by another nucleophile. 
 
 
Scheme 7. Cyclization of a thioester catalysed by imidazole.9 
Crich and Sasaki have developed an amide-bond-forming sequence employing peptide 
thioacids and Sanger’s reagent that is viable for the cyclization of penta- and hexapeptides.46 
Treatment of an N-terminal Fmoc-protected and C-terminal 9-fluorenylmethylthioester peptide 
with piperidine (Scheme 8) gives a precursor, which cyclizes in the presence of Sanger’s 
reagent. The reaction proceeds through an initial reaction with Sanger’s reagent to generate a 
reactive thioester in situ.  
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Scheme 8. Cyclization of a thioester with Sanger’s reagent.9 
 
One of the most convenient and straightforward methods for constraining a peptide into a 
macrocycle is through the bridging of two internal cysteine thiol groups. The resulting 
intramolecular disulfide bridges can stabilize secondary structure motifs in peptides. This side 
chain-to-tail cyclization strategy was used by Anseth and co-workers.47 The macrocyclization 
involves a radical addition of the thiol group of a cysteine residue at the N-terminus of the 
peptide to the alkene of an allyloxycarbonyl protecting group on the ε-NH2 group of a lysine 
residue at the C-terminus (Scheme 9). 
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Scheme 9. Cylization through a thiolene reaction on solid-phase.9 
 
1.1.2. Ion binding proprieties of cyclic peptides 
 
Ionophores are molecules that bind and transport ions selectively.48 To design useful 
ionophores, various factors such as host-guest size complementarity, rigidity of host molecule 
and ion dipolar moiety orientations in host-guest complexes are important.49 These complexes 
are composed of molecules or ions held together by intermolecular forces such as electrostatic 
interactions, hydrogen bonding, dispersion interactions and solvophobic effects.50 The first step 
in a formation of these complexes is the desolvation of the ion, followed by the interaction of 
the free ion and the ligand.51 Thus, molecules of solvents that were part of the solvation spheres 
of ion are now free in the solution and replaced by one molecule of ligand, which is certainly 
entropically favoured. Furthermore, the conformational-electron compatibility of the ions and 
ligands can also result in a favorable enthalpy contribution. Binding processes, as well as other 
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chemical reactions, are characterized by thermodynamic parameters, such as equilibrium 
constant, reaction Gibbs energy, enthalpy and entropy. The above-mentioned parameters 
depend on the temperature and on the solvent in which the reaction takes place.52 The solvent 
plays a significant role in these processes primarily due to the different solvation of the reactants 
and the complexes formed, as well as the inclusion of the solvent molecule in the host molecule, 
resulting in competition processes due to complexation of the host. Cyclic peptides were found 
to have high binding affinity toward various cations and anions53-55 and it has been shown that 
such an affinity is strongly dependent on both structure and conformation.56-59 
 
1.1.2.1.  Anion binding 
 
Anion recognition has become a hot theme in supramolecular chemistry due to its important 
roles in life sciences and in many medical and environmental settings. A number of neutral 
receptors containig amide, urea/thiourea or pyrrole groups have been developed in the recent 
years. Amongst them, cyclic peptides should be of particular interest because they belong to a 
familiy of natural macrocycles known for their importance in life processes. Research in this 
area is steadily increasing but still the development of neutral receptors of anions is quite slow 
compared to the abundance of articles about cation recognition. Strong complexation of anions 
is usually shown when all N-H groups converging towards the center of cavity binding via 
hydrogen bonds.60  
 
 1.1.2.2. Experimental studies of complexation reactions 
 
The methodology of monitoring complexation reactions depends on the system being 
investigated. When designing the experiment, the concentration range that is to be used, the 
expected response, and the possible interference that may arise from the solvent should be taken 
into account. For example, if the ion complexation reaction is monitored by UV spectroscopy 
then solvents and counterions that absorb in the same region as the ligand and/or complex 
should be avoided. With NMR titration it should be noted that a much higher ligand 
concentration is required than for example in the case of fluorimetric titration, and problem can 
be an insufficient solubility. In calorimetry, higher concentrations of salt may result in high heat 
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dissipation which can disable obtaining of reliable results. In this work we used calorimetric 
and NMR titrations that will be explained more in detail in the following part of this section. 
The complexatin reaction of an ion with a peptide can be represented by the equation (1), if the 
complex formed have a stoichiometry 1:1 (anion: ligand). Charges are omitted for simplicity. 
 
                                                  𝐴(𝑠𝑙𝑛) + 𝐿(𝑠𝑙𝑛) ⇄ 𝐴𝐿(𝑠𝑙𝑛)                                                 (1) 
 
                                                                                                         
The thermodynamic (standard) stability constant of the resulting complex is given by the 
following expression: 
 
                                                 𝐾° = ௔ಲಽ
௔ಲା௔ಽ
= [୅୐]ఊಲಽ௖°[୅]ఊಲ∙[௅]ఊಽ ≈
[஺௅]௖°
[஺]∙[௅]
                                             (2) 
                                                                                     
 
The approximate equation (2) derives from the fact that the solutions are diluted and the ligand 
is a neutral species. For processes that would involve charged ligands, especially with multiple 
charges, it would be necessary to take into account activity coefficients. Also, if the ligand is 
neutral, activity coefficients of the free cation and complex are approximately equal and can be 
neglected. 
In the case of calorimetric determinations of stability constants, isothermal microcalorimetric 
titration is the most frequently used approach. In our case, usually a solution of the salt is added 
to the solution of the ligand and the absorbed or emitted heat is monitored.61 The extent of the 
reaction (1) can be expressed by the relation: 
                                                                        
                                                                            𝜉=[AL]V                                                              (3) 
                                                                                
where V is the volume of the reaction system. 
Stochiometric equilibrium constant of the complexation reaction is defined as: 
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                                                                    𝐾 = [஺௅][஺][௅]                                                              (4) 
 
From the stoichiometry of the complexation reaction, it follows: 
 
 
                                                                                𝐿 = 𝑐௅ − [𝐴𝐿]                                                                      (5)                                                                      
                                                                                𝐴 = 𝑐஺ − [𝐴𝐿]                                                                      (6)                                                                                                    
 
Where cL and cA denote analytical (total) concentrations of the ligand and ion, respectively. 
Introducing the relations (5) and (6) into equation (4) results in: 
 
                                                            𝐾 = [஺௅]
(௖ಲି[஺௅])(௖ಽି[஺௅])
                                                    (7) 
 
By solving the above equation for complex equilibrium concentration and substraiting the 
obtained result into (3) one obtains: 
 
                                               𝜉 = [(௄௖ಲା௄௖ಽାଵ)ିඥ(௄௖ಲା௄ ಽାଵ)
మିସ௄మ௖ಲ௖ಽ
ଶ௄
]𝑉                              (8) 
                                                               
 
Since the reaction enthalpy is given by: 
 
                                                                      𝛥௥𝐻 = 𝛥𝐻/𝜉                                                      (9) 
 
The dependence of a cumulative enthalpy change on the analytical concentrations of ion and 
ligand, A and L, can be expressed by the equation: 
 
                                           𝛥𝐻 = 𝛥௥𝐻[
(௄௖ಲା௄௖ಽାଵ)ିඥ(௄௖ಲା௄௖ಽାଵ)మିସ௄మ௖ಲ௖ಽ
ଶ௄
]𝑉                      (10) 
 
To avoid the influence of the experimental errors, it is common to express the successive 
enthalpy changes: 
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                                            𝛥(𝛥𝐻) = (𝛥𝐻௡ − 𝛥𝐻௡ିଵ) = 𝛥௥𝐻(𝜉௡ − 𝜉௡ିଵ)                         (11) 
 
where n represents the ordinal number of titrant addition. Extents 1n  i n  are given by 
equation (8) together with cA(n) and cA(n-1), and cL(n) and cL(n-1),  respectively. 
From HrΔ and K values obtained from calorimetric titrations can, by fundamental 
thermodynamic equations, be reached values rΔ Gand rΔ S . The standard equilibrium constant 
is associated with standard Gibbs energy by equation: 
 
                                                                     rΔ lnG RT K
                                                                      (12) 
 
and rΔ G is associated with rΔ H and rΔ S  by equation: 
 
                                                                   r r rΔ Δ ΔG H T S
                                                                   (13) 
 
In NMR titrations the chemical shift of the signal of each nucleus in the NMR spectrum is the 
linear function of molar fractions of all species present in the solution. In the case of formation 
of 1:1 complex, this dependence is given by the equation: 
 
                                                     𝛿 = 𝛿௅𝑥(𝐿) + 𝛿௅∙஺𝑥(𝐿 ∙ 𝐴)                                                (14) 
 
where δL and δA denote chemical shift of the signal in NMR spectra of the ligand and ion, 
respectively. 
 
 
By incorporating the mass balance in equation (14), the dependence of chemical shift δ on xA 
and xB can be obtained: 
                                   𝛿 = 𝛿௅𝑐௅ − (𝛿௅ − 𝛿௅∙஺)
௫ಽା ௫ಲା
భ
಼ିට(௫ಽା௫ಲା
భ
಼)
మିସ௫ಽ௫ಲ
ଶ
                        (15) 
§ 1. Introduction 16 
Nikolina Vidović PhD thesis 
It should be emphasized that equation (15) is applicable only when the presence of free anion 
does not affect the measured property of the solution, for example, when the only spectral-
active species are receptor and complex. 
It is also important to emphasize that equations (14) and (15) are only valid if the rate of the 
formation and dissociation reactions is high, i.e., rate constant of the exchange reaction (k) is 
significantly greater than the difference in the resonance frequencies of the free receptor and 
complex nuclei: 
 
                                                                     𝑘 ≫ |𝑣௅ − 𝑣௅∙ெ|                                                                    (16) 
 
In the case of a slow exchange, separate signals of the species present in the solution appear in 
the spectrum, and the ratio of their molar fractions is given by the ratio of the area of the 
corresponding signals. In this case, if the total (analytical) concentrations of cL and cM in the 
solution are known, the equilibrium constant becomes very simple to be determined and for the 
simple case of the complex with stoichiometry 1:1 equation for the equilibrium constant is as 
follows: 
 
                                                                    𝐾 = ଵ
(௖ಲି
೑
భశ೑×௖ಽ)
× 𝑓                                                                     (17) 
 
where f is the ratio of integrals of the signal of the complex and the free ligand, i.e. the ratio of 
their equilibrium molar fractions (18). 
 
                                                                          𝑓 = ௫ಽ∙ಲ
௫ಲ
                                                                             (18) 
 
It should be noted that when the difference in the frequencies at which a particular nucleus 
resonates is comparable to the rate constant for the exchange reaction, it is not possible to use 
the above described approach of determining the equilibrium constant. In other words, at a 
temperature at which the following relation is valid: 
 
                                                                   𝑘 ≈ |𝑣௅ − 𝑉௅∙஺|                                                                       (19) 
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it is not possible to quantitatively characterize the equilibrium of such reaction by 1H NMR 
spectroscopy. 
As a confirmation of the importance of anion binding, there are numerous papers published in 
recent years on this topic. Cheng and coworkers62 developed two new pseudopeptides (Figure 
4) incorporating several H-bond donating and conformationally constrained structures (pyrrole, 
pyridine and cystine) into the macrocycle backbone. They found that both receptors possess 
good affinity and selectivity for fluoride and acetate ion in acetonitrile. 
 
 
Figure 4. Structures of a pseudopeptides.62 
 
Jolliffe with her colaboratores prepared a fluorescent chemosensing molecule based on a 
backbone modified cyclic peptide receptor (Figure 5). This product detects pyrophosphate in 
water and has a complete selectivity over monophopsphate anions.63 
 
 
Figure 5. Structure of fluorescent chemosensing molecule.63 
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The same authors synthesized another two criptands (Figure 6) based on cyclic peptides 
featuring three conformationally constrained thiourea groups for anion binding.64 Studies 
indicated that product 1 binds floride, chloride, bromide and acetate but not iodide, nitrate or 
hydrogensulfate. Product 2, instead, is selective towards acetate ions. All measurments were 
done in 0.5 % H2O/DMSO-d6. 
 
 
Figure 6. Structures of criptands.64 
 
The most recent aricle is published by Kubik et el.65 They synthesized two new pseudopeptides 
(Figure 7). Larger receptor 2 binds fully deprotonated sulfate ions with a lower affinity than 1. 
Interestingly, receptor 2 make a sandwich-type binding mode with dihydrogenpyrophosphate 
and dihydrogenphosphhate. All measurments were done in 2.5 % H2O/DMSO. 
 
 
Figure 7. Structure of pseudopeptides.65 
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1.1.2.3. Cation binding 
 
It is well known that cyclic peptides are also able to bind cations. All previously written 
equations are valid also to evaluate thermodynamic parameters for cation binding. For example, 
cyclododecapeptide c(L-Ala-Gly-D-Phe-L-Pro)3, adopts in CDCl3 a conformation which is able 
to bind various cations like Ba2+, K+, Rb+, Cs+, and Tl+ forming 1:1 ion-peptide complexes 
while Na+ and Li+ form 1:2 complexes.66 
Cereulide, produced by Bacillus cereus, is a cyclic dodecadepsipeptide containing three repeats 
of four amino acids: D-Oxy-Leu-D-Ala-L-Oxy-Val-L-Val and acts as ionophore with a high 
affinity for potassium cations.67 
A cyclic peptide (Figure 8) having four cysteinyl residues was found to be very efficient ligand 
for Cd2+, Zn2+ and Ni2+ ions.68 
 
 
Figure 8. Structure of a cyclic peptide.68 
 
More limited structural isomerism of cyclic ligands makes them a suitable choice for the design 
of ion receptors because the resulting metal complex is more predictable compared to the linear 
analogues. 
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Effects of modifications of histidine-based cyclic peptide sequences and ring dimensions 
(Figure 9) on Cu(II) binding studied by Aleksandra Kotynia and co-workers69, indicate a great 
potential to apply these ligands in Cu-based systems. The presence of non-His residues in the 
sequence and its effect on binding capacity indicate that a rational peptide design may be 
applied to create a variety of cyclic peptide Cu complexes to serve different purposes.  
 
 
Figure 9. Hys-based cyclic peptides. 
 
 
Cyclic peptides with two phosphoserines and two glutamic acids were developed by Delangle 
and co-workers to mimic high-affinity binding sites for uranyl found in proteins. They are found 
to chelate uranyl very efficiently even in a presence of calcium and they are relevant for uranyl 
binding in vivo.70 
Kritzer et el.71 found that a peptide shown in a figure coordinates Ni2+ and Cu2+ in a square 
planar geometry by the N-terminal amine, the imidazole and the two amide nitrogens in 
between. 
 
 
Scheme 10. Structure of a tetrapeptide.71 
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Anion and cation binding can be succesfully predicted by DFT methods. Chermachini and co-
workers published several articles on this topic. C(Pro)3, c(Pro)4, c(Ala)3 and c(Ala)4 were 
found to bind Be2+, Mg2+, Ca2+, Ba2+ and Sr2+.72 
 
1.2. INTRODUCTION IN CALIXARENE’S CHEMISTRY  
 
The development of calixarene’s chemistry was initially closely related to the development of 
polymer chemistry. In attempts to find a better synthetic way to obtain bakelite resins (Figure 
10), chemists have tried various conditions to condens phenol and formaldehyde. 
 
Figure 10. Structural fragments of Bakelite. 
 Zinke and Ziegler in 1942 came to the idea of blocking pairs of phenol groups with alkyl groups 
to reduce the possibility of branching, which is the first method of obtaining pure calixarenes.73 
Methods of preparation were published without structure because they were not yet sure 
whether they were cyclic or linear oligomers. Two years later, they proposed a cyclic tetramer 
structure. After that, petroleum oil company Petrolite became involved in the research, which 
became interested in these products as crude oil and water emulsion compounds. Researchers 
of the company in 1974 issue a patent for a new method of obtaining cyclic tetramers, but ten 
years later it becomes clear that their method actually generates octamer. Synthetic methods of 
preparation of these compounds were optimized by D. Gutsche, which examined a variety of 
phenol derivatives and searched for a wide range of reaction conditions to ensure the most 
efficient, obtaining a basic calixarene basket. The protocols mentioned in his works are 
nowadays used as reference methods for the synthesis of basic calixarenes.  
Exist more than one structural conformations of calixarenes (Figure 11). The most stable one 
is called a cone.  
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Figure 11. Structural conformations of Calix[4]arenes. 
 
In this conformation all subunits are equally oriented and the lower rim, if the subunits are not 
substituted, is fully bonded by hydrogen bonds. NMR spectra of calixarenes in cone 
conformation are extremely simple because of the present Cn symmetry so that only one subunit 
is visible. The proton spectrum of the p-tert-butyl-calix[4]arene in deuterated chloroform is 
shown in Figure 12. The 13C spectrum is also very simple and has only 7 signals. If other 
conformations are present, spectra become more complicated.74 The spectrum appearance can 
be influenced by temperature and solvent, which is related to the conformations that the 
molecule may occupy. 
 
 
Figure 12. 1H NMR spectrum of p-tert-butyl-calix[4]arene in chloroform. 
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1.2.1. The synthesis of basic "basket" and derivatization of calixarenes 
1.2.1.1. Synthesis of basic "basket" 
 
One of the reasons why calixarenes are so explored is certainly the simple formation of basic 
cyclic oligomers. Unlike other similar compounds such as cucurbits or porphyrins, basic 
calixarenes are obtained very easily and are now commercially available at an affordable price. 
The synthesis of calix[4]arenes, calix[6]arenes and calix[8]arenes is based on a base catalyzed 
condensation of formaldehyde and p-tert-butylphenol. As can be seen in Scheme 11, the 
reactants are equal in all syntheses, and various products are obtained in excellent yields. The 
difference is, of course, in the reaction conditions and the stoichiometric ratio of the reactants 
as shown by Gutsche.75 
 
 
Scheme 11. Synthesis of basic Calixarenes. 
 
1.2.1.2. Derivatization of calixarene’s lower rim 
 
Calixarenes with free hydroxyl groups do not exhibit significant receptor, catalytic and similar 
properties. To achieve such properties, it is necessary to make structural modifications to the 
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baskets or to functionalize the calixarenes. The two most common approaches are the 
modification of the hydroxyl group or the benzene ring pair relative to the hydroxyl group. In 
the hydroxyl group, the most important are reactions of esterification and translation into ether 
by various modifications of Williamson's synthesis. Ethers are much more frequent because the 
reactions can be better controlled, and the C-O-C bond is much more stable than the ester. The 
most commonly used is the reaction of sodium hydride and acyl chloride as well as the reaction 
of anhydride acid catalyzed by the addition of sulfuric acid.76 The results of these reactions are 
quite unpredictable with regard to the degree of functionalization and conformation of the 
products, which is probably partly responsible for the steric influence of the ester fragments.77 
An interesting example of the reaction of the p-tert-butyl-calix[4]arenes with 3,5-
dinitrobenzoyl chloride provides a whole range of products depending on minor changes in 
reaction conditions (Scheme 12).78 
 
 
Scheme 12. Distribution of the reaction product of the p-tert-butyl-calix[4]arenes with 3,5-
dinitrobenzoyl chloride depending on the reaction conditions.78 
 
Using the imidazole as a base, a conical monoester is obtained, while using 1-methylimidazole, 
syn and anti 1,2-diesters may be formed depending on the solvent used. This example also 
shows one of the problems in the synthetic modifications of calixarenes, which is that besides 
the standard factors such as the compatibility of the reaction conditions and the present 
functional groups, has also been taken into account the stereochemical outcome of the reaction 
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as well as the functionalization degree. When choosing reaction conditions, it is best to rely on 
a large number of prior studies in which the reaction outcome was investigated in detail with 
respect to the reagents / conditions under which the reaction was conducted. 
Much more frequent derivatization is carried out by alkylation than by acylation reactions. 
When introducing alkyl groups through ether bonds to the lower rim of the calix[4]arenes, a 
whole series of methods have been developed that for particular substrates result in the 
emergence of selectively functionalized products. When preparing monoalicylic ethers, sodium 
hydride is most frequently used in toluene with an alkylating reagent.79 Although pKa1 and 
pKa2 are quite different for phenolic groups of calixarenes and is very difficult to avoid multiple 
functionalization. The reason is that pKa1 of the starting compound and pKa1 of monoalkylated 
product are comparable since monoanion of the single alkylated derivative is stabilized by 
hydrogen bonds with the two adjacent hydroxyl groups (Figure 13).80 
 
 
Figure 13. Hydrogen bonds in monoanion a) Unfunkcionalized and b) Monoalkylated calix[4]arenes.80 
 
Tetrasubstituted alkyl calixarenes in the conformation of the cone are obtained by reaction with 
an excess of alkylating agent (about 4 equivalents per group) with sodium hydride as a base and 
tetrahydrofuran as a solvent. In these conditions, it has been found that the only tetra-substituted 
product is produced in the desired conformation. In addition to ordinary alkyl substituents, 
previously prepared branched esters such as bromoacetate esters, substituted bromoacetamides, 
substituted chloroacetones and the like can be introduced.81 In such cases mild bases such as 
potassium carbonate in solvents such as acetone or acetonitrile are used. Alkylating reagents 
are then used in high excess and the reactions last for several days at reflux temperature. 
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1.2.2. Calixarenes as hosts 
 
Calixarenes have been recognized as suitable parent compounds for the synthesis of a wide 
variety of ionophores and molecular receptors almost thirty years ago.82-86 By the appropriate 
choice of the introduced donor atoms and the number of the repeating phenol units notable 
selectivity and high affinity towards variety of guests can be achieved.85,87,88 The remarkable 
hosting abilities of calixarene derivatives have opened a path towards the design of specific 
receptors which could, for instance, be used in waste water treatment (the removal of toxic, 
heavy-metal ions).89 Also, by properly choosing the substituents, one can prepare ion-selective 
ligands which may be useful for analytical purposes.88,90 The receptor affinity towards 
particular cation is affected by several factors, the most important being the nature of the 
substituents on phenolic oxygen atoms forming the cation-binding site85,86 and the compatibility 
of the size of this site with that of the metal ion.85 In addition, the binding process is often 
strongly influenced by the solvation of the reactants and the complex(es) formed.91-92 As shown 
in the literature,93-96 the specific solvent-ligand and solvent-complex interactions, i.e. inclusion 
of the solvent molecule in a calixarene hydrophobic cavity, can play a very important role in 
determining the complexation equilibrium. In derivatives having substituents with both, a 
hydrogen-bond acceptor (carbonyl group) and a hydrogen-bond donor (e.g. –NH– group in 
secondary amides), intramolecular NH···O=C hydrogen bonds are formed.97 These bonds need 
to be disrupted upon cation complexation and that was shown to have remarkable effect on the 
macrocycle binding abilities.98 
 
1.3. PEPTIDOCALIXARENES 
 
The ion-binding affinities of a cyclic peptides are often reduced by the inadequate orientation 
of amide functional groups. Moreover, the amide groups frequently participate in the formation 
of intramolecular hydrogen bonds and can be solvent exposed in the native conformation of 
cyclopeptide. A way to surpass these problems is to covalently bind cyclopeptide to a molecule 
with a well defined structure via amino acid side chains. In that way a proper orientation of 
amide groups and solvent-shielded binding site can be obtained. The molecules with a rigid 
geometry could be calixarenes and their derivatives. There have been reports in the literature 
on the calixarene amino acid derivatives as anion binders,99-101 but, to the best of our knowledge, 
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there are no examples of derivatives with cyclopeptide substituents which are bound to 
calixarene moiety through amino acid side-chain groups. Most of the investigated compounds 
have amino acid substituents attached to separate subunits of calixarene molecule, and these 
substituents are not covalently connected to each other. The conjugation of peptides to 
calixarenes can be performed through terminal amino or carboxylic group. These two classes 
show different supramolecular properties as shown by Ungaro and co-workers102 that 
synthesized compounds from both classes (Figure 14). The first difference appears in the 
conformational properties. 1H NMR spectra of N-linked compounds are solvent independent 
with no evidence of intramolecular hydrogen bonding in a solution. On the contrary, 1H NMR 
spectra of C-linked compounds in different solvents very clear demonstrate the shift from a 
closed to an open flattened cone conformation on switching from an apolar to a polar solvent. 
The two series of receptors have also different self-assembley properties in the solid state and 
they behave quite differently also in their molecular recognition properties. N-linked 
compounds are able to complex carboxylic acids and ammonium cations but not anionic guests. 
On the contrary, C-linked compounds don’t bind primary ammonium cations but weakly bind 
carboxylate anions. 
 
 
Figure 14. N- and C-linked peptidocalixarenes.102 
 
The same group synthesized also bridged peptidocalixarenes103 (Figure 15). N-bridged 
compounds contain a pseudopeptide bridge in 1,3 positions at the upper rim of a cone 
calix[4]arene consisting of α-amino acids linked through 1,3,5-diethylenetriamine spacer. This 
compound show formation of 1:1 complexes with peptides, simple amino acids and carboxylic 
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acids. On the other hand, C-bridged compounds were shown to possess high selectivity for 
carboxylate and no interaction with corresponding carboxylic acids. 
 
 
Figure 15. Structure of bridged peptidocalixarenes.103 R= H, CH3, CH2C6H5. 
 
Ungaro showed also that calix[4]arene amino acid can be easly incorporated in linear and cyclic 
peptides (Figure 16) via solid-phase synthetic protocols.102 
 
 
Figure 16. Peptidocalixarenes containing calix[4]arene amino acid.102 
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Soltani and co-workers104 synthesized water-soluble peptidocalix[4]arenes (Figure 17) by 
incorporating arginine-rich short narrow groove binding residues on the lower rim of 
calixarene’s scaffold with a goal of recognizing well-matched and mismatched DNA duplexes. 
By fluorescence measurments they confirmed the high afiinity of this compounds for DNA. 
 
 
Figure 17. Structure of water-soluble, arginine-rich peptidocalix[4]arenes.104 
 
 
Varma et el.105 prepared series of tripeptoid and tetrapeptoid calix[4]arenes (Figure 18). By 
NMR and UV-VIS titrations they confirmed binding affinities toward different cations such as 
Cr3+, Mn2+, Fe2+, Co2+, Ni2+, Hg2+, Zn2+. Ag+, Pb2+, Cd2+, Na+, K+, Ca+, Al3+ and Cu2+. 
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Figure 18. Structure of calixarene peptoid.105
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§ 2. AIMS 
In the last years, there has been a growing interest in the development of efficient and selective 
receptors of charged species and many cyclic and acyclic molelules with ion binding capacity 
have been investigated. Although most of the research regarding the complexation of ionic 
species by a variety of receptors has been focused on cation binding, recently anion recognition 
has become an intensively-studied area of supramolecular chemistry due to the ubiquitous role 
that anionic species play in biology, medicine, catalysis and the environment.106  
The hydrogen bond is the most common non-covalent interaction employed in the design of 
anion receptors and organic compounds containing nitrogen atoms, such as amines, amides, as 
well as urea, thiourea and guanidine derivatives are used as hydrogen bond donors.107 
Among them, cyclopeptides are of particular interest due to their occurrence in nature, the 
presence of peptide functional groups, and the possibility of introducing a range of amino-acid 
side-chain substituents able to give additional contributions to anion binding.106,108 
A particular type of cyclopeptides are homocyclopeptides, i.e. peptides with multiple 
occurrences of a single amino acid residue. As these compounds may potentially form 
symmetric coordinating spheres around anion, which could result in receptors with high affinity 
for anions.  
However, to the best of our knowledge they are still poorly investigated from the points of view 
of both synthesis and characterization and affinity towards anions. 
Aim of this PhD thesis is the synthesis of homocyclopeptides bearing functional groups on the 
side chains able to enhance the binding affinity and selectivity of these receptors for anions. 
Specific goals are: 
1) To prepare linear precursors comprised of 4-6 amino acid residues by standard solution-
phase peptide synthesis using three dimensional orthogonal protecting schemes (Figure 
19). 
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Figure 19. Structure of linear precursors 
 
 
2) To investigate various strategies of head-to-tail macrocyclization and to find the 
optimal experimantal conditions to prepare cyclic tetra-, penta- and hexapeptides 
(Figures 20 and 21). 
 
 
 
Figure 20. Structures of cyclic tetra-, penta- and hexaserines. 
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Figure 21. Structures of cyclic tetra-, penta- and hexalysines. 
 
3) To study the complexation abilities of the above mentioned compounds towards 
various ions (cations, halides and molecular anions such as NO3–, ClO4–, HSO4–, 
H2PO4–) by using an integrated approach including microcalorimetric, 1H NMR and 
ESI-MS titrations as well as molecular dynamics simulations. Microcalorimetric 
measurements are extremely informative, providing the complexation enthalpy, and the 
standard entropy.109 The groups forming binding site can be identified by 1H NMR 
spectroscopy. Information about complex stoichiometry can be obtained by processing 
titration data and also by mass spectrometry. 
4) To conjugate the cyclic peptides through side chain functional groups to rigid structures 
such as calixarene derivates in order to enhance their binding capacity and overcome 
their conformational freedom. The choice of serine, lysine and aminoalanine as starting 
materials is brought by the necessity to have a functionalized side chain in order to bind 
the cyclic compounds to calixarenes. 
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§ 3. EXPERIMENTAL SECTION 
3.1. MATERIALS AND METHODS 
 
All solvents and reagents were purchased from Sigma-Aldrich, Carbolution, Fluorochem or 
Merk and were used without further purification. Solvents were of HPLC grade. 
Analytical Thin Layer Chromatography TLC was performed on silica gel 60 F254 precoated 
aluminum sheets (0.2 mm layer; Merck, Darmstadt, Germany); components were detected 
under an UV lamp (λ 254 nm) and by spraying with a cerium sulfate/ammonium molybdate 
solution or with a ninhydrin solution [5% (w/v) ninhydrin in ethanol], followed by heating at 
about 150 °C. 
Silica Gel 60, 40-63 μm (Merk, Darmstadt, Germany) was used for flash chromatography. 
NMR spectra were acquired at 400.13 and 100.61 MHz on a Bruker Advance 400 spectrometer 
(Bruker, Karlsruhe, Germany) interfaced with a workstation running a Windows operating 
system and equipped with a TOPSPIN software package. 1H chemical shifts (δ) are given in 
parts per million (ppm) and are referenced to the solvent signals. Solutions of peptide 
complexes with ions were prepared by dissolving ligand in deuterated solvent followed by the 
addition of appropriate salt dissolved in the same deuterated solvent. Sonification of the 
solutions was used to ensure complete complexation. 1H NMR titrations were processed by 
HypNMR program. 
Matrix assisted laser desorption/ionization spectra (MALDI-TOF) were acquired on a Bruker 
Microflex LT Spectrometer. Electrospray ionization mass spectra (ESI-MS or ESI-Q-TOF-MS) 
were recorded on a Thermo Finnigan LCQ Advantage spectrometer (Hemel Hempstead, 
Hertfordshire, UK) and Agilent 1200. 
HPLC were performed using an Amersham pharmacia biotech (P900) liquid chromatographer 
connected to an UV-VIS detector; chromatographic conditions were set as follows: column for 
analytical HPLC, Jupiter RP-18 (10 µm proteo 90A size: 250x4.60 mm, Phenomenex); column 
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for semipreparative HPLC, Jupiter RP-18 (10 µm proteo 90A size: 250x10 mm, Phenomenex); 
detector λ 226 and 280 nm; mobile phase: A (0.1 % TFA/H2O) and B (CH3CN) gradient elution 
from 5 % to 100 % B in 60 min.  
The following solvents were used for physico-chemical measurements: mQ water, methanol 
(J.T. Baker, HPLC grade and Sigma-Aldrich, spectroscopic grade), CH3CN (Sigma-Aldrich, 
spectroscopic grade). In the 1H NMR spectroscopy, deuterated DMF (Sigma-Aldrich > 99.8%) 
and deuterated CD3CN (Sigma-Aldrich > 99.8) were used as solvents. 
Microcalorimetric measurements were conducted with an isothermal titration calorimeter 
Microcal VP-ITC at 25.0 °C. The calorimeter was calibrated electrically, and its reliability was 
additionally checked by carrying out the complexation of barium(II) by 18-crown-6 in aqueous 
medium at 25 °C. The results obtained (log K = 3.75, ΔrH = –31.7 kJ mol–1) were in excellent 
agreement with the literature values (log K = 3.73, ΔrH = –31.5 kJ mol–1).1 Thermograms were 
processed using the Microcal OriginPro 7.0 program. 
In the calorimetric studies, the enthalpy changes were recorded upon stepwise additions of 
acetonitrile solution of salts into solution of ligand (V0 = 1.4182 cm3). The heats measured in 
the titration experiments were corrected for heats of titrant dilution obtained by blank 
experiments. The dependence of successive enthalpy changes on the titrant volume was 
processed by non-linear least-squares fitting procedure using OriginPro 7.5 program. All 
measurements were repeated three or more times. 
The molecular dynamics simulations were carried out by means of the GROMACS package 
(version 2016.4). Intramolecular and nonbonded intermolecular interactions were modelled by 
the OPLS-AA (Optimized Parameters for Liquid Simulations-All Atoms) force ﬁeld. The linear 
and cyclic peptide ligands, and their anion complexes were solvated in cubical boxes containing 
between 1800 and 2500 molecules of acetonitrile or DMF, with periodic boundary conditions. 
The solvent boxes were equilibrated prior to inclusion of ligands and their complexes with the 
box density after equilibration in all cases being close to the experimental one within 2 %. 
During the simulations of the systems comprising anion-ligand complexes, 
tetramethylammonium (TMA) cation was included to neutralize the box. The TMA counterion 
was kept ﬁxed at the box periphery whereas the complex was initially positioned at the box 
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center. In all simulations an energy minimization procedure was performed followed by a 
molecular dynamics simulation in NpT conditions for 50.5 ns, where the first 0.5 ns were not 
used in data analysis. The Verlet algorithm with a time step of 1 fs was employed. The cutoff 
radius for nonbonded van der Waals and short-range Coulomb interactions was 16 Å. Long-
range Coulomb interactions were treated by the Ewald method as implemented in the PME 
(Particle Mesh Ewald) procedure. The simulation temperature was kept at 298 K with the Nosé-
Hoover algorithm using a time constant of 1 ps. The pressure was kept at 1 bar by Martyna-
Tuckerman-Tobias-Klein algorithm and the time constant of 1 ps.  
 
3.2. GENERAL PROCEDURES 
3.2.1. General procedure A: synthesis of succinimidyl ester110 
 
 
 
A round-bottom flask was filled with N-protected amino acid A (1.0 mmol), NHS (1.1 mmol), 
dissolved in CH2Cl2 (DCM, 15 mL). A solution of DCC (1.1 mmol) in DCM (10 mL) was 
added dropwise. The resulting mixture was stirred at 0° C for 4 h and left in a refrigerator 
overnight. The next day, the N, N′-Dicyclohexylurea (DCU) precipitated was filtered off and 
the solvent was removed on a rotary evaporator. The residue was dissolved in ethyl acetate 
(EtOAc) and the remaining precipitate was filtered off. The solution was washed with NaHCO3 
(0.5 M, 15 mL), H2O (15 mL), HCl (0.5 M, 15 mL), and H2O (15 mL), dried over anhydrous 
Na2SO4, filtered and the solvent was removed on a rotary evaporator. The crude succinimidyl 
ester B was used in the coupling step without additional purification.   
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3.2.2. General procedure B: peptide bond formation through succinimidyl ester110 
 
 
A round-bottom flask was charged with amino acid C (1.0 mmol), NaHCO3 (2.2 mmol) and 
THF-H2O (1:1, 10 mL). A solution of succinimidyl-activated ester B (1.1 mmol) in THF (7 
mL) was added dropwise to the mixture, and the reaction was stirred at RT for 1–2 days. THF 
was removed under reduced pressure and the reaction mixture was acidified with HCl (0.1 M) 
to pH 7. The product was extracted with EtOAc (3×20 mL). The reunited organic layers were 
washed with water (15 mL) and dried over anhydrous Na2SO4. After filtration and evaporation 
of the solvent, the product D was purified by flash column chromatography on silica gel. 
 
 
3.2.3.  General procedure C: synthesis of methyl ester111 
 
 
 
A solution of MeOH (5 mL) and SOCl2 (2.0 mmol) was stirred for 30 minutes at 0°C. Reagent 
A (1.0 mmol) was then added and the mixture was stirred at RT overnight. 
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Solvents were removed under reduced pressure; obtained crude solid was dissolved in EtOAc 
and washed with a saturated solution of NaHCO3 (5 mL) and H2O (5 mL). Organic layer was 
dried over anhydrous Na2SO4 and evaporated under reduced pressure to obtain product E. 
 
 
3.2.4.  General procedure D: cleavage of methyl ester112 
 
 
 
Reagent E (1.0 mmol) and LiOH×H2O (2.0 mmol) were added to a solution of MeOH/H2O 
(3:1, 12 mL). Reaction mixture was stirred at RT for 2 hours and monitored by TLC until the 
complete consume of reagent E. 
The obtained crude solid, after removal of solvents, was dissolved in EtOAc (5 mL) and washed 
with HCl (0.1 M, 5 mL) and H2O (2×5 mL). Organic layer was dried over Na2SO4 and 
evaporated under reduced pressure to give product A. 
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3.2.5.  General procedure E: cleavage of Fmoc protecting group113 
 
 
 
To a solution of reagent E (1.0 mmol) in EtOH (50 mL), DEA (10.0 mmol) was added dropwise. 
Reaction mixture was stirred at RT overnight and monitored by TLC. EtOH and DEA were 
removed under reduced pressure to obtain a crude product that was then dissolved in H2O (10 
mL). Remaining DEA and by-product of the reaction were extracted with DCM (2×10 mL) and 
inorganic layer was then freeze-dried to give the product F that was used in the next step without 
further purification. 
 
 
3.2.6.  General procedure F: cleavage of CbZ protecting group114 
 
 
Mixture of reagent E (1.0 mmol) and Pd/C (10wt. %) in EtOH (15 mL) was maintained under 
H2 flow for 2 hours. Catalyst was then filtered through celite bed and solvent was removed 
under reduced pressure to obtain pure product F.   
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3.2.7.  General procedure G: peptide bond formation through HOBt ester115 
 
 
Reagent A (1.1 mmol) and HOBt (1.5 mmol) were dissolved in DMF (10 mL), cooled at 0 °C 
and maintained under stirring for 15 minutes. Were then added F (1.0 mmol.), HBTU or EDC 
× HCl (1.5 mmol) and after 5 minutes TEA (5 mmol). 
Reaction mixture was stirred at RT for 24 hours and monitored by TLC until the complete 
consume of reagent F. Product G was precipitated adding cold water (10 mL) dropwise under 
stirring. Further purifications were performed by extraction with DCM (3×10 mL) and flash 
column chromatography in isocratic flow (10 % MeOH/DCM). 
 
 
3.2.8.  General procedure H: cleavage of tBu protecting group116 
 
 
 
To a solution of H (1.0 mmol) in DCM (1 mL) aqueous phosphoric acid (10.0 mmol) was added 
dropwise. The mixture was stirred for 4 h at room temperature. Then, the solution was 
neutralized with NaHCO3 (0.5 M, 5 mL) and water (10 mL) was added. The mixture was 
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extracted with EtOAc (3×5 mL). Combined organic phases were dried over Na2SO4 and 
concentrated in vacuum to give the desired product I. 
 
 
3.2.9. General procedure I: peptide bond formation through succinimidyl ester and 
protected amino acid on C-terminus107 
 
 
Succinimidyl ester B (1.0 mmol) was dissolved in DMF (5 mL) and resulting mixture was 
cooled at 0 °C. TEA (2.0 mmol) and amino acid F were added and reaction mixture was stirred 
at RT overnight. Cold H2O (5 mL) was added to the solution to precipitate G as a white powder, 
which was filtered using sintered funnel (D4), washed several times with cold water and dried 
under reduced pressure. 
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3.2.10. General procedure J: ion-assisted head-to-tail cyclization through DEPBT ester29 
 
 
 
To a solution of reagent J (1.0 mmol) and DEPBT (1.1 mmol) in DMF (500 mL) were added 
salt (5 or 100 mmol) dissolved in the minimum amount possible of H2O, and TEA (at least 2 
mmol) to reach pH 8. Reaction mixture was stirred at RT 3-5 days. Solvents were removed 
under reduced pressure and obtained crude solid was dissolved in EtOAc (10 mL) and washed 
with saturated solution of NaHCO3 (5 mL), H2O (5 mL), HCl (0.1 M, 5 mL), and H2O (5 mL) 
H2O. Organic layer was dried over Na2SO4 and evaporated under reduced pressure to obtain 
product K. Further purifications were performed by flash column chromatography (gradient 
flow of 1-10%.MeOH/DCM). 
 
 
3.3. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-
butyloxycarbonyl-L-lysine succinimidyl ester (1) 
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DCC (3.39 g, 16.4 mmol) dissolved in DCM (15 mL) was added dropwise to a solution of 
Fmoc-Lys(Boc)-COOH (7.00 g, 14.9 mmol) and NHS (1.89 g, 16.4 mmol) in DCM (15 mL). 
Following General procedure A, product 1 was obtained as a white powder (8.17 g, 14.5 mmol, 
97 %) and was used in the next step without further purification. 
Rf: 0.75 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.09 (d, 1H), 7.90 (d, 2H), 7.72 (t, 2H), 7.43 (t, 2H), 
7.34 (t, 2H), 6.81-6.77 (m, 1H), 4.40-4.37 (m, 1H), 4.36-4.34 (m, 2H), 4.31-4.26 (m, 1H), 2.92 
(br. s, 2H), 2.82 (br. s, 4H), 1.92-1.79 (m, 2H), 1.41 (br. s, 9H), 1.38-1.19 (m, 2H), one signal 
(2H) is covered by signal of Boc. 
 
 
3.4. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysine 
 
 
 
Fmoc-Lys(Boc)-COOH (0.10 g, 0.2 mmol) was dissolved in THF (10 mL) and under magnetic 
stirring 1-octanthiol (3.64 mL, 2.1 mmol) and catalytical amount of DBU (0.01 mL, 0.006 
mmol) were added. Resulting mixture was stirred at RT for 24 hours and solvent was then 
removed under reduced pressure. Crude was dissolved in EtOAc and, after extraction, inorganic 
phase was evaporated. In this way was not possible to obtain the desired product. 
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3.5. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysine (2) 
 
 
 
Fmoc-Lys(Boc)-COOH (0.10 g, 0.2 mmol) was dissolved in EtOH (20 mL) and under magnetic 
stirring Et2NH (2.0 mL, 0.02 mmol) was added. Resulting mixture was stirred overnight at RT 
and solvent was then removed under reduced pressure. Crude was dissolved in EtOAc and, after 
extraction, inorganic phase was evaporated. In this way the desired product 2 (0.04 g, 0.18 
mmol, 85 %) was obtained as a white powder. 
Rf: 0.05 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 3.68 (t, J = 6.1 Hz, 1H), 3.04 (t, J = 6.7 Hz, 2H), 1.92 
– 1.73 (m, 2H), 1.49 (dt, J = 13.7, 6.9 Hz, 2H), 1.39 (br s, 9H), 1.35-1.30 (m, 2H). 
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3.6. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine (3) 
 
 
 
H2N-Lys(Boc)-COOH (2) (3.32 g, 13.5 mmol) and NaHCO3 (2.58 g, 30.7 mmol) were 
dissolved in water (38 mL) and THF (76 mL). The rsulting mixture was stirred 10 min at 0 °C 
and after amino acid 1 (7.63 g, 13.5 mmol) dissolved in THF (38 mL) was added dropwise. 
Reaction mixture was left 24 hours at RT. The resulting solution was acidified until pH 6 using 
HCl (1.0 M) and THF was removed under reduced pressure. Extraction with DCM (3×100 mL) 
was performed and the reunited organic phases were washed with water (100 mL), dried over 
MgSO4 and evaporated under reduced pressure. Resulting crude product was purified by flash 
column chromatography (gradient flow 0-10% MeOH/DCM) to obtain 3 as a white powder 
(7.15 g, 12.6 mmol, 93 %). 
Rf: 0.53 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 7.90 (d, J = 7.2 Hz, 2H), 7.73 (t, J = 7.6 Hz, 2H), 7.56 
(t, 1H), 7.42 (t, J = 7.6 Hz, 2H), 7.34 (t, J = 7.6 Hz, 2H), 6.76 (t, 1H), 6.69 (t, 1H), 4.32-4.23 
(m, 3H), 3.96-3.90 (m, 2H), 2.89-2.84 (m, 4H), 1.70-1.65 (m, 2H), 1.54-1.51 (m, 2H), 1.37 (br. 
s, 9H), 1.35 (br. s, 9H) 1.35-1.21 (m, 8H). 
13C NMR (300 MHz, DMSO-d6) δ/ppm: 171.1, 155.9, 155.5, 143.9, 143.7, 140.7, 128.9, 
127.6, 127.3, 127.1, 125.4, 121.4, 120.1, 77.3, 65.6, 58.1, 54.9, 53.1, 46.7, 31.7, 29.5, 29.3, 
28.3, 22.9, 22.5. 
ESI-Q-TOF: [M+Na] + Calcd: 719.36, found 719.48. 
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3.7. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine 
succinimidyl ester (4) 
 
 
 
DCC (2.33 g, 11.3 mmol) dissolved in DCM (20 mL) was added dropwise to a solution of 
Fmoc-Lys(Boc)-Lys(Boc)-COOH (3) (7.15 g, 10.3 mmol) and NHS (1.31 g, 11.3 mmol) in 
DCM (60 mL). Following General procedure A product 4 was obtained as a white powder (7.07 
g, 8.9 mmol, 86 %) that was used in the next step without further purification. 
Rf: 0.93 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.57 (d, 1H), 7.90 (d, 2H), 7.73 (d, 2H), 7.50 (d, 1H), 
7.43 (t, 2H), 7.34 (t, 2H), 6.81-6.77 (m, 2H),  4.62-4.55 (m, 1H), 4.30-4.18 (m, 3H), 4.12-3.96 
(m, 1H), 2.98-2.92 (m, 4H), 2.82 (br. s, 4H), 1.86-1.77 (m, 2H), 1.72-1.63 (m, 4H), 1.55-45 (m, 
2H), 1.37 (br. s, 9H), 1.34(br. s, 9H), 1.28-1.21 (m, 6H). 
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3.8. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysine (5) 
 
 
 
H2N-Lys(Boc)-COOH (2) (2.41 g, 9.8 mmol) and NaHCO3 (1.64 g, 19.6 mmol) were 
dissolved in water (38 mL) and THF (76 mL). The rsulting mixture was stirred 10 min at 0 °C 
and after ester 4 (7.07 g, 8.9 mmol) dissolved in THF (38 mL) was added dropwise. 
Following General procedure B, crude product was obtained and purified by flash column 
chromatography (10% MeOH/DCM) to obtain 5 as a white powder (4.22 g, 4.4 mmol, 50 %). 
Rf: 0.34 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.12 (s, 1H), 7.89 (d, J = 7.5 Hz, 2H), 7.73 (t, J = 6.4 
Hz, 2H), 7.50 (s, 1H), 7.41 (t, J = 7.3 Hz, 2H), 7.32 (t, J = 7.4 Hz, 2H), 6.79 (d, J = 76.4 Hz, 
2H), 4.23 (d, J = 7.0 Hz, 3H), 4.14 (s, 1H), 4.00 (s, 1H), 3.77 (s, 1H), 2.86 (d, J = 18.6 Hz, 6H), 
1.65 (s, 3H), 1.50 (s, 3H), 1.36 (br s, 18H), 1.33 (br s, 9H), 1.33-1.10 (m, 3H). 
13C NMR (300 MHz, DMSO-d6) δ/ppm: 129.0, 127.4, 127.3, 121.4, 120.1, 108.8, 76.7, 46.8, 
28.4. Some peaks are not visible. 
ESI-Q-TOF: [M+Na] + Calcd: 947.51, found 947.72. 
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3.9. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysine succinimidyl ester (6) 
 
 
 
DCC (1.01 g, 4.9 mmol) dissolved in DCM (20 mL) was added dropwise to a solution of 5 (4.20 
g, 4.4 mmol) and NHS (0.6 g, 4.9 mmol) in DCM (50 mL). Following General procedure A 
product 6 was obtained as a white powder (3.65 g, 3.6 mmol, 81 %) that was used in the next 
step without further purification. 
Rf: 0.91 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.57-8.52 (m, 1H), 7.89 (d, J=7.4 Hz, 2H), 7.72 (t, 
J=6.1 Hz, 2H), 7.53-7.48 (m, 1H), 7.42 (t,J= 7.5 Hz, 2H), 7.33 (t, J= 7.4 Hz,2H), 6.80-6.67 (m, 
3H),  4.62-4.50 (m, 1H), 4.33-4.18 (m, 4H), 2.93-2.92 (m, 6H), 2.91-2.75 (m, 4H), 1.86-1.77 
(m, 3H), 1.75-1.55 (m, 5H), 1.52-1.45 (m, 3H), 1.37 (br. s, 18H), 1.34 (br. s, 9H), 1.29-1.21 (m, 
7H), one signal is covered by solvent. 
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3.10. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-
lysine (7) 
 
 
 
H2N-Lys(Boc)-COOH (2) (1.06 g, 5.2 mmol) and NaHCO3 (0.87 g, 10.3 mmol) were dissolved 
in water (30 mL) and THF (60 mL). The rsulting mixture was stirred 10 min at 0 °C and after 
ester 6 (4.90 g, 4.7 mmol) dissolved in THF (30 mL) was added dropwise. Following a General 
procedure B crude product was obtained and purified by flash column chromatography (10% 
MeOH/EtOAc) to obtain 7 as a white powder (1.00 g, 0.8 mmol, 18%). 
Rf: 0.31 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.57-8.52 (m, 1H), 7.89 (d, J=7.4 Hz, 2H), 7.72 (t, 
J= 6.1 Hz, 2H), 7.53-7.48 (m, 1H), 7.42 (t,J= 7.5 Hz, 2H), 7.33 (t, J= 7.4 Hz, 2H), 6.80-6.67 
(m, 4H),  4.37-4.09 (m, 6H), 3.95-3.91 (m, 1H), 2.95-2.91 (m, 8H), 1.78-1.60 (m, 6H), 1.59-
1.42 (m, 6H),1.37 (br. s, 36H), 1.34-1.15 (m, 12H). 
ESI-Q-TOF: [M+Na] + Calcd: 1175.66, found: 1176.15. 
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3.11. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysine succinimidyl ester (8) 
 
 
 
DCC (8.95 g, 43.4 mmol) dissolved in DCM (100 mL) was added dropwise to a solution of 
CbZ-Lys(Boc)-COOH (15.00 g, 39.4 mmol) and NHS (4.99 g, 43.4 mmol) in DCM (350 mL). 
Following a General procedure for a synthesis of succinimidyl ester, product 8 was obtained as 
a white powder (17.86 g, 37.4 mmol, 95 %) and was used in the next step without further 
purification. 
Rf: 0.99 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.04 (d, J = 7.5 Hz, 1H), 7.42 – 7.27 (m, 5H), 6.77 (t, 
J = 4.9 Hz, 1H), 5.07 (s, 2H), 4.45 – 4.35 (m, 1H), 2.89 (d, J = 5.5 Hz, 2H), 2.81 (s, 4H), 1.88 
– 1.69 (m, 2H), 1.44-1.36 (m, 4H), 1.37 (s, 9H), one peak is covered by Boc. 
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3.12. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine tert-butyl ester (9) 
 
 
 
Compound 8 (5.40 g, 11.3 mmol) was dissolved in DMF (40 mL) and resulting mixture was 
cooled at 0 °C. TEA (3.6 mL, 20.6 mmol) and NH3+Cl—Lys(Boc)-COOtBu (3.50 g, 10.3 mmol) 
were added and reaction mixture was stirred at RT overnight. As described in a General 
procedure I, product 9 (6.05 g, 9.1 mmol, 81 %) was isolated as a white powder and used in the 
next step without further purification. 
Rf: 0.93 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.07 (d, J = 6.9 Hz, 1H), 7.38 – 7.22 (m, 6H), 6.67 
(br s, 1H), 5.00 (s, 2H), 4.08 – 3.93 (m, 2H), 1.69 – 1.44 (m, 4H), 1.36 (br s, 9H), 1.34 (br s, 
18H), 1.29 – 1.16 (m, 8H), one signal is covered by signal of DMF. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.6, 171.6, 163.0, 137.3, 128.8, 128.3, 128.0,88.0, 
80.0, 65.9, 54.8, 53.0, 32.1, 31.1, 29.6, 29.4, 28.6, 28.0, 23.1, 22.9. 
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3.13. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysine tert-butyl ester (10) 
 
 
 
Peptide 9 (6.05 g, 7.7 mmol) was dissolved in EtOH (150 mL) and 10wt. % Pd/C (0.61 g) was 
added. In a way described in General procedure F product 10 (5.29 g, 7.5 mmol, 98 %) was 
obtained as a yellowish oil and used in the next step without further purification. 
Rf: 0.03 (10% MeOH/DCM) 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.04 (d, J = 7.7 Hz, 1H), 6.78 – 6.69 (m, 2H), 4.09 
(d, J = 5.8 Hz, 1H), 3.15 (t, J = 6.0 Hz, 1H), 2.89 (q, J = 5.7 Hz, 4H), 1.71-1.61 (m, 1H), 1.60-
1.52 (m, 2H), 1.40 (br s, 9H), 1.37 (br s, 18H), 1.35 – 1.20 (m, 7H) one signal is covered by 
signal of Boc. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 73.6, 72.7, 68.7, 49.8, 43.7, 43.2, 42.7, 38.3, 37.4, 
36.7, 36.5, 35.2, 34.2. 
ESI-Q-TOF: [M+H] + Calcd: 530.70, found: 531.28.  
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3.14. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysine tert-butyl ester (11) 
 
 
 
Succinimidyl ester 8 (3.68 g, 7.7 mmol) was dissolved in DMF (25 mL) and the resulting 
mixture was cooled at 0 °C. TEA (1.9 mL, 14.0 mmol) and peptide 10 (4.00 g, 7.0 mmol) were 
added and reaction mixture was stirred at RT overnight. As described in a general procedure I, 
product 11 (5.42 g, 6.4 mmol, 83 %) was isolated as a white powder and used in the next step 
without further purification. 
Rf: 0.87 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.09 (d, J = 5.8 Hz, 1H), 7.84 (d, J = 7.5 Hz, 1H), 
7.42 – 7.24 (m, 6H), 6.73 (br s, 3H), 5.02 (br s, 2H), 4.29-4.24 (m, 1H), 4.11 – 3.99 (m, 2H), 
1.70 – 1.44 (m, 7H), 1.38 (br s, 9H), 1.36 (br s, 27H), 1.29-1.20 (m, 9H), two signals are covered 
by others. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 72.8, 72.7, 72.6, 70.4, 64.0, 61.2, 61.7, 49.8, 46.0, 
44.6,  43.3, 42.8, 42.7, 38.6, 37.6, 37.3, 36.7, 36.3, 35.2. 
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3.15. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine tert-
butyl ester (12) 
 
 
Tripeptide 11 (5.42 g, 5.8 mmol) was dissolved in EtOH (100 mL) and 10wt. % Pd/C (0.54 g) 
was added. In a way described in General procedure F product 12 (4.54 g, 5.7 mmol, 98 %) was 
obtained as a yellowish oil and used in the next step without further purification. 
Rf: 0.02 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.18 (d, J = 7.4 Hz, 1H), 6.81 – 6.67 (m, 3H), 4.44 – 
4.25 (m, 2H), 3.12 (dd, J = 7.4, 4.8 Hz, 1H), 2.89 – 2.83 (m, 6H), 1.69 – 1.58 (m, 3H), 1.58 – 
1.45 (m, 4H), 1.39 (br s, 9H), 1.37 (br s, 27H), 1.34 – 1.18 (m, 11H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 73.5, 72.7, 72.6, 70.4, 68.7, 49.8, 49.0,43.7, 43.3, 
42.8, 42.5, 38.6, 36.9, 36.7, 34.2. 
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3.16. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine tert-
butyl ester (13) 
 
 
Succinimidyl ester 8 (0.66 g, 1.4 mmol) was dissolved in DMF (7 mL), the resulting mixture 
was cooled at 0 °C. TEA (0.3 mL, 2.5 mmol) and peptide 12 (1.00 g, 1.3 mmol) were added 
and reaction mixture was stirred at RT overnight. As described in a general procedure I, product 
13 (1.26 g, 1.1 mmol, 86 %) was isolated as a white powder and used in the next step without 
further purification. 
Rf: 0.85 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.05 (s, 1H), 7.88 (s, 1H), 7.82 (s, 1H), 7.39-7.31 (m, 
6H), 6.70 (s, 4H), 5.02 (s, 2H), 4.24 (s, 2H), 4.05 (s, 1H), 3.97 (s, 1H), 2.89 – 2.79 (m, 8H), 
1.69 – 1.55 (m, 4H), 1.53-1.39 (m,4H), 1.38 (brs, 9H), 1.36 (brs, 36H), 1.34 – 1.17 (m, 12H), 
one signal is covered by a signal of Boc. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 72.8, 72.7, 72.6, 70.4, 64.0, 61.8, 61.7, 49.8, 49.0, 
46.0, 38.6, 37.3, 36.5, 35.9, 36.7, 35.2. 
ESI-Q-TOF: [M+Na] + Calcd: 1143.69, found: 1144.35. 
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3.17. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysine tert-butyl ester (14) 
 
 
Tetrapeptide 14 (1.26 g, 1.1 mmol) was dissolved in EtOH (60 mL) and 10wt. % Pd/C (0.13 g) 
was added. In a way described in General procedure F, 14 (1.16 g, 1.1 mmol, 99 %) was 
obtained as a yellowish oil and used in the next step without further purification. 
Rf: 0.01 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 4.43 – 4.31 (m, 2H), 4.31 – 4.24 (m, 1H), 3.42-3.36 
(m, 1H), 3.10 – 3.02 (m, 8H), 1.90 – 1.76 (m, 3H), 1.74-1.64 (m, 4H), 1.56-1.49 (m, 11H), 1.48 
(br s, 9H), 1.45 (br s, 36H), 1.42 – 1.33 (m, 6H). 
 
 
3.18. Selective removal of tert-buthyl ester in a presence of Boc protecting 
group 
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CeCl3 x 7H2O (0.04 g, 0.1 mmol) and NaI (0.01 g, 0.1 mmol) were dissolved in CH3CN (5 mL) 
and the resulting mixture was refluxed for 24 hours. After cooling to the RT, peptide (0.06 g, 
0.1 mmol) was added and reflux was continued. Reaction was monitored by TLC (10 % MeOH/ 
DCM) until a spot of the starting material didn't dissapear. Solvent was reduced under reduced 
pressure, resulting crude was dissolved in EtOAc (10 mL) and extracted with water (5 mL). 
Aquous phase, that was containig a product, was evaporated under reduced pressure to obtain 
product 15 (0.05 g, 0.1 mmol, 80 %). 
 
 
Peptide (0.05 g, 0.1 mmol) was dissolved in THF (5 mL) and KOH (0.08 g, 0.2 mmol) was 
added. The resulting mixture was stirred at RT for 3 hours and monitored by TLC 
(hexane/EtOAc = 20/1). Solvent was then removed under the reduced pressure, H2O (5 mL) 
was added and extraction with EtOAc (3 x 10 mL) was done. Reunited organic phases were 
dried over MgSO4 and evaporated. In this way was not possible to obtain wanted product 15. 
 
 
3.19. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysine (16) 
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CeCl3 x 7H2O (1.67 g, 4.5 mmol) and NaI (0.60 g, 3.9 mmol) were dissolved in CH3CN (200 
mL) and the resulting mixture was refluxed for 24 hours. After cooling to the RT, peptide 11 
(3.50 g, 2.9 mmol) was added and reflux was continued. Reaction was monitored by TLC (10 
% MeOH/ DCM) until a spot of the starting material didn't dissapear. Solvent was reduced 
under reduced pressure, resulting crude was dissolved in EtOAc (100 mL) and extracted with 
water (150 mL). Aquous phase, that was containig a product, was evaporated under reduced 
pressure to give a product 16 (0.67g, 0.6 mmol, 20 %). 
 
 
3.20. Selective removal of benzyl ester in a presence of CbZ protecting 
group 
 
 
 
Protected lysine (0.05 g, 0.2 mmol) was dissolved in MeOH (5 mL) and Et3SiH (33 μL, 0.3 
mmol) and 10wt. % Pd/C were added. Reaction was monitored by TLC (10 % MeOH/DCM). 
Catalyst was filtered out and supernatant evaporated under the reduced pressure to give 17 (0.01 
g, 0.1 mmol, 50%). 
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3.21. Synthesis of N-alpha-acetyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine tert-butyl ester (18) 
 
 
Peptide 14 (1.15 g, 1.1 mmol), HOBt (0.21 g, 1.6 mmol), Ac2O (0.21 mL, 2.2 mmol) and TEA 
(0.3 mL, 2.2 mmol) were dissolved in DMF (10 mL) and sonicated for 2 minutes. Enother 2 
equivalents of Ac2O were added and the resulting mixture was sonicated for enother 2 minutes. 
This action was repeated for 5 times. Cold H2O (10 mL) was added to the solution to precipitate 
18 (0.75 g, 0.7 mmol, 63 %) as a white powder, which was filtered using sintered funnel (D4), 
washed several times with cold water and dried under reduced pressure. 
Rf: 0.85 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.02 (d, J = 7.5 Hz, 1H), 7.95 (d, J = 8.0 Hz, 1H), 
7.87 (d, J = 7.3 Hz, 1H), 7.76 (d,J = 7.2 Hz, 2H), 6.85-6.68 (m, 4H), 4.2-4.15 (m, 3H), 4.08-
4.01 (m, 1H), 2.95 – 2.81 (m, 8H), 1.85 (s, 3H), 1.69-1.56 (m, 4H), 1.54 – 1.43 (m, 3H), 1.39 
(br s, 9H), 1.37 (br s, 36H), 1.35-1.30 (m, 5H), 1.28-1.15 (m, 7H), one signal is covered by a 
signal of Boc. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.3, 171.9, 171.8, 156.0, 80.9, 77.8, 53.1, 52.9, 
52.4, 28.7, 28.1, 23.0, some peaks are not visible. 
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3.22. Synthesis of N-alpha-acetyl-L-lysyl-N-epsilon-L-lysyl-N-epsilon-L-
lysyl-N-epsilon -L-lysine tetra-trifluoroacetate salt(19) 
 
 
Peptide 18 (0.75 g, 0.7 mmol) was dissolved in dry DCM (10 mL) and TFA (15 mL) was added 
dropwise  within 45 minutes. The resulting mixture was stirred under inert atmosphere 30 
minutes at 0 °C and enother 60 minutes at RT. Reaction was monitored by TLC (10 % MeOH/ 
DCM). Solvent was removed under the reduced pressure and cold EtOEt (35 mL) was added 
to precipitate 19 (0.70 g, 0.7 mmol, 98 %) as a white powder that, after filtration, was dried in 
exicator over KOH and P2O5 for 36 hours. 
Rf: 0.01 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.15 (d, J = 7.4 Hz, 1H), 8.08 (d, J = 7.8 Hz, 1H), 
7.97 (d, J = 7.9 Hz, 1H), 7.88 (d, J = 7.4 Hz, 1H), 4.30 – 4.20 (m, 2H), 4.20 – 4.10 (m, 2H), 
2.85 – 2.68 (m, 8H), 1.86 (s, 3H), 1.77-1.62 (m, 4H), 1.59 – 1.43 (m, 12H), 1.43 – 1.22 (m, 
8H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 173.8, 172.3, 172.0, 171.8, 158.8, 158.5, 53.0, 52.6, 
52.5, 52.2, 31.9, 31.7, 31.6, 30.8, 27.1, 27.0, 22.8, 22.6, 22.6, some peaks are not visible. 
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3.23. Synthesis of N-alpha-acetyl-N-epsilon-L-lysyl-N-epsilon-L-lysyl-N-
epsilon-L-lysyl-N-epsilon-L-lysine tetrachloride salt methyl ester (20) 
 
 
MeOH (30 mL) was cooled at 0°C and SOCl2 (0.2 mL, 2.1 mmol)  was added dropwise. 
Resulting mixture was stirred at 0 °C for 30 minutes. Peptide 19 (0.60 g, 1.1 mmol) was then 
added and mixture was stirred at RT overnight and enother 3 hours on reflux. Solvent was 
removed under the reduced pressure and the resulting crude was dissolved in EtOAc (30 mL) 
and washed with saturated solution of NaHCO3 (20 mL) and H2O (20 mL). Organic layer was 
dried over MgSO4 and solvent was removed under the reduced pressure to give 20 (0.55 g, 0.8 
mmol, 78 %) as a white solid. 
Rf: 0.02 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 4.39 – 4.17 (m, 4H), 3.63 (s, 3H), 2.83-2.70 (m, 8H), 
1.88 (s, 3H), 1.78-1.75 (m, 2H), 1.4-1.65 (m, 3H), 1.64-1.50 (m, 11H), 1.50 – 1.27 (m, 8H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 52.71, 52.00, 51.87, 48.66, 38.48, 38.47, 38.34, 
26.48, 26.39, 22.27, some peaks are not visible. 
ESI-Q-TOF: [M+H] + Calcd: 586.68, found: 587.38. 
 
 
§ 3. Experimental section 62 
Nikolina Vidović PhD thesis 
3.24. Synthesis of cyclic N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-t-
butyloxycarbonyl-lysyl-N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-
t-butyloxycarbonyl-lysine (L4) 
 
 
Dipeptide 10 (0.10 g, 0.2 mmol) and Na2(PdCl4) (0.29 g, 0.1 mmol) were dissolved in MeOH 
(4 mL) and NaOMe (0.1 mL, 0.5 mmol) was added dropwise. The resulting mixture was stirred 
24 hours at 65 °C. Cold H2O (4 mL) and (PPN)Cl (0.11 g, 0.2 mmol) were added to precipitate 
product L4 (0.01 g, 0.01 mmol, 5 %) as a white solid. 
Rf: 0.73 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.23 – 7.66 (m, 4H), 6.88 – 6.62 (m, 4H), 4.32 – 3.88 
(m, 4H), 2.96 – 2.76 (m, 8H), 1.76 – 1.44 (m, 9H), 1.37 (br s, 36H), 1.25-0.87 (m, 11H), one 
signal is covered by a signal of Boc. 
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3.25. Synthesis of L-lysine methyl ester (21) 
 
 
MeOH (200 mL) was cooled at 0 °C and SOCl2 (3.9 mL, 54.0 mmol) was added dropwise. 
Resulting mixture was stirred at 0 °C for 30 minutes. L-Lysine (6.75 g, 37.0 mmol) was then 
added and mixture was stirred at RT overnight and another 3 hours on reflux. Solvent was 
removed under the reduced pressure and the resulting crude was dissolved in EtOAc (150 mL) 
and washed with saturated solution of NaHCO3 (100 mL) and H2O (100 mL). Organic layer 
was dried over MgSO4 and solvent was removed under the reduced pressure to give 21 (4.62 g, 
28.9 mmol, 78 %) as a white solid. 
Rf: 0.35 (10%MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 3.97 – 3.92 (m, 1H), 3.74 (s, 3H), 2.78 – 2.68 (m, 
2H), 1.90 – 1.76 (m, 2H), 1.65 – 1.54 (m, 2H), 1.53 – 1.31 (m, 2H). 
 
 
3.26. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysine methyl ester (22) 
 
 
In a round bottom flask reagent 21 (4.40 g, 27.5 mmol) and TEA (15.4 mL, 110.0 mmol) were 
dissolved in MeOH (200 mL) and cooled at 0°C under stirring. Solution of Boc2O (6.59 g, 30.3 
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mmol), in DCM (200 mL) was then added dropwise within 10 minutes. After 6 hours at 0°C, 
solvents were removed under reduced pressure. Crude was purified by flash column 
chromatography (isocratic flow of 10% MeOH/DCM). In this way product 22 (4.00 g, 15.4 
mmol, 56%) was isolated as a yellow oil. 
Rf: 0.60 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 3.61 (s, 3H), 3.27 (dd, J = 7.3, 5.7 Hz, 1H), 2.88 (dd, 
J = 12.8, 6.6 Hz, 2H), 1.54 (m, 1H), 1.46 – 1.21 (m, 5H), 1.37 (s, 9H). 
13C NMR (400 MHz, CDCl3,) δ/ppm: 175.77, 155.04, 76.77, 53.38, 50.82, 33.77, 28.78, 
27.74, 21.96, singnal of CH2ε is covered by DMSO. 
 
 
3.27. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine methyl ester (23) 
 
 
 
The product was obtained according to General procedure G using HCl×NH2-Lys(Boc)-
COOMe (3.50 g, 13.4 mmol) and Z-Lys(Boc)-COOH (5.63 g, 14.8 mmol), EDC×HCl (3.85 g, 
20.1 mmol) and HOBt (2.72 g, 20.1 mmol), TEA (7.8 mL 67.0 mmol) and DMF (25 mL) as 
solvent.  
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After precipitation of a crude product, flash chromatography was performed in isocratic flow 
of 10% MeOH/DCM and the product 23 was isolated as white powder (7.91 g, 12.7 mmol, 
95%). 
Rf: 0.70 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.21 (d, J = 7.4 Hz, 1H), 7.40 - 7.25 (m, 6H), 6.75 
(br s, 2H), 5.02 (s, 2H), 4.20 (dd, J = 13.3, 7.9 Hz, 1H), 4.01 (dd, J = 13.0, 8.4 Hz, 1H), 3.61 
(s, 3H), 2.95 – 2.84 (m, 4H), 1.75 – 1.44 (m, 4H), 1.37 (s, 18H), 1.35 – 1.31 (m, 4H), 1.31 – 
1.19 (m, 4H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.62, 172.34, 155.97, 155.66, 137.14, 128.42, 
127.86, 127.80, 77.44, 65.43, 54.39, 51.97, 51.84, 48.69, 31.70, 30.60, 29.32, 29.13, 28.36, 
22.80, 22.72. 
ESI-Q-TOF: [M+Na] + Calcd: 645.76, found: 645.25. 
 
 
3.28. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysine methyl ester (24) 
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Dipeptide 23 (7.91 g, 12.7 mmol) was dissolved in EtOH (200 mL) and 10wt. % Pd/C (0.60 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 24 (6.14 g, 12.6 mmol, 99 %) was obtained as a yellowish oil and used in the next step 
without further purification. 
Rf: 0.01 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.13 (d, J = 7.6 Hz, 1H), 6.84 – 6.69 (m, 2H), 4.35 
(s, 1H), 4.22 (dd, J = 13.5, 8.0 Hz, 1H), 3.62 (s, 3H), 2.94 – 2.84 (m, 4H), 1.75 – 1.44 (m, 4H), 
1.37 (s, 18H), 1.35 - 1.22 (m, 4H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 175.49, 172.71, 167.97, 155.67, 77.44, 77.40, 56.12, 
55.00, 54.36, 54.00, 51.86, 51.68, 45.29, 34.93, 30.86, 29.54, 29.16, 28.37, 22.69, 22.59, 18.65. 
ESI-Q-TOF: [M+Na] + Calcd: 511.31, found: 511.34. 
 
 
3.29. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysine methyl ester (25) 
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The product was obtained according to General procedure G starting with a product 24 (5.63 g, 
11.5 mmol) and Z-Lys(Boc)-COOH (3.96 g, 10.4 mmol), HOBt (2.35 g, 17.3 mmol) and HBTU 
(6.55 g, 17.3 mmol), TEA (6.7 mL 57.6 mmol) and DMF (30 mL) as solvent.  
After precipitation of a crude product, flash chromatography was performed in isocratic flow 
of 10% MeOH/DCM and the product 25 was isolated as white powder (8.81 g, 11.4 mmol, 
99%). 
Rf: 0.74 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.22 (d, J = 7.1 Hz, 1H), 7.84 (d, J = 8.0 Hz, 1H), 
7.42 – 7.21 (m, 6H), 6.80 – 6.70 (m, 3H), 5.02 (s, 2H), 4.27 (dd, J = 13.5, 8.2 Hz, 1H), 4.19 
(dd, J = 13.1, 7.8 Hz, 1H), 3.97 (dd, J = 13.1, 8.4 Hz, 1H), 3.61 (s, 3H), 2.93 – 2.85 (m, 6H), 
1.78 – 1.45 (m, 6H), 1.37 (s, 27H), 1.33 – 1.30 (m, 5H), 1.29-1.23 (m, 7H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm:  172.52, 171.87, 155.66, 137.12, 128.43, 127.86, 
127.77, 77.44, 65.47, 54.00, 52.13, 51.84, 45.80, 28.37, two peaks are covered bby peak of 
DMSO. 
 
 
3.30. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine 
methyl ester (26) 
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Tripeptide 25 (8.81 g, 12.6 mmol) was dissolved in EtOH (200 mL) and 10wt. % Pd/C (0.88 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 26 (8.85 g, 12.3 mmol, 98 %) was obtained as a yellowish oil and used in the next step 
without further purification. 
Rf: 0.01 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.31 (d, J = 7.3 Hz, 1H), 7.97 (d, J = 8.3 Hz, 1H), 
6.75 (t, J = 9.1 Hz, 3H), 4.31 (d, J = 6.8 Hz, 1H), 4.25 – 4.13 (m, 1H), 3.62 (s, 3H), 3.11 (dd, J 
= 7.4, 4.7 Hz, 1H), 2.88 (t, J = 6.4 Hz, 6H), 1.58 (dtt, J = 35.9, 13.6, 6.5 Hz, 6H), 1.37 (s, 27H), 
1.34 (d, J = 2.0 Hz, 6H), 1.31 – 1.11 (m, 6H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 175.37, 172.89, 172.31, 156.03, 77.82, 54.92, 52.38, 
52.23, 51.99, 35.12, 32.79, 30.86, 29.87, 29.75, 29.48, 28.48, 23.14, 22.98, 22.74. 
ESI-Q-TOF: [M+Na] + Calcd: 739.46, found: 739.32. 
 
 
3.31. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine 
methyl ester (27) 
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The product was obtained following General procedure G starting with a product 26 (5.51 g, 
7.7 mmol) and Z-Lys(Boc)-COOH (3.14 g, 8.2 mmol), HOBt (1.52 g, 11.5 mmol) and HBTU 
(4.26 g, 11.5 mmol), TEA (4.4 mL 38.5 mmol) and DMF as solvent (40 mL).  
After precipitation of a crude product, flash chromatography was performed in isocratic flow 
of 10% MeOH/DCM and the product 27 was isolated as white powder (6.71 g, 6.1 mmol, 79%). 
Rf: 0.78 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.19 (d, J = 7.3 Hz, 1H), 7.89 (d, J = 8.1 Hz, 1H), 
7.83 (d, J = 7.9 Hz, 1H), 7.41 – 7.26 (m, 6H), 6.82 – 6.63 (m, 4H), 5.03 (s, 2H), 4.22 (tt, J = 
15.9, 13.1, 6.0 Hz, 3H), 3.97 (td, J = 8.5, 4.6 Hz, 1H), 3.61 (s, 3H), 2.94 – 2.80 (m, 8H), 1.73 – 
1.55 (m, 5H), 1.50 (t, J = 10.4 Hz, 4H), 1.37 (s, 36H), 1.33 (d, J = 6.7 Hz, 6H), 1.24 (dt, J = 
12.3, 6.5 Hz, 9H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.86, 172.35, 172.13, 171.75, 156.43, 156.01, 
137.48, 128.79, 128.13, 77.80, 65.86, 55.20, 52.77, 52.60, 52.38, 52.19, 32.30, 32.18, 32.04, 
30.96, 29.67, 29.55, 28.73, 23.30, 23.06, 23.00, 22.93. 
ESI-Q-TOF: [M+Na] + Calcd: 1101.68, found: 1101.72. 
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3.32. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine (28) 
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 The product was obtained according to General procedure D starting with compound 27 (1.70 
g, 1.5 mmol) and LiOH (0.13 g, 3.0 mmol) in MeOH (24 mL) and H2O (8 mL) as solvents. 
After work-up product 28 was isolated as white powder (1.65 g, 1.5 mmol, 99%). 
Rf: 0.43 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 8.13 (s, 2H), 8.07 (s, 1H), 7.44 – 7.27 (m, 5H), 
7.27 – 7.13 (m, 1H), 5.12 (s, 2H), 4.48 – 4.24 (m, 3H), 4.12 (s, 1H), 3.04 (t, J = 6.6 Hz, 8H), 
1.86 (d, J = 19.6 Hz, 4H), 1.71 (dd, J = 15.1, 9.2 Hz, 4H), 1.49 (d, J = 9.8 Hz, 9H), 1.44 (d, J = 
2.2 Hz, 36H), 1.44-1.33 (m, 7H). 
13C NMR (400 MHz, Methanol-d4) δ/ppm: 165.87, 165.68, 164.69, 149.13, 128.76, 120.12, 
119.65, 119.47, 70.48, 58.36, 47.22, 45.22, 44.20, 31.82, 31.63, 23.43, 23.35, 23.23, 23.00, 
21.10, 19.45, 14.73. 
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3.33. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysine (29) 
 
 
Tetrapeptide 28 (1.65 g, 1.5 mmol) was dissolved in EtOH (40 mL) and 10wt. % Pd/C (0.17 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 29 (1.40 g, 1.5 mmol, 100 %) was obtained as a white powder and used in the next step 
without further purification. 
Rf: 0.00 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.07 (d, J = 7.9 Hz, 2H), 7.75 (s, 1H), 6.83 (s, 1H), 
6.75 (dd, J = 8.7, 4.7 Hz, 3H), 4.27 (s, 1H), 4.22 – 4.14 (m, 1H), 4.10 (s, 1H), 3.95 (s, 1H), 2.87 
(q, J = 6.5 Hz, 8H), 1.65 (s, 3H), 1.61 – 1.44 (m, 4H), 1.38 (s, 9H), 1.37 (s, 27H), 1.34 (s, 5H), 
1.29 – 1.13 (m, 7H), some signals are covered by Boc. 
13C NMR (300 MHz, Methanol-d4) δ/ppm: 155.55, 144.03, 77.30, 57.53, 54.44, 53.72, 52.91, 
51.92, 31.99, 31.55, 29.66, 29.20, 28.31, 22.60. 
ESI-Q-TOF: [M+Na] + Calcd: 954.16, found: 955.07. 
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3.34. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysine methyl ester (30) 
 
 
Fully protected tetrapeptide 27 (4.10 g, 3.7 mmol) was dissolved in EtOH (200 mL) and 10wt. 
% Pd/C (0.41 g) was added. In a way described in General procedure for a cleavage of CbZ 
protecting group product 30 (3.60 g, 3.7 mmol, 100 %) was obtained as a yellowish oil and 
used in the next step without further purification. 
Rf: 0.01 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 4.42 (d, J = 6.6 Hz, 1H), 4.39 – 4.30 (m, 2H), 3.73 
(s, 3H), 3.12 – 2.99 (m, 8H), 1.95 – 1.77 (m, 3H), 1.70 (s, 4H), 1.50 (s, 5H), 1.45 (s, 36H), 1.43-
1.31 (m, 12H). 
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3.35. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysine methyl ester (31) 
 
 
The product was obtained according to General procedure G starting from a product 30 (3.6 g, 
3.8 mmol) and Z-Lys(Boc)-COOH (1.09 g, 4.2 mmol), HOBt (0.77 g, 5.7 mmol) and EDC×HCl 
(1.00 g, 5.7 mmol), TEA (1.7 mL 19.0 mmol) and DMF as solvent (25 mL).  
After precipitation of a crude product, flash chromatography was performed in isocratic flow 
of 10% MeOH/DCM and the product 31 was isolated as white powder (3.93 g, 3.3 mmol, 87%). 
Rf: 0.82 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.19 (d, J = 7.2 Hz, 1H), 7.96 – 7.85 (m, 2H), 7.80 
(d, J = 7.8 Hz, 1H), 7.44 – 7.22 (m, 6H), 6.72 (q, J = 9.3, 5.2 Hz, 5H), 5.03 (s, 2H), 4.22 (dt, J 
= 14.7, 7.2 Hz, 4H), 3.96 (t, J = 6.6 Hz, 1H), 3.61 (s, 3H), 2.87 (t, J = 6.4 Hz, 10H), 1.60 (dd, J 
= 15.2, 8.0 Hz, 6H), 1.50 (t, J = 9.7 Hz, 5H), 1.43-1.41 (m, 4H), 1.40 – 1.35 (m, 45H), 1.33 (d, 
J = 7.2 Hz, 7H), 1.24 (s, 8H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 155.67, 128.45, 127.81, 77.45, 65.48, 55.01, 52.48, 
28.36, 22.70, some peaks are not visible. 
ESI-Q-TOF: [M+Na] + Calcd: 1329.79, found: 1330.50. 
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3.36. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysine (32) 
 
 
The product was obtained according to General procedure D starting with compound 31 (2.14 
g, 1.6 mmol) and LiOH (0.13 g, 3.3 mmol) in MeOH (36 mL) and H2O (12 mL) as solvents. 
After work-up product 32 was isolated as white powder (2.12 g, 1.6 mmol, 97%). 
Rf: 0.40 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.52 (s, 1H), 7.98 (s, 1H), 7.89 (d, J = 7.8 Hz, 2H), 
7.82 (s, 1H), 7.46 – 7.19 (m, 6H), 6.73 (q, J = 6.4, 5.9 Hz, 5H), 5.03 (s, 2H), 4.23 (d, J = 9.2 
Hz, 3H), 4.12 (s, 1H), 3.97 (d, J = 5.9 Hz, 1H), 2.87 (p, J = 6.4 Hz, 10H), 1.64 (d, J = 22.9 Hz, 
5H), 1.56 – 1.43 (m, 5H), 1.37 (d, J = 1.5 Hz, 45H), 1.33 (s, 10H), 1.30 – 1.17 (m, 10H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 173.84, 172.39, 171.93, 171.72, 156.44, 156.02, 
77.83, 65.87, 55.20, 52.86, 52.69, 52.35, 32.27, 32.12, 31.42, 31.24, 29.69, 28.73, 23.28, 23.11, 
23.05. 
ESI-Q-TOF: [M+Na] + Calcd: 1315.77, found: 1316.61. 
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3.37. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-
lysine (33) 
 
 
Pentapeptide 32 (2.04 g, 1.6 mmol) was dissolved in EtOH (60 mL) and 10wt. % Pd/C (0.21 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 33 (1.83 g, 1.6 mmol, 100 %) was obtained as a white powder and used in the next step 
without further purification. 
Rf: 0.00 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.19 (s, 1H), 8.01 (d, J = 7.9 Hz, 1H), 7.89 (s, 2H), 
6.82 – 6.67 (m, 5H), 4.27 (s, 1H), 4.21 (s, 3H), 2.87 (d, J = 6.8 Hz, 10H), 1.75 – 1.57 (m, 5H), 
1.52 (dd, J = 13.0, 8.0 Hz, 5H), 1.37 (s, 45H), 1.34 (d, J = 6.9 Hz, 10H), 1.24 (s, 10H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 173.72, 173.37, 171.81, 171.74, 171.62, 156.01, 
77.80, 54.31, 52.95, 52.90, 52.79, 52.66, 32.53, 32.23, 32.09, 31.55, 28.74, 23.04. 
ESI-Q-TOF: [M+H] + Calcd: 1159.61, found: 1159.67. 
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3.38. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-
lysine methyl ester (34) 
 
 
Fully protected pentapeptide 31 (1.79 g, 1.4 mmol) was dissolved in EtOH (50 mL) and 10wt. 
% Pd/C (0.18 g) was added. In a way described in General procedure for a cleavage of CbZ 
protecting group product 34 (1.60 g, 1.4 mmol, 99 %) was obtained as a colourless oil and used 
in the next step without further purification. 
Rf: 0.01 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.18 (d, J = 7.2 Hz, 1H), 7.99 (d, J = 7.9 Hz, 2H), 
7.79 (d, J = 7.9 Hz, 1H), 6.73 (q, J = 7.2, 5.7 Hz, 5H), 4.32 – 4.13 (m, 4H), 3.61 (s, 3H), 3.12 
(t, J = 6.0 Hz, 1H), 2.88 (p, J = 8.0, 7.2 Hz, 10H), 1.62 (q, J = 10.8, 7.0 Hz, 5H), 1.50 (t, J = 
10.3 Hz, 4H), 1.37 (s, 54H), 1.35 – 1.30 (m, 10H), 1.30 – 1.14 (m, 11H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.86, 172.15, 171.68, 156.00, 77.80, 56.49, 55.00, 
52.38, 52.21, 35.16, 29.90, 29.73, 29.65, 29.56, 28.73, 23.07, 22.91. 
ESI-Q-TOF: [M+H] + Calcd: 1173.84, found: 1173.90. 
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3.39. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-
lysine methyl ester (35) 
 
 
The product was obtained following General procedure G starting from a product 34 (1.60 g, 
1.4 mmol) and Z-Lys(Boc)-COOH (0.39 g, 1.5 mmol), HOBt (0.28 g, 2.1 mmol) and EDC×HCl 
(0.39 g, 2.1 mmol), TEA (0.8 mL 6.8 mmol) and DMF as solvent (15 mL).  
After precipitation of a crude product, flash chromatography was performed in isocratic flow 
of 10% MeOH/DCM and the product (35) was isolated as white powder (1.63 g, 1.1 mmol, 
78%). 
Rf: 0.85 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.18 (d, J = 7.1 Hz, 1H), 7.89 (s, 3H), 7.79 (s, 1H), 
7.45 – 7.26 (m, 6H), 6.72 (dt, J = 11.7, 7.4 Hz, 6H), 5.03 (s, 2H), 4.22 (s, 5H), 3.97 (s, 1H), 
3.61 (s, 3H), 2.96 – 2.78 (m, 12H), 1.61 (s, 7H), 1.55 – 1.43 (m, 7H), 1.37 (s, 54H), 1.33 (d, J 
= 7.8 Hz, 9H), 1.23 (d, J = 15.7 Hz, 13H). 
ESI-Q-TOF: [M+Na] + Calcd: 1557.94, found: 1557.95. 
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3.40. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-
lysine (36) 
 
 
The product was obtained according to General procedure D starting from compound 35 (1.63 
g, 1.1 mmol) and LiOH (0.09 g, 2.2 mmol) in MeOH (27 mL) and H2O (9 mL) as solvents. 
After work-up product 36 was isolated as white powder (1.53 g, 1.0 mmol, 95%). 
Rf: 0.45 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.50 (s, 1H), 7.98 (s, 1H), 7.88 (s, 2H), 7.80 (s, 1H), 
7.42 – 7.26 (m, 6H), 6.72 (t, J = 8.9 Hz, 6H), 5.03 (s, 2H), 4.22 (s, 4H), 3.97 (s, 1H), 2.87 (t, J 
= 6.6 Hz, 12H), 1.61 (s, 7H), 1.55 – 1.43 (m, 6H), 1.37 (d, J = 1.6 Hz, 54H), 1.33 (d, J = 6.4 
Hz, 10H), 1.30 – 1.15 (m, 13H), one signal is covered by solvents. 
ESI-Q-TOF: [M+Na] + Calcd: 1543.83, found: 1543.98. 
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3.41. Synthesis of N-epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-
butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-lysyl-N-
epsilon-t-butyloxycarbonyl-L-lysyl-N-epsilon-t-butyloxycarbonyl-L-
lysyl-N-epsilon-t-butyloxycarbonyl-L-lysine (37) 
 
 
Hexapeptide 36 (1.53 g, 1.0 mmol) was dissolved in EtOH (50 mL) and 10wt. % Pd/C (0.15 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 37 (1.39 g, 1.0 mmol, 100 %) was obtained as a white powder and used in the next step 
without further purification. 
Rf: 0.00 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.26 (s, 1H), 8.08 (s, 1H), 7.88 (s, 3H), 6.78-6.68 (m, 
6H), 4.32-4.14 (m, 4H), 4.13-3.97 (m, 2H), 2.87 (d, J = 6.7 Hz, 12H), 1.73 – 1.56 (m, 6H), 
1.55-1.43 (m, 7H), 1.37 (s, 54H), 1.34-1.29 (m, 10H), 1.29-1.10 (m, 13H). 
ESI-Q-TOF: [M-H] - Calcd: 1385.89, found: 1386.11. 
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3.42. Synthesis of cyclic N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-t-
butyloxycarbonyl-lysyl-N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-
t-butyloxycarbonyl-lysine (L4) 
 
 
Under inert atmosphere DPPA (0.01 mL, 0.06 mmol) and DIPEA (0.01 mL, 0.06 mmol) were 
dissolved in dry DMF (10 mL). Product 29 (0.05 g, 0.05 mmol), previously dissolved in dry 
DMF (5 mL), was slowly added to the obtained solution in a 3 hours. 
Reaction mixture was stirred at RT under inert atmosphere for 4 days and monitored by TLC. 
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3.43. Synthesis of cyclic N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-t-
butyloxycarbonyl-lysyl-N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-
t-butyloxycarbonyl-lysine (L4) 
 
 
Product L4 was obtained through general procedure J using compound 29 (0.20 g, 0.2 mmol), 
DEPBT (0.08 g, 0.2 mmol), LiCl (0.04 g, 1.0 mmol) or NATPB (0.74 g, 20.0 mmol) or TEACl 
(0.36 g, 20.0 mmol) dissolved in 0.125 mL of H2O, TEA until pH 8 and DMF (200 mL). 
After work-up flash chromatography was performed in isocratic flow of 10 % MeOH/DCM 
and the product L4 was isolated as white powder (0.04 g, 0.05 mmol, 21%; 0.02 g, 0.02 mmol,  
8 %; 0.09 g, 0.11 mmol,  47 %). 
Rf: 0.37 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.04 (d, J = 9.7 Hz, 4H), 6.76 (d, J = 5.8 Hz, 4H), 
4.09 (q, J = 5.2 Hz, 4H), 2.88 (q, J = 6.4 Hz, 8H), 1.76-1.55 (m, 4H), 1.55-1.43 (m, 2H), 1.37 
(s, 9H), 1.30 – 1.14 (m, 10H). 
13C NMR (400 MHz, Methanol-d4) δ/ppm: 148.61, 69.93, 47.55, 39.95, 31.21, 27.06, 21.40, 
20.67, one peak is not visible. 
ESI-Q-TOF: [M+Na] + Calcd: 936.16, found: 936.47. 
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3.44. Synthesis of cyclic N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-t-
butyloxycarbonyl-lysyl-N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-
t-butyloxycarbonyl-lysyl-N-epsilon-t-butyloxycarbonyl-lysine (L5) 
 
 
Product L5 was obtained through general procedure J using compound 33 (0.20 g, 0.2 mmol), 
DEPBT (0.06 g, 0.2 mmol), NaCl (0.06 g, 1.0 mmol) or NATPB (0.58 g, 2.0 mmol) or TEACl 
(0.28 g, 2.0 mmol) dissolved in 0.125 mL of H2O, TEA until pH 8 and DMF (200 mL). 
Solvents were removed under reduced pressure; the obtained crude solid was dissolved in 
AcOEt (10 mL) and washed with NaHCO3 (sat. 5 mL), H2O (5 mL), 0.1 M HCl (5 mL) and 
H2O (5 mL). Organic layer was dried over Na2SO4 and evaporated under reduced pressure. 
Flash chromatography was performed in isocratic flow of 10 % MeOH/DCM and the product 
L5 was isolated as white powder (0.08 g, 0.07 mmol, 35%; 0.06 g, 0.05 mmol, 26%; 0.1 g, 0.08 
mmol, 43 %). 
Rf: 0.41 (10% MeOH/DCM). 
1H NMR (400 MHz, Acetonitrile-d3) δ/ppm: 7.19 (d, J = 7.8 Hz, 5H), 5.43 (s, 5H), 4.02 (q, J 
= 7.8, 7.3 Hz, 5H), 3.11 – 2.97 (m, 10H), 1.91 – 1.71 (m, 10H), 1.59 – 1.44 (m, 10H), 1.42 (s, 
45H), 1.40 – 1.25 (m, 10H). 
ESI-Q-TOF: [M+Na] + Calcd: 1163.73, found: 1163.75. 
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3.45. Synthesis of cyclic N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-t-
butyloxycarbonyl-lysyl-N-epsilon-t-butyloxycarbonyl-lysyl-N-epsilon-
t-butyloxycarbonyl-lysyl-N-epsilon-t-butyloxycarbonyl-lysyl-N-
epsilon-t-butyloxycarbonyl-lysine (L6) 
 
 
 Product L6 was obtained following General procedure J using compound 37 (0.20 g, 0.1 mmol) 
as a starting material, DEPBT (0.05 g, 0.2 mmol), NaCl (0.04 g, 0.7 mmol) or NATPB (0.49 g, 
14.4 mmol) or TEACl (0.24 g, 14.4 mmol) dissolved in 0.125 mL of H2O, TEA until pH 8 and 
DMF (200 mL). 
Solvents were removed under reduced pressure; the obtained crude solid was dissolved in 
AcOEt (10 mL) and washed with NaHCO3 (sat. 5 mL), H2O (5 mL), 0.1 M HCl (5 mL) and 
H2O (5 mL). Organic layer was dried over Na2SO4 and evaporated under reduced pressure. 
Flash chromatography was performed in isocratic flow of 10 % MeOH/DCM and the product 
L5 was isolated as white powder (0.03 g, 0.03 mmol, 15 %; 0.02 g, 0.02 mmol, 10 %; 0.03 g, 
0.03 mmol, 17 %). 
Rf: 0.46 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 4.07 – 3.96 (m, 6H), 2.94 (t, J = 6.9 Hz, 12H), 1.90 
– 1.65 (m, 12H), 1.41 (q, J = 7.0 Hz, 12H), 1.33 (s, 54H), 1.31 – 1.17 (m, 12H). 
13C NMR (400 MHz, Methanol-d4) δ/ppm: 172.60, 78.45, 54.72, 39.79, 30.46, 29.22, 27.46, 
23.08, one peak is not visible. 
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ESI-Q-TOF: [M+Na] + Calcd: 1391.87, found: 1391.81. 
 
 
3.46. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-L-β-
aminoalanine (38) 
 
 
 
Fmoc-L-Asn-COOH (6.76 g, 19.1 mmol) and PIDA (7.36 g, 22.9 mmol) were dissolved in 
EtOAc:CH3CN:H2O = 2:2:1 (350 mL). Reaction mixture was stirred 30 min at 10 °C and 
enother 3 hours at 20 °C. Reaction was monitored by TLC. Solvents were then evaporated under 
reduced pressure and product 38 (3.11 g, 9.5 mmol, 50 %) was precipitated as a white solid by 
addition of EtOAc (100 mL), filtered out and dryed in exicator.  
Rf: 0.00 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 7.90 (d, J = 7.5 Hz, 2H), 7.71 (d, J = 7.5 Hz, 2H), 
7.54 (d, J = 8.3 Hz, 1H), 7.42 (t, J = 7.5 Hz, 2H), 7.34 (d, J = 6.8 Hz, 2H), 4.38 – 4.30 (m, 1H), 
4.27 (d, J = 6.9 Hz, 2H), 4.25 – 4.20 (m, 1H), 2.57 (dd, J = 15.4, 5.3 Hz, 1H), 2.47 – 2.42 (m, 
1H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 171.11, 155.79, 143.84, 140.73, 127.65, 127.11, 
125.23, 120.13, 65.74, 46.64, one signal is covered by DMSO. 
ESI-Q-TOF: [M+Na] + Calcd: 349.12, found 349.10. 
 
§ 3. Experimental section 85 
Nikolina Vidović PhD thesis 
3.47. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-t-
butyloxycarbonyl-L-β-aminoalanine (39) 
 
 
 
K2CO3 (3.96 g, 28.7 mmol) was dissolved in a mixture of dioxane:H2O = 1:1 (45 mL) and 
temperature was lowered to 0 °C. Starting material 38 (3.11 g, 9.6 mmol) and Boc2O (2.09 g, 
9.6 mmol), previuosly dissolved in dioxane (15 mL), were added in a mixture and reaction was 
stirred at RT overnight. pH of the reaction mixture was then brought to 4 by adding KHSO4 
(sat) and extraction with EtOAc (3×25 mL) was performed. Organic layer was dried over 
anhydrous MgSO4 and solvent was removed under reduced pressure. In this way product 39 
(4.05 g, 9.6 mmol, 100 %) was obtained as a white powder and used in the next step without 
further purification. 
Rf: 0.25 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 12.68 (s, 1H), 7.90 (d, J = 7.5 Hz, 2H), 7.72 (d, J = 
7.5 Hz, 2H), 7.47 (d, J = 8.0 Hz, 1H), 7.42 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 6.84 (s, 
1H), 4.30 (d, J = 7.0 Hz, 2H), 4.26 – 4.17 (m, 1H), 4.08 (q, J = 6.7 Hz, 1H), 3.31-3.26 (m, 2H), 
1.37 (s, 9H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.05, 156.04, 155.61, 143.82, 140.74, 127.80, 
127.22, 125.31, 120.04, 78.12, 65.73, 54.11, 46.63, 28.20.  
ESI-Q-TOF: [M+Na] + Calcd: 449.17, found 449.30. 
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3.48. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine (40) 
 
 
Starting material 39 (0.10 g, 0.2 mmol) was dissolved in EtOH (100 mL) and under magnetic 
stirring Et2NH (0.3 mL, 0.02 mmol) was added. Resulting mixture was stirred overnight at RT 
and solvent was then removed under reduced pressure. Crude was dissolved in EtOAc and, after 
extraction, inorganic phase was evaporated. In this way the desired product 40 (0.05 g, 0.2 
mmol, 100 %) was obtained in a form of white powder. 
Rf: 0.00 (10% MeOH/DCM). 
1H NMR (400 MHz, Deuterium Oxide-d2) δ/ppm: 3.75 (dd, J = 6.9, 3.8 Hz, 1H), 3.57 (dd, J 
= 15.0, 3.8 Hz, 1H), 3.39 (dd, J = 15.1, 6.9 Hz, 1H), 1.35 (s, 9H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 174.33, 155.56, 80.46, 42.97, 54.21, 28.20. 
ESI-Q-TOF: [M+Na] + Calcd: 227.10, found 227.21. 
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3.49. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine 
methyl ester (41) 
 
 
The product was obtained according to General procedure G using HCl×NH2-DAP(Boc)-
COOMe (3.50 g, 16.0 mmol) and Z-Lys(Boc)-COOH (5.97 g, 17.6 mmol), EDC×HCl (3.25 g, 
24.1 mmol) and HOBt (4.61 g, 24.1 mmol), TEA (11.2 mL 87.0 mmol) and DMF as solvent 
(30 mL).  
After precipitation product 41 was isolated as white powder (8.62 g, 16.0 mmol, 100%). 
Rf: 0.97 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.23 (d, J = 7.6 Hz, 1H), 7.40 – 7.28 (m, 5H), 7.19 
(d, J = 8.1 Hz, 1H), 6.86 (d, J = 6.7 Hz, 1H), 6.67 (s, 1H), 5.11 – 4.96 (m, 2H), 4.32 (t, J = 6.6 
Hz, 1H), 4.14 (q, J = 7.2 Hz, 1H), 3.61 (s, 3H), 3.14 (dt, J = 13.9, 7.2 Hz, 1H), 3.08 – 2.98 (m, 
1H), 1.37 (s, 18H). 
ESI-Q-TOF: [M+Na] + Calcd: 561.49, found 561.50. 
 
  
§ 3. Experimental section 88 
Nikolina Vidović PhD thesis 
3.50. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-aminoalanine methyl ester (42) 
 
 
 
Dipeptide 41 (6.54 g, 12.1 mmol) was dissolved in EtOH (150 mL) and 10wt. % Pd/C (0.65 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 42 (4.91 g, 12.1 mmol, 100 %) was obtained as a yellowish oil and used in the next 
step without further purification. 
Rf: 0.72 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.30 (s, 1H), 6.98 (t, J = 6.4 Hz, 1H), 6.71 (s, 1H), 
4.32 (d, J = 5.5 Hz, 1H), 3.62 (s, 3H), 3.26 (dt, J = 5.6, 2.1 Hz, 1H), 3.21 – 3.08 (m, 1H), 3.02 
– 2.91 (m, 1H), 1.39 (s, 9H), 1.38 (s, 9H), one signal is covered by signal of H2O. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 173.00, 171.11, 166.55, 156.21, 124.93, 123.66, 
118.91, 111.01, 78.56, 78.36, 56.50, 55.17, 52.88, 52.51, 44.58, 41.54, 28.62, 18.99. 
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3.51. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-
epsilon-t-butyloxycarbonyl-L-β-aminoalanine methyl ester (43) 
 
 
 
The product was obtained according to General procedure G starting with a product 42 (4.91 g, 
12.1 mmol) and Z-DAP(Boc)-COOH (4.50 g, 13.3 mmol), EDC×HCl (3.48 g, 18.5 mmol) and 
HOBt (2.45 g, 18.5 mmol), TEA (3.5 mL 30.3 mmol) and DMF as solvent (30 mL).  
After precipitation product 43 was isolated as white powder (8.50 g, 11.7 mmol, 97%). 
 
Rf: 0.99 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.16 (d, J = 7.6 Hz, 1H), 8.02 (d, J = 8.0 Hz, 1H), 
7.37 (d, J = 4.8 Hz, 5H), 6.90 – 6.79 (m, 1H), 6.75 (s, 1H), 6.56 (s, 1H), 5.14 – 4.96 (m, 2H), 
4.41 – 4.25 (m, 1H), 4.10 (dd, J = 24.2, 6.6 Hz, 2H), 3.61 (s, 3H), 3.20 (dq, J = 21.2, 7.7, 6.7 
Hz, 4H), 1.37 (s, 27H), one signal is covered by signal of H2O. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 170.54, 169.96, 169.60, 156.05, 155.88, 155.65, 
136.79, 128.42, 127.94, 127.81, 78.22, 78.20, 78.10, 65.81, 56.11, 55.58, 52.91, 52.55, 52.06, 
41.71, 41.07, 28.24, 28.20, 18.62. 
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3.52. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanine methyl ester (44) 
 
 
 
Tripeptide 43 (8.50 g, 11.7 mmol) was dissolved in EtOH (150 mL) and 10wt. % Pd/C (0.85 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 44 (6.70 g, 11.3 mmol, 97 %) was obtained as a yellowish oil and used in the next step 
without further purification. 
Rf: 0.62 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.31 (d, J =7.5 Hz, 1H), 6.89 – 6.84 (m, 1H), 6.72 (s, 
1H), 6.66 (d, J = 6.2 Hz, 1H), 4.43 – 4.23 (m, 2H), 3.62 (s, 3H), 3.50 – 3.36 (m, 2H), 3.14 (dt, 
J = 12.2, 6.5 Hz, 2H), 2.96 (dt, J = 13.9, 7.5 Hz, 1H), 1.39 (s, 9H), 1.38 (s, 9H), 1.37 (s, 9H), 
one signal is covered by a signal of H2O. 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 169.80, 78.22, 60.21, 56.10, 55.28, 52.65, 52.47, 
52.08, 28.22, 14.11, some paks are covered by a solvent peak. 
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3.53. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-
epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-
butyloxycarbonyl-L-β-aminoalanine methyl ester (45) 
 
 
The product was obtained following General procedure G starting from a product 45 (5.51 g, 
9.3 mmol) and Z-Lys(Boc)-COOH (3.47 g, 10.2 mmol), HOBt (1.89 g, 14.0 mmol) and 
EDC×HCl (2.68 g, 14.0 mmol), TEA (5.5 mL, 46.7 mmol) and DMF as solvent (30 mL).  
After precipitation of a crude product, flash chromatography was performed in isocratic flow 
of 10% MeOH/DCM and the product 45 was isolated as white powder (6.65 g, 7.3 mmol, 79%). 
Rf: 0.98 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.14 (d, J = 7.7 Hz, 1H), 8.05 (d, J = 7.4 Hz, 1H), 
7.95 (d, J = 9.7 Hz, 1H), 7.40 – 7.19 (m, 6H), 6.80 (s, 1H), 6.75 (s, 1H), 6.66 (d, J = 6.4 Hz, 
1H), 6.56 (s, 1H), 5.19 – 4.93 (m, 2H), 4.41 – 4.21 (m, 3H), 4.09 (s, 1H), 3.60 (s, 3H), 3.45-
3.32 (s, 4H), 3.30 – 3.04 (m, 4H), 1.37 (s, 36H). 
ESI-Q-TOF: [M+Na] + Calcd: 933.44, found 933.76. 
 
 
 
 
§ 3. Experimental section 92 
Nikolina Vidović PhD thesis 
3.54. Synthesis of N-alpha-carbobenzoxy-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-
epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-
butyloxycarbonyl-L-β-aminoalanine (46) 
 
 
 Compound 45 (6.65 g, 7.3 mmol) and LiOH (0.60 g, 14.6 mmol) were dissolved in MeOH 
(120 mL) and H2O (30 mL) as solvents. Reaction was monitored by TLC and standard work-
up was performed. In this way was not possible to obtain the desired product 46. 
 
 
3.55. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine (47) 
 
 
Compound 46x (0.10 g, 0.1 mmol) was dissolved in toluene (20 mL) and reaction mixture was 
stirred under reflux of toluen for 48 hours. Solvent was then removed under reduced pressure. 
In this way was not possible to obtain the desired product 47.  
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3.56. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine (47) 
 
 
Compound 46x (0.10 g, 0.1 mmol) was dissolved in methanol (20 mL) and reaction mixture 
was stirred under reflux for 48 hours. Solvent was then removed under reduced pressure. In this 
way was not possible to obtain the desired product 47. 
 
 
3.57. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine (47) 
 
 
Compound 46x (0.10 g, 0.1 mmol) was dissolved in H2O (20 mL) and reaction mixture was 
stirred under reflux for 48 hours. Solvent was then removed under reduced pressure. In this way 
was not possible to obtain the desired product 47.  
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3.58. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine (47) 
 
 
Compound 46x (0.10 g, 0.1 mmol) was dissolved in HCl (0.1 M, 20 mL) and reaction mixture 
was stirred under reflux for 48 hours. Solvent was then removed under reduced pressure. In this 
way was not possible to obtaine the desired product 47. 
 
 
3.59. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine (47) 
 
  
Compound 46x (0.10 g, 0.1 mmol) was dissolved in MeOH (20 mL) and amberlite resin (0.02 
g) was added. Reaction mixture was stirred at RT for 24 hours. Resin was removed by filtration 
and solvent was evaporated under reduced pressure. In this way was not possible to obtaine the 
desired product 47. 
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3.60. Synthesis of N-epsilon-t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-
t-butyloxycarbonyl-L-β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-
β-aminoalanyl-N-epsilon-t-butyloxycarbonyl-L-β-aminoalanine (47) 
 
 
Compound 46x (0.10 g, 0.1 mmol) was dissolved in MeOH (20 mL) and 18-crown-6-ether 
(0.02 g) was added. Reaction mixture was stirred at RT for 24 hours. Solvent was then 
evaporated under reduced pressure. In this way was not possible to obtaine the desired product 
47. 
 
 
3.61. Synthesis of N-(9-Fluorenylmethyloxycarbonyl)-O-t-butyl-L-serine 
succinimidyl ester (48) 
 
 
 
The 
product was obtained through General procedure A using Fmoc-Ser(tBu)-COOH (10.00 g, 26.1 
mmol) commercially available, DCC (6.45 g, 31.3 mmol), NHS (3.60 g, 31.3 mmol) and DCM 
(80 mL) as solvent. The obtained crude solid was dissolved in EtOAc (50 mL) and washed with 
NaHCO3 (0.5 M, 50 mL), H2O (50 mL), HCl (0.1 M, 50 mL) and H2O (50 mL). Organic layer 
was dried over Na2SO4 and evaporated under reduced pressure to give product 48 (11.60 g, 24.1 
mmol, 92%) that was used in the next step without further purification. 
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Rf: 0.80 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6,) δ/ppm: 8.09 (d, J = 8.3 Hz, 1H), 7.90 (d, J = 7.5 Hz, 2H), 
7.74 (m, 2H), 7.42 (t, J = 7.4 Hz, 2H), 7.33 (t, J = 7.4 Hz, 2H), 4.62 (dd, J = 13.4, 5.4 Hz, 1H), 
4.38 – 4.21 (m, 3H), 3.76 – 3.63 (m, 2H), 2.81 (s, 4H), 1.16 (s, 9H). 
 
 
3.62. Synthesis of N-(9-Fluorenylmethyloxycarbonyl)-O-t-butyl-L-seryl-L-
serine (49) 
 
 
 
The product was obtained following General procedure B using compound 3 (11.50 g, 23.9 
mmol), Ser×HCl (3.08 g, 21.8 mmol), NaHCO3 (4.02 g, 47.9 mmol) and THF (90 mL)/H2O 
(60 mL) as solvents. 
The crude product was dissolved in DCM (50 mL) and washed with HCl (0.1 M, 2×30 mL) and 
H2O (2×30 mL); the crude solid was dissolved in Et2O (70 mL) and then were added water (30 
mL) and hexane until the product start precipitating. The inorganic phase was separated and the 
product was extracted with DCM. Solvents were removed under reduced pressure. Flash 
chromatography was performed in gradient flow of 2%-10% MeOH/DCM and the product 49 
was isolated as white powder (8.10 g, 17.2 mmol, 79%). 
Rf: 0.25 (10% MeOH/DCM). 
§ 3. Experimental section 97 
Nikolina Vidović PhD thesis 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 7.89 (d, J = 7.5 Hz, 2H), 7.75 – 7.72 (m, 2H), 7.66 
(d, J = 6.2 Hz, 1H), 7.49 (d, J = 8.4 Hz, 1H), 7.42 (t, J = 7.4 Hz, 2H), 7.36 – 7.29 (m, 2H), 4.35 
– 4.21 (m, 3H), 4.11 (dd, J = 13.1, 6.2 Hz, 1H), 3.96 (dd, J = 10.4, 5.0 Hz, 1H), 3.67 (dd, J = 
9.7, 3.7 Hz, 1H), 3.56 – 3.44 (m, 3H), 1.12 (s, 9H). 
 
 
3.63. Synthesis of N-(9-Fluorenylmethyloxycarbonyl)-O-t-butyl-L-seryl-L-
serine methyl ester (50) 
 
 
 
The product was obtained through general procedure C using compound 49 (0.80 g, 1.7 mmol), 
SOCl2 (0.24 mL, 3.4 mmol) and MeOH (30 mL). 
Solvents were removed under reduced pressure; the obtained crude solid was dissolved in 
EtOAc (20 mL) and washed with a saturated solution of NaHCO3 (20 mL) and H2O (2×20 mL). 
Organic layer was dried over Na2SO4 and evaporated under reduced pressure to obtain product 
50 as white powder (0.82 g, 1.6 mmol, 95%). 
Rf: 0.50 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6,) δ/ppm:  8.19 (d, J = 7.5 Hz, 1H), 7.89 (d, J = 7.5 Hz, 2H), 
7.73 (d, J = 7.2 Hz, 2H), 7.42 (t, J = 7.3 Hz, 2H), 7.32 (t, J = 7.4 Hz, 2H), 4.37 (m, 1H), 4.29 – 
4.19 (m, 3H), 3.73 (dd, J = 11.9, 4.6 Hz, 1H), 3.62 (s, 3H), 3.67 – 3.57 (m, 1H), 3.54 – 3.43 (m, 
2H), 1.13 (s, 9H). 
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3.64. Synthesis of N-(9-Fluorenylmethyloxycarbonyl)-L-seryl-L-serine 
methyl ester (51) 
 
 
 
To a solution of 50 (0.78 g, 1.6 mmol) in DCM (1 mL) aqueous phosphoric acid (0.94 mL, 16.1 
mmol) was added dropwise. The mixture was stirred for 4 h at room temperature. Then the 
solution was neutralized with NaHCO3 (0.5 M, 5 mL) and water (10mL) was added. The 
mixture was extracted with ethyl acetate (3×5 mL). The combined ethyl acetate phases were 
dried over Na2SO4 and concentrated in vacuum to give the desired product 6 as yellow powder 
(0.60 g, 1.4 mmol, 87%). 
Rf: 0.40 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 7.82 (d, J = 7.5 Hz, 2H), 7.69 (t, J = 6.69 Hz, 2H), 
7.41 (t, J = 7.5 Hz, 2H), 7.33 (t, J = 7.5 Hz, 2H), 4.57 (t, J = 4.1 Hz, 1H), 4.43-4.37 (m, 2H), 
4.34-4.24 (m, 2H), 3.94 (dd, J = 11.3, 4.3 Hz, 1H), 3.86-3.79 (m, 3H), 3.76 (s, 3H). 
 
3.65. Synthesis of L-seryl-L-serine methyl ester (52) 
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The reaction was performed through General procedure E using compound 51 (0.30 g, 0.7 
mmol), DEA (0.72 mL, 7.0 mmol) and EtOH (30 mL). 
Solvents were removed under reduced pressure. The crude product was dissolved in EtOAc (10 
mL) and extracted with H2O (3×10 mL). Inorganic phase was then freeze-dried but in this way 
was not possible to obtain the desired product 52. 
 
 
3.66. Synthesis of N-(9-Fluorenylmethyloxycarbonyl)-L-seryl-L-serine (53) 
 
 
 
To a solution of 49 (0.65 g, 1.4 mmol) in DCM (2 mL) aqueous phosphoric acid (0.84 mL, 14.5 
mmol) was added dropwise. The mixture was stirred for 4 h at room temperature. Then the 
solution was neutralized with NaHCO3 (0.5 M, 5 mL) and water (10 mL) was added. The 
mixture was extracted with ethyl acetate (3×5 mL). The combined ethyl acetate phases were 
dried over Na2SO4 and concentrated in vacuum to give the desired product 53 as yellow powder 
(0.50 g, 1.21 mmol, 83%). 
Rf: 0.45 (20% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 7.95 (d, J = 6.9 Hz, 1H), 7.90 (d, J = 7.5 Hz, 2H), 
7.77 – 7.70 (m, 2H), 7.42 (t, J = 7.2 Hz, 2H), 7.36 – 7.30 (m, 2H), 4.39 – 4.12 (m, 5H), 3.77 – 
3.40 (m, 4H). 
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3.67. Synthesis of L-seryl-L-serine (54) 
 
 
 
The reaction was performed through General procedure E starting from compound 53 (0.05 g, 
0.1 mmol) and using different bases and reaction conditions: 
I. Using DEA (0.12 mL, 1.2 mmol) as base and EtOH (5 mL) as solvent obtaining product 
54 as white powder (0.01 g, 0.1 mmol, 60%) 
II. Using DEA (0.12 mL, 1.2 mmol) as base and MeOH (5 mL) as solvent obtaining product 
54 as white powder (0.02 g, 0.1 mmol, 78%) 
Purification was performed in the same way for both reactions: solvents were removed under 
reduced pressure; the crude solid was dissolved in H2O (10 mL) and washed with DCM (2×10 
mL); inorganic phase was then freeze-dried to obtain product 54. 
III. Using NaOH (5 mL from a solution 1M, 0.20 g 5.0 mmol) as base and THF/H2O as 
solvent (1:1, 5 mL) obtaining product 54 as white powder (0.01 g, 0.05 mmol, 43%). 
The solution was neutralized with a solution of HCl (1 M), and washed with hexane (5 mL).  
Solvents were removed under reduced pressure; the crude product was dissolved in EtOAc (15 
mL) and NaCl was filtered out through a sintered funnel. EtOAc was then removed under 
reduced pressure to obtain product 54. 
Best yield was encountered using reaction condition II and reaction was repeated starting from 
compound 53 (0.30 g, 0.7 mmol ) in MeOH (20 mL) and product 54 was obtained as white 
powder (0.12 g, 0.6 mmol, 86%). 
Rf: 0.50 (35% tBuOH/ 23% H2O/ 35% (CH3)2CO/ 7% AcOH). 
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1H NMR (400 MHz, Deuterium Oxide-d2) δ/ppm:  4.29 (dd, J = 6.0, 3.9 Hz, 1H), 4.08 (t, J 
= 4.9 Hz, 1H), 3.95 (d, J = 4.8 Hz, 2H), 3.86 (dd, J = 11.5, 3.8 Hz, 1H), 3.80 (dd, J = 11.6, 6.2 
Hz, 1H). 
 
 
3.68. Synthesis of L-seryl-L-serine methyl ester (55) 
 
 
 
The product was obtained through General procedure C starting from compound 54 (3.80 g, 2.0 
mmol), SOCl2 (0.29 mL, 4.0 mmol) and MeOH (15 mL). 
Solvents were removed under reduced pressure. The obtained crude solid was dissolved in 
EtOAc (10 mL) and washed with a saturated solution of NaHCO3 (10 mL) and H2O (2×10 mL). 
Organic layer was dried over Na2SO4 and evaporated under reduced pressure to give product 
52 as white powder (0.35 g, 1.7 mmol, 86%). 
Rf: 0.40 (20% MeOH/DCM). 
1H NMR (400 MHz, Deuterium Oxide-d2) δ/ppm: 4.65 (t, J = 4.4 Hz, 1H), 4.20 (dd, J = 5.8, 
4.2 Hz, 1H), 4.04 (dd, J = 12.4, 4.2 Hz, 1H), 3.99 – 3.93 (m, 2H), 3.88 (dd, J = 11.8, 4.0 Hz, 
1H), 3.76 (s, 3H). 
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3.69. Synthesis of N-t-butyloxycarbonyl-L-serine succinimidyl ester (55) 
 
 
 The product was obtained through General procedure A using Boc-Ser(OH)-COOH (4.00 g, 
19.6 mmol) previously synthetized by our research group, DCC (4.44 g, 21.6 mmol), NHS (2.48 
g, 21.6 mmol) and DCM (50 mL) as solvent. 
The obtained crude solid was dissolved in EtOAc (50 mL) and washed with NaHCO3 (0.5 M, 
50 mL), H2O (50 mL), HCl (0.1 M, 50 mL) and H2O (50 mL). Organic layer was dried over 
Na2SO4 and evaporated under reduced pressure to obtain product 55 (5.30 g, 17.5 mmol, 90%) 
that was used in the next step without further purification. 
Rf: 0.90 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 4.45 (dd, J = 12.2, 6.5 Hz, 1H), 3.86 – 3.67 (m, 2H), 
2.81 (s, 4H), 1.40 (s, 9H). 
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3.70. Synthesis of N-t-butyloxycarbonyl-L-seryl-O-t-butyl-L-serine tert-
butyl ester (56) 
 
 
 
The product was obtained through General procedure I using compound 55 (2.00 g, 6.6 mmol), 
NH2-Ser(tBu)-COOtBu (1.31 g, 6.0 mmol) previously synthetized by our research group, TEA 
(1.85 mL, 13.2 mmol) and DMF (50 mL) as solvent. 
TEA was removed under reduced pressure and the precipitation was performed adding cold 
water dropwise, under stirring. The product 56 was isolated as white powder (1.45 g, 3.6 mmol, 
54%). 
Rf: 0.7 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 4.31 (dt, J = 7.3, 3.5 Hz, 1H), 4.05 (dd, J = 12.7, 6.5 
Hz, 1H), 3.62 (dd, J = 8.9, 4.2 Hz, 1H), 3.60 – 3.51 (m, 2H), 3.44 (dd, J = 9.0, 4.2 Hz, 1H), 
1.41 (s, 9H) 1.39 (s, 9H), 1.12 (s, 9H). 
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3.71. Synthesis of L-seryl-L-serine (54) 
 
 
 
To a solution of 56 (1.2 g, 3.0 mmol) in DCM (50 mL) TFA (35 mL, 457.1 mmol) was added 
dropwise. The mixture was stirred for 4 h at room temperature. The solution was reduced to 
half its volume under reduced pressure and then cooled at 0°C. The product 54 was then 
precipitated slowly adding Et2O (40 mL). 
The solution was left at -20°C overnight and next day filtered out through a sintered funnel 
obtaining product 54 as white powder (0.51 g, 2.7 mmol, 90%). 
Rf: 0.1 (20% MeOH/DCM). 
1H NMR (400 MHz, Deuterium Oxide-d2) δ/ppm:  4.29 (dd, J = 6.0, 3.9 Hz, 1H), 4.08 (t, J 
= 4.9 Hz, 1H), 3.95 (d, J = 4.8 Hz, 2H), 3.86 (dd, J = 11.5, 3.8 Hz, 1H), 3.80 (dd, J = 11.6, 6.2 
Hz, 1H). 
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3.72. Synthesis of N-t-butyloxycarbonyl-L-seryl-O-t-butyl-L-serine methyl 
ester (57) 
 
 
 
The reaction was performed through general procedure B using compound 55 (2.80 g, 9.3 
mmol), NH2-Ser(OH)-COOMe (1.46 g, 8.4 mmol), NaHCO3 (1.72 g, 20.5 mmol) and THF (90 
mL)/H2O (60 mL) as solvents. In this way was not possible to obtain the desired product 57. 
 
 
3.73. Synthesis of N-(9-Fluorenylmethyloxycarbonyl)-O-t-butyl-L-seryl-L-
serine succinimidyl ester (58) 
 
 
 
The reaction was performed through General procedure A using compound 49 (5.00 g, 10.6 
mmol), DCC (2.63 g, 12.8 mmol), NHS (1.47 g, 12.8 mmol) and DCM (200 mL) as solvent. In 
this way was not possible to obtain the desired produt 58. 
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3.74. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-serine 
methyl ester (59) 
 
 
The product was obtained through General procedure G using HCl×NH2-Ser(tBu)-COOMe 
(2.44 g, 12.2 mmol) and Z-Ser(tBu)-COOH (4.00 g, 13.5 mmol) commercially available, 
EDC×HCl (3.97 g, 20.3 mmol) and HOBt (2.78 g, 20.3 mmol), TEA (9.53 mL 67.5 mmol) and 
DMF as solvent (30 mL).  
Solvent was removed under reduced pressure. The crude solid was dissolved in DCM (50 mL) 
and washed with water (3×50 mL). Flash chromatography was performed in isocratic flow of 
10%  MeOH/DCM and the product 59 was isolated as orange oil (5.16 g, 11.4 mmol, 92%). 
Rf: 0.85 (10% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ/ppm: 7.64 (d, J = 7.3 Hz, 1H), 7.42 – 7.30 (m, 6H), 5.15-5.13 
(m, 2H), 4.73 (dt, J = 8.6, 3.0 Hz, 1H), 4.31 (m, 1H), 3.86 (dd, J = 9.1, 2.9 Hz, 1H), 3.83-3.81 
(m, 1H), 3.75 (s, 3H), 3.56 (dd, J = 9.1, 3.0 Hz, 1H), 3.46 (t, J = 8.5 Hz, 1H), 1.26 (s, 9H), 1.15 
(s, 9H).  
13C NMR (400 MHz, CDCl3) δ/ppm: 170.94, 170.76, 156.45, 136.73, 128.95, 128.57, 128.51, 
73.88, 67.37, 62.43, 53.55, 52.65, 27.79, 27.74. 
ESI-Q-TOF: [M+Na] + Calcd: 475.24, found: 475.25. 
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3.75. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-serine methyl ester (60) 
 
 
 
The product was obtained folowwing General procedure F using compound 59 (7.30 g, 16.1 
mmol), 10wt. % Pd/C (0.73 g) and EtOH as solvent (200 mL). 
Catalyst was filtered through celite bed and solvent was removed under reduced pressure to 
give product 60 as a white powder (4.77 g, 15.0 mmol, 93%). 
Rf: 0.5 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 4.64 (t, J = 3.5 Hz, 1H), 3.86 (dd, J = 9.3, 3.6 Hz, 
1H), 3.75 (s, 3H), 3.62 (dd, J = 9.3, 3.5 Hz, 1H), 3.58 (d, J = 5.5 Hz, 2H), 3.52 – 3.47 (m, 1H), 
1.24 (s, 9H), 1.19 (s, 9H). 
13C NMR (400 MHz, DMSO-d6,) δ/ppm 173.28, 171.11, 73.40, 73.05, 64.35, 62.27, 55.06, 
52.67-52.37, 27.68. 
ESI-Q-TOF: [M+Na]+ Calcd: 341.21, found: 341.24. 
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3.76. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-serine methyl ester (61) 
 
 
The product was obtained through General procedure G using compound 60 (0.10 g, 0.3 mmol) 
and Z-Ser(tBu)-COOH (0.10 g, 0.3 mmol), HOBt (0.07 g, 0.5 mmol), DMF as solvent (5 mL) 
and three different coupling reagents: 
I. DCC (0.10 g, 0.5 mmol) obtaining product 61 as yellow powder (0.08 g, 0.1 mmol, 
44%). 
II. HBTU (0.20 g, 0.5 mmol), TEA (0,24 mL 1.7 mmol) obtaining product 61 as yellow 
powder (0.13 g, 0.2 mmol, 72%). 
III. EDC×HCl (0.10 g, 0.5 mmol), TEA (0,24 mL 1.7 mmol) obtaining product 61 as yellow 
powder (0.15 g, 0.3 mmol, 83%). 
Solvents were removed under reduced pressure; the crude solid was dissolved in Et2O (5 mL) 
and washed with water (3×5 mL). Flash column chromatography was performed in isocratic 
flow of 10% MeOH/DCM and the product 61 was isolated as yellow powder. 
Scale up was performed using conditions II following General procedure G starting from 
compound 60 (4.27 g, 13.4 mmol, 50 mL of DMF). Product 61 was obtained as a yellow powder 
(5.73 g, 9.6 mmol, 72%) 
Rf: 0.80 (10% MeOH/DCM). 
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1H NMR (400 MHz, DMSO-d6,) δ/ppm: 8.05 (d, J = 8.2 Hz, 1H), 7.82 (d, J = 7.9 Hz,1H), 
7.39 – 7.30 (m, 6H), 5.05 (s, 2H), 4.49 (dt, J = 8.6, 4.5 Hz, 1H), 4.43 (m, 1H), 4.14 (dd, J = 
14.1, 6.0 Hz, 1H), 3.63 (s, 3H), 3.68 – 3.60 (m, 1H), 3.54 – 3.38 (m, 5H), 1.13 (s, 18H), 1.12 
(s, 18H), 1.10 (s, 9H).  
13C NMR (400 MHz, Methanol-d4) δ/ppm: 137.45, 128.79, 128.22, 128.10, 73.45, 73.10, 
71.98, 65.94, 62.21, 62.02, 55.76, 53.47, 53.28, 53.09, 52.31, 26.15.  
ESI-Q-TOF: [M+Na] + Calcd: 618.34, found: 618.29.  
 
 
3.77. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine 
methyl ester (62) 
 
 
 
The product was obtained through General procedure F using compound 61 (5.70 g, 9.6 mmol), 
10wt. % Pd/C (0.57 g) and EtOH as solvent (300 mL).  
Catalyst was filtered through celite bed and solvent was removed under reduced pressure to 
obtain product 62 as a white powder (4.34 g, 9.4 mmol, 98%). 
Rf: 0.50 eluted in (10% MeOH/DCM). 
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1H NMR (400 MHz, DMSO-d6,) δ/ppm: 8.07 (d, J = 8.1 Hz, 2H), 4.52 – 4.45 (dt, J = 8.2, 4.3 
Hz, 1H), 4.41 (dd, J = 11.9, 6.4 Hz, 1H), 3.70 – 3.60 (m, 1H), 3.64 (s, 3H), 3.53 (dd, J = 8.8, 
4.6 Hz, 1H), 3.51 (dd, J = 8.8, 4.6 Hz, 1H) 3.64 (m, 2H), 1.13 (s, 18H), 1.11 (s, 9H).  
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.35, 172.17, 170.56, 169.87, 172.17, 170.56, 
169.87, 73.08, 72.70, 63.98, 61.97, 61.64, 54.96, 52.88, 52.31, 51.99, 27.35, 27.21, 21,26.  
ESI-Q-TOF: [M+Na] + Calcd: 484.30, found: 484.25. 
 
 
3.78. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-serine methyl ester (63) 
 
 
 
The product was obtained following General procedure G using compound 62 (3.42 g, 7.4 
mmol) and Z-Ser(tBu)-COOH (1.50 g, 8.2 mmol), commercially available, HBTU (4.21 g, 11.1 
mmol) and HOBt (1.90 g, 11.1 mmol), TEA (5.17 mL 37.0 mmol) and DMF as solvent (50 
mL). Solvent was removed under reduced pressure; the crude solid was dissolved in DCM (50 
mL) and washed with water (3×50 mL). Flash chromatography was performed in isocratic flow 
of (10% MeOH/DCM) and the product 63 was isolated as yellow powder (3.00 g, 4.1 mmol, 
55 %). 
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Rf: 0.70 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6,) δ/ppm: 8.03 (d, J = 8.1 Hz, 1H), 7.84 – 7.79 (m, 2H), 7.39 – 
7.29 (m, 6H), 5.05 (s, 2H), 4.49 (dt, J = 8.2, 4.2 Hz, 1H), 4.45– 4.42 (m, 1H), 4.38 (dt, J = 7.6, 
5.9 Hz, 1H), 4.14 (dd, J = 14.4, 6.1 Hz, 1H), 3.66 – 3.60 (m, 1H), 3.64 (s, 3H), 3.55 – 3.39 (m, 
7H), 1.12 (s, 27H), 1.10 (s, 9H). 
13C NMR (400 MHz, CDCl3) δ/ppm: 170.86, 170.18, 169.98, 169.74, 156.39, 137.45, 128.79, 
128.22, 128.10, 73.47, 65.94, 62.21, 62.02, 55.76, 53.47, 53.28, 53.09, 52.31, 27.57.  
ESI-Q-TOF: [M+Na] + Calcd: 761.43, found: 761.41.  
 
 
3.79. Synthesis of N-carbobenzoxy-L-seryl-L-seryl-L-seryl-L-serine methyl 
ester (64) 
 
 
 
To a solution of 63 (0.10 g, 0.2 mmol) in DCM (1 mL) aqueous phosphoric acid (0.08 mL, 1.4 
mmol) was added dropwise. The mixture was stirred for 4 h at room temperature.  
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Solvents were removed under reduced pressure; the crude product was dissolved in AcOEt (5 
mL) and extracted with H2O (5 mL). Inorganic phase was then freeze-dried to obtain product 
64 as yellow powder (0.06 g, 0.1 mmol, 86%). 
Rf: 0.50 (20% MeOH/DCM). 
1H NMR (DMSO-d6, 400 MHz) δ/ppm: 8.11 – 8.04 (m, 2H), 8.02 (d, J = 8.3 Hz, 1H), 7.41 – 
7.26 (m, 6H), 5.04 (s, 2H), 4.42 – 4.29 (m, 3H), 4.16 (dd, J = 13.9, 5.9 Hz, 1H), 3.74 – 3.49 (m, 
8H), 3.62 (s, 3H). 
 
 
3.80. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-serine (65) 
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The product was obtained following General procedure D starting with compound 63 (0.80 g, 
1.1 mmol), LiOH×H2O (0.10 g, 1.65 mmol) and MeOH (30 mL) / H2O (10 mL). 
Solvents were removed under reduced pressure; the crude product was dissolved in AcOEt (5 
mL) and washed with HCl (0.1 M, 2×20 mL) and H2O (2×20 mL). Organic layer was dried 
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over Na2SO4 and evaporated under reduced pressure to obtain product 65 as a white powder 
(0.65 g, 0.9 mmol, 83%). 
Rf: 0.40 (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6,) δ/ppm: 7.83 (d, J = 7.6 Hz, 1H), 7.81 (d, J = 7.8 Hz, 1H), 
7.64 (d, J = 7.2 Hz, 1H), 7.39 – 7.27 (m, 6H), 5.04 (s, 2H), 4.38 (dt, J = 7.8, 5.8 Hz, 1H), 4.34 
– 4.32 (m, 1H),   4.15 (dd, J = 13.9, 6.3, 1H), 4.09 (dt, J = 7.2, 3.4 Hz, 1H), 3.46 (m, 8H), 1.12 
(s, 27H), 1.07 (s, 9H). ESI-Q-TOF: [M+Na] + Calcd: 747.87, found: 748.78.  
 
 
3.81. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-serine (66) 
 
 
 
The reaction was performed through General procedure F using compound 65 (0.63 g, 0.9 
mmol), 10wt. % Pd/C (0.06 g) and EtOH as solvent (50 mL). 
Catalyst was filtered through celite bed and solvent was removed under reduced pressure but 
the product didn’t decarboxylate and desired compound 66 was not obtained. 
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3.82. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-serine methyl ester (67)  
 
 
 
The product was obtained through General procedure F using compound 63 (2.30 g, 3.1 mmol), 
10wt. % Pd/C (0.23 g) and EtOH as solvent (50 mL). 
Catalyst was filtered through celite bed and solvent was removed under reduced pressure to 
obtain product 67 as white powder (1.78 g, 2.9 mmol, 95%). 
Rf: 0.5 eluted in (10% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ/ppm: 8.11 (d, J = 7.2 Hz, 1H), 7.61 – 7.45 (m, 3H), 4.72 (dt, J 
= 6.5, 2.7 Hz, 1H), 4.55 – 4.44 (m, 2H), 3.88-3.36 (m, 9H), 3.74 (s, 3H), 1.27 – 1.23 (m, 18H), 
1.22 (s, 9H), 1.15 (s, 9H). 
13C NMR (400 MHz, CDCl3,) δ/ppm 173.14, 170.56, 170.26, 170.19, 73.18, 73.57, 73.41, 
63.74, 62.06, 61.56, 61.26, 55.39, 53.22-53.11, 55.39, 27.41. 
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3.83. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-serine (66) 
 
 
 
The product was obtained through General procedure D using compound 67 (0.50 g, 0.8 mmol), 
LiOH×H2O (0.07 g, 1.7 mmol) and MeOH (9 mL) / H2O (3 mL). 
Solution was neutralized using HCl (0.1 M) and solvent was removed under reduced pressure; 
the crude product was dissolved in cold MeOH (5 mL) and LiCl was filtered out through a 
sintered funnel. Solvent was removed under reduced pressure to obtain product 66 as white 
powder (0.37 g, 0.6 mmol, 75%). 
Rf: 0.20 eluted in (20% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 4.65 – 4.50 (m, 3H), 4.12 (dd, J = 16.2, 9.2 Hz, 
1H), 3.98 – 3.54 (m, 8H), 1.26 (s, 9H), 1.25 – 1.22 (br, 18H), 1.20 (s, 9H). 
13C NMR (400 MHz, Methanol-d4) δ/ppm: 174.34, 173.89, 173.01, 172.21, 75.51, 75.35, 
75.07, 74.91, 63.33, 63.13, 62.00, 57.37-55.09, 28.06.  
ESI-Q-TOF: [M+H] + Calcd: 591.40, found: 591.73.  
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3.84. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine methyl ester (68) 
 
 
 
The product was obtained through General procedure G using compound 67 (1.00 g, 1.7 mmol) 
and Z-Ser(tBu)-COOH (0.54 g, 1.8 mmol), commercially available, HBTU (0.94 g, 2.5 mmol) 
and HOBt (0.34 g, 2.5 mmol), TEA (1.15 mL 8.3 mmol) and DMF as solvent (50 mL). Solvent 
was removed under reduced pressure. The crude solid was dissolved in DCM (50 mL) and 
washed with H2O (3×50 mL). Flash chromatography was performed in isocratic flow of (10% 
MeOH/DCM) and the product 68 was isolated as yellow powder (0.80 g, 4.9 mmol, 55 %). 
Rf: 0.65 (10% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ/ppm: 7.61 (d, J = 5.7 Hz, 1H), 7.56 (d, J = 8.5 Hz, 1H), 7.47 
– 7.42 (m, 2H), 7.41 – 7.31 (m, 6H), 5.14 (s, 2H), 4.72 (dt, J = 8.3, 2.7 Hz, 1H), 4.53 – 4.45 (m, 
3H), 4.30 (m, 1H), 3.89 – 3.77 (m, 5H), 3.73 (s, 3H), 3.55 (dd, J = 9.1, 2.9 Hz, 1H), 3.50 – 3.36 
(m, 4H), 1.25 (s, 9H), 1.23 (s, 9H), 1.23 (s, 18H), 1.15 (s, 9H). 
13C NMR (400 MHz, CDCl3) δ/ppm: 170.55, 170.25, 170.09, 169.81, 156.03, 136.31, 128.51, 
128.11, 74.31, 74.20, 73.39, 66.98, 62.06, 61.88, 61.46, 61.32, 54.63, 53.62, 53.56, 53.16, 
53.06, 52.10, 27.38.  
ESI-Q-TOF: [M+Na] + Calcd: 905.08, found: 905.70.  
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3.85. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-serine methyl ester (69) 
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The product was obtained through General procedure F starting from compound 68 (0.75 g, 0.9 
mmol), 10wt. % Pd/C (0.09 g) and EtOH as solvent (60 mL). 
Catalyst was filtered through celite bed and solvent was removed under reduced pressure to 
obtain product 69 as white powder (0.59 g, 0.8 mmol, 93%). 
Rf: 0.55 (10% MeOH/DCM). 
1H NMR (400 MHz, CDCl3,) δ/ppm: 8.14 (d, J = 7.1 Hz, 1H), 7.57 (d, J = 8.4 Hz, 1H), 7.51 
(d, J = 6.9 Hz, 1H), 7.48 (d, J = 6.6 Hz, 1H), 4.71 (dt, J = 8.5, 3.0 Hz, 1H), 4.55 – 4.44 (m, 3H), 
3.90 – 3.77 (m, 4H), 3.73 (s, 3H), 3.66 (dd, J = 8.2, 4.8 Hz, 1H) 3.61 – 3.37 (m, 6H), 1.25 (s, 
9H), 1.23 (s, 18H). 1.22 (s, 9H). 1.14 (s, 9H). 
13C NMR (400 MHz, CDCl3) δ/ppm 173.27, 170.83, 170.51, 170.38, 170.23, 74.49, 73.87, 
73.67, 63.89, 62.31, 61.79, 61.65, 55.61, 55.61, 53.81, 53.44, 52.40, 27.65.  
ESI-Q-TOF: [M+Na] + Calcd: 748.51, found: 748.84.  
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3.86. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-serine (70) 
 
 
 
The product was obtained through general procedure D using compound 69 (0.57 g, 0.8 mmol), 
LiOH×H2O (0.06 g, 1.5 mmol) and MeOH (9 mL) / H2O (3 mL). 
Solution was neutralized using HCl (0.1 M) and solvent was removed under reduced pressure; 
the crude product was dissolved in cold MeOH (5 mL) and LiCl was filtered out through a 
sintered funnel. Solvent was removed under reduced pressure to obtain product 70 as white 
powder (0.44 g, 0.6 mmol, 79%). 
Rf: 0.20 (20% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 4.59 – 4.47 (m, 3H), 4.44 – 4.40 (m, 1H), 4.13 – 
4.05 (m, 1H), 3.93 – 3.56 (m, 10H), 1.27 (s, 9H), 1.25 (s, 9H), 1.25 (s, 9H), 1.24 (s, 9H), 1.18 
(s, 9H).  
ESI-Q-TOF: [M+H] + Calcd: 756.47, found: 756.80.  
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3.87. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-serine 
methyl ester (59) 
 
 
The product was obtained through General procedure G using HCl×NH2-Ser(tBu)-COOMe 
(6,53 g, 30.9 mmol) and Z-Ser(tBu)-COOH (10.00 g, 34.0 mmol), commercially available, 
HBTU (17.56 g, 46.3 mmol) and HOBt (6.26 g, 46.3 mmol), TEA as base (21.45 mL 154.3 
mmol) and DMF as solvent (50 mL). 
Precipitation was unsuccessful; after the removal of solvent under reduced pressure, the crude 
solid was dissolved in hexane (50 mL) and washed with water (3×30 mL). 
Flash chromatography was performed in isocratic flow of (10% MeOH/DCM) and the product 
59 was isolated as orange oil (11.20 g, 24.8 mmol, 80%). 
Rf: 0.85 eluted in (10% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ/ppm: 7.64 (d, J = 7.3 Hz, 1H), 7.42 – 7.30 (m, 6H), 5.15-5.13 
(m, 2H), 4.73 (dt, J = 8.6, 3.0 Hz, 1H), 4.31 (m, 1H), 3.86 (dd, J = 9.1, 2.9 Hz, 1H), 3.83-3.81 
(m, 1H)., 3.75 (s, 3H), 3.56 (dd, J = 9.1, 3.0 Hz, 1H), 3.46 (t, J = 8.5 Hz, 1H), 1.26 (s, 9H), 1.15 
(s, 9H). 
13C NMR (400 MHz, CDCl3) δ/ppm: 170.94, 170.76, 156.45, 136.73, 128.95, 128.57, 128.51, 
73.88, 67.37, 62.43, 53.55, 52.65, 27.79, 27.74.  
ESI-Q-TOF: [M+Na] + Calcd: 475.24, found: 475.25.  
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3.88. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-serine methyl ester (60) 
 
 
 
The product was obtained through General procedure F using compound 59 (6.00 g, 13.3 
mmol), 10wt. % Pd/C (0.60 g) and EtOH as solvent (100 mL).  
Catalyst was filtered through celite bed and solvent was removed under reduced pressure to 
give product 60 as a white powder (4,10 g, 12.9 mmol, 97%). 
Rf: 0.5 eluted in (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 7.92 (s, 1H), 4.64 (t, J = 3.5 Hz, 1H), 3.86 (dd, J 
= 9.3, 3.6 Hz, 1H), 3.75 (s, 3H), 3.62 (dd, J = 9.3, 3.5 Hz, 1H), 3.58 (d, J = 5.5 Hz, 2H), 3.52 – 
3.47 (m, 1H), 1.24 (s, 9H), 1.19 (s, 9H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm 173.28, 171.11, 73.40, 73.05, 64.35, 62.27, 55.06, 
52.67, 52.37, 27.68.  
ESI-Q-TOF: [M+Na] + Calcd: 341.21, found: 341.24. 
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3.89. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-serine (71) 
 
 
The product was obtained through general procedure D using compound 59 (5.20 g, 11.5 
mmol), LiOH×H2O (0.96 g, 23.0 mmol) and MeOH (30 mL) / H2O (10 mL). 
Solution was neutralized using HCl (0.1 M), solvent was removed under reduced pressure; the 
crude product was dissolved in cold MeOH (10 mL) and LiCl was filtered out through a sintered 
funnel. Solvent was removed under reduced pressure to obtain product 71 as orange oil (4.30 
g, 9.8 mmol, 85%). 
Rf: 0.50 (20% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 7.97 (d, J = 7.5 Hz, 1H), 7.90 (d, J = 8.4 Hz, 1H), 
7.44 – 7.22 (m, 6H), 5.13 (s, 2H), 4.58 (s, 1H), 4.32 (dd, J = 6.6, 3.3 Hz, 1H), 3.88 – 3.85 (m, 
1H), 3.71 – 3.62 (m, 3H), 1.22 (s, 9H), 1.18 (s, 9H).  
ESI-Q-TOF: [M-H]- Calcd: 437.23, found: 437.63.  
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3.90. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-serine methyl ester (63) 
 
 
 
The product was obtained through General procedure G using compound 71 (3.03 g, 6.9 mmol) 
and compound 60 (2.00 g, 6.3 mmol), HBTU (3.57 g, 9.4 mmol), HOBt (1.27 g, 9.4 mmol), 
TEA (4.38 mL 31.4 mmol) and DMF as solvent (50 mL). 
The product was precipitated adding water dropwise under stirring at RT, the crude solid was 
dissolved in AcOEt (50 mL) and washed with H2O (3×50 mL). Flash chromatography was 
performed in isocratic flow of (10% MeOH/DCM) and the product 63 was isolated as an orange 
powder (1.80 g, 2.4 mmol, 39%). 
Rf: 0.70 eluted in (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 8.03 (d, J = 8.1 Hz, 1H), 7.84 – 7.79 (m, 2H), 7.39 – 
7.29 (m, 6H), 5.05 (s, 2H), 4.49 (dt, J = 8.2, 4.2 Hz, 1H), 4.45– 4.42 (m, 1H), 4.38 (dt, J = 7.6, 
5.9 Hz, 1H), 4.14 (dd, J = 14.4, 6.1 Hz, 1H), 3.66 – 3.60 (m, 1H), 3.64 (s, 3H), 3.55 – 3.39 (m, 
7H), 1.12 (s, 27H), 1.10 (s, 9H). 
13C NMR (400 MHz, CDCl3) δ/ppm: 170.86, 170.18, 169.98, 169.74, 156.39, 137.45, 128.79, 
128.22, 128.10, 73.47, 65.94, 62.21, 62.02, 55.76, 53.47, 53.28, 53.09, 52.31, 27.57. 
ESI-Q-TOF: [M+Na] + Calcd: 761.43, found: 761.41.   
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3.91. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-serine (65) 
 
 
 
The product was obtained through General procedure D using compound 63 (1.70 g, 2.3 mmol), 
LiOH×H2O (0.19 g, 4.6 mmol) and MeOH (30 mL) / H2O (10 mL). 
Solution was neutralized using HCl (0.1 M), solvent was removed under reduced pressure; the 
crude product was dissolved in cold MeOH (10 mL) and LiCl was filtered out through a sintered 
funnel. Solvent was removed under reduced pressure to give product 65 as an orange powder 
(1.30 g, 1.8 mmol, 78%). 
Rf: 0.30 eluted in (20% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 7.98 (d, J = 7.9 Hz, 1H), 7.90 (d, J = 8.2 Hz, 1H), 
7.44 – 7.22 (m, 6H), 5.13 (s, 2H), 4.58 (s, 1H), 4.32 (s, 1H), 3.89 – 3.82 (m, 1H), 3.72 – 3.60 
(m, 3H), 1.22 (d, J = 3.5 Hz, 9H), 1.18 (d, J = 6.2 Hz, 9H). 
 ESI-Q-TOF: [M-H]- Calcd: 437.23, found: 437.63.  
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3.92. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine 
methyl ester (72) 
 
 
 
The product was obtained through General procedure G using compound 59 (0.51 g, 1.6 mmol) 
and compound 65 (1.29 g, 1.8 mmol), HBTU (0.92 g, 2.4 mmol), HOBt (3.27 g, 2.4 mmol), 
TEA (1.13 mL 8.1 mmol) and DMF as solvent (25 mL) 
Precipitation was unsuccessful; after the removal of solvent under reduced pressure, the crude 
solid was dissolved in AcOEt (50 mL) and washed with water (3×50 mL). 
Flash chromatography was performed in isocratic flow of (10% MeOH/DCM) and the product 
72 was isolated as an orange powder (0.80 g, 0.8 mmol, 48%). 
Rf: 0.70 eluted in (10% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 7.36 (br s, 6H), 5.05 (s, 2H), 4.51 – 4.55 – 4.31 (br s, 
4H), 4.23 – 4.09 (br s, 2H), 3.62 (s, 3H), 3.68 – 3.60 (br s, 1H), 3.56 – 3.37 (br s, 11H), 1.14 – 
1.09 (br s, 54H). 
 ESI-Q-TOF: [M+Na] + Calcd: 1047.62, found: 1048.34.   
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3.93. Synthesis of N-carbobenzoxy-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine 
(73) 
 
 
 
The product was obtained through general procedure D using compound 72 (0.80 g, 0.8 mmol), 
LiOH×H2O (0.07 g, 1.6 mmol) and MeOH (30 mL) / H2O (10 mL). 
Solution was neutralized using HCl (0.1 M), solvent was removed under reduced pressure; the 
crude product was dissolved in cold MeOH (10 mL) and LiCl was filtered out through a sintered 
funnel. Solvent was removed under reduced pressure to obtain product 73 as an orange powder 
(0.75 g, 0.7 mmol, 95%). 
Rf: 0.30 (20% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 7.38 – 7.27 (m, 5H), 4.54 – 4.47 (br, 2H), 4.36 – 
4.28 (br s, 2H), 4.16 – 4.12 (br s, 1H), 4.04 – 3.98 (br s, 1H), 3.82 – 3.54 (br s, 12H), 1.24 – 
1.18 (br s, 54H).  
ESI-Q-TOF: [M+Na] + Calcd: 1033.60, found: 1033.86.  
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3.94. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine (74) 
 
 
 
The reaction was performed through General procedure F using compound 73 (0.75 g, 0.7 
mmol), 10wt. % Pd/C (0.08 g) and EtOH as solvent (30 mL). Catalyst was filtered through 
celite bed and solvent was removed under reduced pressure. In this way was not possible to 
obtain the desired product 74. 
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3.95. Synthesis of O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-
butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine (74) 
 
 
 
A solution of compound 74b (0.25 g, 0.3 mmol) in toluene (50 mL) was stirred at 120° C 
overnight. After removal of a solvent under reduced pressure, product 74 as obtained as an 
orange powder (0.21 g, 0.2 mmol, 88%). 
Rf: 0.40 (20% MeOH/DCM). 
1H NMR (400 MHz, DMSO-d6) δ/ppm: 4.50 – 4.13 (br s, 6H), 3.62 – 3.39 (br s, 12H), 1.11 
(s, 654H). 
ESI-Q-TOF: [M+H] + Calcd: 877.59, found: 877.42. 
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3.96. Synthesis of N-(9-Fluorenylmethyloxycarbonyl)-O-tosyl-L-seryl-O-
tosyl-L-serine methyl ester (75) 
 
 
 
Compound 51 (0.05 g, 0.1 mmol) and DIPEA (0.14 mL, 0.8 mmol) were dissolved under inert 
atmosphere in DCM (2 mL). The mixture was then cooled at 0°C and a solution of TsCl (0.07 
g, 0.4 mmol) in DCM (1 mL) was slowly added. 
Reaction mixture was stirred at RT for 3 hours and 30 minutes and monitored by TLC. 
Solvents were removed under reduced pressure, the crude solid was dissolved in EtOAc and 
washed with H2O. Organic layer was dried over Na2SO4 and evaporated under reduced 
pressure. In this way was not possible to obtain the desired product 75. 
 
 
3.97. Synthesis of N-t-butyloxycarbonyl-O-t-mesyl-L-seryl-O-mesyl-L-serine 
tert-butyl ester (76) 
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Reaction was performed under inert atmosphere. Compound 58 (0.10 g, 0.2 mmol) and DIPEA 
(0.17 mL, 1.0 mmol) were dissolved in dry DCM (2 mL) and cooled at 0°C under stirring. Was 
then slowlly added a solution of MsCl (0,057 mL, 0.7 mmol) in DCM (1 mL). 
Reaction mixture was stirred at RT for 3 hours and 30 minutes and monitored by TLC. Solvents 
were removed under reduced pressure, the crude solid was dissolved in EtOAc and washed with 
H2O. Organic layer was dried over Na2SO4 and evaporated under reduced pressure. 
In this way was not possible to obtain the desired product 76. 
 
 
3.98. Synthesis of N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-beta-azido-
L-seryl-N-beta-azido-L-serine methyl ester (77) 
 
 
 
Under inert atmosphere compound 51 (0.05 g, 0.1 mmol) was dissolved in dry DMF (0.1 mL) 
and cooled at 0°C under stirring. Was then slowly added DBU (0.02 mL, 0.2 mmol), DPPA 
(0.03 mL, 0.2 mmol) and NaN3 (0.01 g, 0.2 mmol). 
Reaction mixture was stirred at RT for 8 hours and monitored by TLC. 
EtOAc was added to the solution (3 mL) and the mixture was washed with H2O (3×3 mL). 
Organic layer was separated, dried over Na2SO4 and evaporated under reduced pressure. In this 
way was not possible to synthesize the desired product 77.  
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3.99. Synthesis of N-alpha-carbobenzoxy-N-beta-azido-L-seryl-N-beta-
azido-L-seryl-N-beta-azido-L-seryl-N-beta-azido-L-serine methyl ester 
(78) 
 
 
 
Under inert atmosphere compound 64 (0.05 g, 0.1 mmol) was dissolved in dry DMF (0.1 mL) 
and cooled at 0°C under stirring. Was then slowly added DBU (0.02 mL, 0.1 mmol), DPPA 
(0.03 mL, 0.1 mmol) and NaN3 (0.01 g, 0.1 mmol). Reaction mixture was stirred at RT for 8 
hours and monitored by TLC. EtOAc was added to the solution (3 mL) and the mixture was 
washed with H2O (3×3 mL). Organic layer was separated, dried over Na2SO4 and evaporated 
under reduced pressure. 
In this way was not possible to obtain the desired product 78. 
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3.100. Synthesis of cyclo L-seryl-L-seryl-L-seryl-L-serine (S4) 
 
 
 
Compound 52 was dissolved in a solution of HCl (0.5 M, 2 mL) and MeOH (2 mL) to obtain 
hydrochloride salt of product 52. 
Under inert atmosphere product 52 (0.05 g, 0.2 mmol) and Na2PdCl4 (0.12 g, 0.4 mmol) were 
dissolved in MeOH (3 mL) under stirring. Was then slowly added MeONa (0.14 mL, 1.2 mmol 
from a solution 25 wt. % in methanol). 
Reaction mixture was stirred at RT under inert atmosphere overnight and monitored by TLC. 
In this way was not possible to obtain cyclic product S4. 
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3.101. Synthesis of cyclo O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-
seryl-O-t-butyl-L-serine (S4) 
 
 
 
Under inert atmosphere product 66 (0.05 g, 0.1 mmol) and DIPEA (0.74 mL, 4.2 mmol) were 
dissolved in dry DMF (3 mL) under stirring. Was then slowly added to a solution of PfOH (0.41 
g, 2.1 mmol) and EDC×HCl (0.39 g, 2.1 mmol) in dry DMF (7 mL) in 3 hours. 
Reaction mixture was stirred at RT under inert atmosphere for 4 days and monitored by TLC. 
In this way was not possible to obtain cyclic product S4. 
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3.102. Synthesis of cyclo O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-
seryl-O-t-butyl-L-serine (S4) 
 
 
 
Under inert atmosphere product 66 (0.05 g, 0.1 mmol) was dissolved in dry DMF under stirring. 
Was then slowly added to a solution of DPPA (0.03 mL, 0.1 mmol) and DIPEA (0.03 mL, 0.2 
mmol) in dry DMF in 3 hours. 
Reaction mixture was stirred at RT under inert atmosphere for 4 days and monitored by TLC. 
In this way was not possible to obtain cyclic product S4. 
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3.103. Synthesis of cyclo O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-
seryl-O-t-butyl-L-serine (S4) 
 
 
 
The product was obtained following general procedure J starting from compound 66 (0.05 g, 
0.1 mmol), DEPBT (0.03 g, 0.1 mmol), LiCl (0.02 g, 0.4 mmol) dissolved in 0.125 mL of H2O, 
TEA until pH 8 and DMF (50 mL). 
Solvents were removed under reduced pressure; the obtained crude solid was dissolved in 
EtOAc (5 mL) and washed H2O (5×5 mL). Organic layer was dried over Na2SO4 and evaporated 
under reduced pressure. Flash chromatography was performed in gradient flow of MeOH/DCM 
(from 1% to 10%) and the product S4 was isolated as white powder (~0.01 g, ~10%). 
Rf: 0.30 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 7.41 – 7.33 (br s, 2H), 4.62 – 4.37 (br s, 4H), 3.94 
– 3.70 (br s, 8H), 1.33 – 1.18 (br s, 36H).  
ESI-Q-TOF: [M+Na] + Calcd: 595.37, found: 595.42. 
 
  
§ 3. Experimental section 135 
Nikolina Vidović PhD thesis 
3.104. Synthesis of cyclo O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-
seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine (S5) 
 
 
 
The product was obtained through general procedure J using compound 70 (0.17 g, 0.1 mmol), 
DEPBT (0.07 g, 0.3 mmol), NaCl (0.07 g, 1.0 mmol) dissolved in 0.125 mL of H2O, TEA until 
pH 8 and DMF (170 mL). Solvents were removed under reduced pressure; the crude solid 
obtained was dissolved in DCM (10 mL) and washed H2O (5×10 mL). Organic layer was dried 
over Na2SO4 and evaporated under reduced pressure. Flash chromatography was performed in 
gradient flow from 1% to 10% MeOH/DCM and the product S5 was isolated as white powder 
(0.04 g, 0.05 mmol, 21%). 
Rf: 0.50 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 8.63 (d, J = 5.4 Hz, 1H), 8.22 (d, J = 8.2 Hz, 1H), 
8.16 (d, J = 6.5 Hz, 1H), 8.08 (d, J = 9.0 Hz, 1H), 7.46 (d, J = 8.4 Hz, 1H), 4.69 – 4.62 (m, 1H), 
4.51 (dt, J = 7.6, 3.6 Hz, 1H), 4.41 (dd, J = 12.4, 6.5 Hz, 2H), 4.20 (dt, J = 6.8, 3.6 Hz, 1H), 
3.91 (dd, J = 9.3, 4.1 Hz, 1H), 3.80 (dt, J = 10.2, 3.0 Hz, 2H), 3.75 – 3.65 (m, 3H), 3.63 – 3.54 
(m, 4H), 1.35 (s, 9H), 1.24 (s, 9H), 1.23 (s, 9H), 1.21 (s, 9H), 1.18 (s, 9H). 
13C NMR (400 MHz, Methanol-d4) δ/ppm: 171.81, 171.66, 171.50, 171.02, 170.74, 74.12, 
73.39, 73.11, 73.03, 72.87, 61.73, 60.72, 60.24, 59.68, 56.39, 55.28, 54.36, 53.12, 52.40, 26.13. 
1H NMR (400 MHz, CDCl3) δ/ppm: 4.57 (br s, 5H), 3.74 (br s, 10H), 1.22 (br s, 45H). 
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13C NMR (400 MHz, CDCl3) δ/ppm: 171.77, 74.05, 60.64, 54.88, 27.44. 
ESI-Q-TOF: [M+Na] + Calcd: 738.46, found: 738.54 
 
 
3.105. Synthesis of cyclo O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-
seryl-O-t-butyl-L-seryl-O-t-butyl-L-seryl-O-t-butyl-L-serine (S6) 
 
 
The product was obtained following General procedure J starting from compound 74 (0.20 g, 
0.2 mmol), DEPBT (0.08 g, 0.3 mmol), NaCl (0.07 g, 1.1 mmol) dissolved in 0.5 mL of H2O, 
TEA until pH 8 and DMF (200 mL). 
Solvents were removed under reduced pressure; the obtained crude solid was dissolved in DCM 
(10 mL) and washed H2O (5×10 mL). Organic layer was dried over Na2SO4 and evaporated 
under reduced pressure. Flash chromatography was performed in gradient flow from 1% to 10% 
MeOH/DCM and the product S6 was isolated as white powder (0.04 g, 0.04 mmol, 15%). 
Rf: 0.50 (10% MeOH/DCM). 
1H NMR (400 MHz, Methanol-d4) δ/ppm: 4.59 – 4.41 (br s, 6H), 3.85 – 3.61 (br s, 12H), 1.26 
– 1.17 (br s, 54H).  
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ESI-Q-TOF: [M+Na] + Calcd: 881.56, found: 881.81. 
 
 
3.106. Synthesis of L-leucyl- L-leucine-methyl ester (79) 
 
 
 
MeOH (200 mL) was cooled at 0 °C and SOCl2 (3.9 mL, 53.4 mmol)  was added dropwise. 
Resulting mixture was stirred at 0 °C for 30 minutes. L-Lysine (7.00 g, 26.7 mmol) was then 
added and mixture was stirred at RT overnight and enother 3 hours on reflux. Solvent was 
removed under the reduced pressure and the resulting crude was dissolved in EtOAc (150 mL) 
and washed with saturated solution of NaHCO3 (100 mL) and H2O (100 mL). Organic layer 
was dried over MgSO4 and solvent was removed under the reduced pressure to give 79 (5.80 g, 
22.5 mmol, 84 %) as a white solid. 
Rf: 0.38 (10%MeOH/DCM). 
1H NMR (400 MHz, DMSO- d6) δ/ppm: 8.12 (d, J = 7.9 Hz, 1H), 4.38 – 4.25 (m, 1H), 3.62 
(s, 3H), 3.18 (dd, J = 8.8, 5.5 Hz, 1H), 1.79 – 1.45 (m, 4H), 1.43 – 1.36 (m, 1H), 1.26 – 1.15 
(m, 1H), 0.89 (dd, J = 6.5, 3.6 Hz, 6H), 0.85 (d, J = 6.5 Hz, 6H). 
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3.107. Synthesis of N-carbobenzoxy-L-leucyl-L-leucyl-L-leucine methyl ester 
(80) 
 
 
 
The product was obtained according to General procedure G starting from CbZ-Leu-COOH 
(5.87 g, 11.4 mmol) and H2N-Leu-Leu-COOMe (2.95 g, 10.3 mmol), EDC×HCl (3.28 g, 17.1 
mmol) and HOBt (2.31 g, 17.1 mmol), TEA (5.2 mL 57.1 mmol) and DMF as solvent (30 mL).  
After precipitation product 80 was isolated as white powder (4.05 g, 8.0 mmol, 78 %). 
Rf: 0.99 (5% MeOH/DCM). 
1H NMR (400 MHz, DMSO- d6) δ/ppm: 8.19 (d, J = 7.6 Hz, 1H), 7.89 (d, J = 8.4 Hz, 1H), 
7.41 (d, J = 8.3 Hz, 1H), 7.37 – 7.29 (m, 5H), 5.03 (s, 2H), 4.40 – 4.24 (m, 2H), 4.10 – 3.99 (m, 
1H), 3.61 (s, 3H), 1.74 – 1.33 (m, 9H), 0.99 – 0.75 (m, 18H). 
13C NMR (400 MHz, DMSO-d6) δ/ppm: 172.38, 171.65, 155.50, 136.73, 127.95, 127.30, 
126.56, 64.94, 52.74, 51.41, 50.20, 49.76, 40.49, 40.38, 24.12, 23.49, 23.04, 22.24, 21.47, 
21.16, 20.83. 
ESI-Q-TOF: [M+Na]+- Calcd: 528.62, found: 528.66. 
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3.108. Synthesis of L-leucyl- L-leucyl- L-leucine methyl ester (81) 
 
 
 
Tripeptide 80 (7.30 g, 16.1 mmol) was dissolved in EtOH (200 mL) and 10wt. % Pd/C (0.73 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 81 (4.77 g, 15.0 mmol, 93 %) was obtained as a white powder and used in the next step 
without further purification. 
Rf: 0.43 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 4.51 – 4.46 (m, 2H), 3.72 (s, 3H), 3.39 (dd, J = 8.0, 
6.3 Hz, 1H), 1.81 – 1.46 (m, 8H), 1.38 – 1.36 (m, 1H), 1.06 – 0.88 (m, 18H). 
13C NMR (400 MHz, MeOD-d4) δ/ppm: 176.43, 173.28, 173.03, 53.03, 51.24, 50.60, 44.26, 
40.70, 39.99, 24.41, 22.01, 21.96, 21.90, 21.16, 20.90, 20.36. 
ESI-Q-TOF: [M+H]+- Calcd: 372.18, found: 372.35. 
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3.109. Synthesis of N-carbobenzoxy-L-leucyl- L-leucyl- L-leucyl- L-leucyl-L-
leucine methyl ester (82) 
 
 
The product was obtained according to General procedure G starting from 81 (4.83 g, 12.7 
mmol) and CbZ-Leu-Leu-COOH (4.70 g, 11.6 mmol), EDC×HCl (3.33 g, 17.4 mmol) and 
HOBt (2.35 g, 17.4 mmol), TEA (8.1 mL 57.9 mmol) and DMF as solvent (30 mL).  
After precipitation product 82 was isolated as white powder (5.30 g, 7.4 mmol, 64 %). 
Rf: 0.98 (5% MeOH/DCM). 
1H NMR (400 MHz, DMSO- d6) δ/ppm: 8.14 (d, J = 7.6 Hz, 1H), 7.95 (d, J = 7.9 Hz, 1H), 
7.88 (d, J = 8.2 Hz, 1H), 7.81 (d, J = 8.3 Hz, 1H), 7.43 (d, J = 8.1 Hz, 1H), 7.39 – 7.28 (m, 5H), 
5.03 (s, 2H), 4.40 – 4.22 (m, 4H), 4.09 – 3.99 (m, 1H), 3.60 (s, 3H), 1.61 – 1.39 (m, 15H), 0.94 
– 0.75 (m, 30H). 
13C NMR (400 MHz, DMSO) δ/ppm: 172.71, 172.16, 171.88, 171.60, 171.32, 155.90, 137.06, 
65.30, 64.90, 53.13, 51.77, 50.82, 50.46, 50.33, 50.07, 40.96, 40.86, 40.86, 40.55, 40.25, 39.33, 
39.16, 38.97, 24.14, 24.10, 24.05, 24.01, 23.97, 22.99, 22.97, 22.78, 21.71, 21.68 , 21.50, 21.16, 
15.16. 
ESI-Q-TOF: [M+Na]+- Calcd: 754.89, found: 754.10. 
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3.110. Synthesis of L-leucyl- L-leucyl- L-leucyl- L-leucyl- L-leucyl- L-leucine 
methyl ester (83) 
 
 
Hexapeptide 82 (5.30 g, 7.4 mmol) was dissolved in EtOH (100 mL) and 10wt. % Pd/C (0.53 
g) was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 82 (4.26 g, 7.3 mmol, 98 %) was obtained as a white powder and used in the next step 
without further purification. 
Rf: 0.41 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 4.50 – 4.40 (m, 4H), 3.72 (s, 3H), 3.39 (dd, J = 8.2, 
6.1 Hz, 1H), 1.78 – 1.51 (m, 15H), 0.96 – 0.89 (m, 30H). 
13C NMR (400 MHz, MeOD) δ/ppm: 178.24, 174.70, 174.67, 174.52, 174.35, 54.62, 53.15, 
53.10, 52.90, 52.73, 52.13, 45.77, 42.04, 41.93, 41.87, 41.82, 41.48, 32.85, 25.91, 23.80, 23.66, 
23.39, 22.62, 22.43, 22.07, 21.88, 14.53. 
ESI-Q-TOF: [M-H] - Calcd: 597.45, found: 597.25. 
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3.111. Synthesis of L-leucyl- L-leucyl- L-leucyl- L-leucyl- L-leucyl- L-leucine 
(84) 
 
 
The product was obtained through General procedure D using compound 83 (4.26 g, 7.3 mmol), 
LiOH×H2O (0.63 g, 14.6 mmol) and MeOH (39 mL) / H2O (13 mL). 
Solution was neutralized using HCl (0.1 M), solvent was removed under reduced pressure; the 
crude product was dissolved in cold MeOH (10 mL) and LiCl was filtered out through a sintered 
funnel. Solvent was removed under reduced pressure to give product 84 as an white powder 
(3.99 g, 7.1 mmol, 96%). 
Rf: 0.26 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 4.52 – 4.45 (m, 4H), 3.91 (t, J = 6.9 Hz, 1H), 1.79 – 
1.54 (m, 15H), 1.06 – 0.87 (m, 30H). 
13C NMR (400 MHz, MeOD) δ/ppm: 175.81, 174.50, 174.24, 173.95, 170.59, 53.27, 52.72, 
52.02, 42.05, 41.90, 41.75, 26.01, 25.92, 25.81, 25.42, 23.56, 23.44, 23.27, 22.33, 22.25, 22.21, 
22.15, 21.93. 
 ESI-Q-TOF: [M+Na]+ Calcd: 584.51, found: 584.76.  
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3.112. Synthesis of N-carbobenzoxy-L-phenylalanyl-L-leucyl-L-leucine 
methyl ester (85) 
 
 
 
The product was obtained according to General procedure G starting from 79 (2.95 g, 10.3 
mmol) and CbZ-Phe-COOH (3.42 g, 11.4 mmol), EDC×HCl (3.28 g, 17.1 mmol) and HOBt 
(2.31 g, 17.1 mmol), TEA (5.23 mL 57.1 mmol) and DMF as solvent (40 mL).  
After precipitation product 85 was isolated as white powder (4.96 g, 9.2 mmol, 89 %). 
Rf: 0.98 (5% MeOH/DCM). 
1H NMR (400 MHz, CDCl3) δ/ppm:7.40 – 7.13 (m, 11H), 6.52 (d, J = 7.5 Hz, 1H), 6.39 (d, J 
= 7.2 Hz, 1H), 5.09 (s, 2H), 4.59 (td, J = 8.6, 5.2 Hz, 1H), 4.45 (td, J = 8.5, 5.9 Hz, 2H), 3.75 
(s, 3H), 3.18 – 3.03 (m, 2H), 1.73 – 1.42 (m, 6H), 1.00 – 0.85 (m, 12H). 
13C NMR (101 MHz, CDCl3 ) δ/ppm: 173.04, 171.16, 170.81, 135.99, 129.29, 128.82, 128.61, 
128.35, 128.13, 127.22, 67.28, 56.12, 52.32, 51.76, 50.81, 41.33, 40.83, 37.91, 24.84, 24.57, 
22.83, 21.98, 21.91. 
ESI-Q-TOF: [M+Na]+- Calcd: 562.53, found: 562.86. 
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3.113. Synthesis of -L-phenylalanyl- L-leucyl- L-leucine methyl ester (86) 
 
 
 
Tripeptide 85 (2.89 g, 5.4 mmol) was dissolved in EtOH (200 mL) and 10wt. % Pd/C (0.29 g) 
was added. In a way described in General procedure for a cleavage of CbZ protecting group 
product 86 (2.00 g, 4.9 mmol, 92 %) was obtained as a white powder and used in the next step 
without further purification. 
Rf: 0.42 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 7.33 – 7.20 (m, 5H), 4.50 – 4.46 (m, 2H), 3.72 (s, 
3H), 3.67 – 3.60 (m, 1H), 3.06 (dd, J = 13.6, 5.1 Hz, 1H), 2.81 (dd, J = 13.6, 7.7 Hz, 1H), 1.82 
– 1.48 (m, 6H), 1.06 – 0.86 (m, 12H). 
13C NMR (400 MHz, MeOD) δ/ppm: 176.46, 174.78, 174.52, 174.25, 138.73, 130.62, 129.62, 
127.84, 57.29, 52.74, 52.72, 52.17, 42.40, 42.13, 41.82, 40.82, 25.96, 25.96, 25.77, 23.48, 
23.42, 22.36, 21.98. 
ESI-Q-TOF: [M-H] - Calcd: 404.52, found: 404.78. 
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3.114. Synthesis of N-carbobenzoxy-L-phenylalanyl- L-leucyl- L-leucine (87) 
 
CbZHN
O
H
N
O
N
H O
O LiOH
MeOH/H2O CbZHN
O
H
N
O
N
H O
OH
(85) (87)  
 
The product was obtained through General procedure D using compound 85 (2.89 g, 5.4 mmol), 
LiOH×H2O (0.45 g, 10.7 mmol) and MeOH (27 mL) / H2O (9 mL). 
Solution was neutralized using HCl (0.1 M), solvent was removed under reduced pressure; the 
crude product was dissolved in cold MeOH (10 mL) and LiCl was filtered out through a sintered 
funnel. Solvent was removed under reduced pressure to give product 87 as an white powder 
(2.75 g, 5.2 mmol, 97%). 
Rf: 0.28 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 8.23 (d, J = 7.7 Hz, 1H), 8.12 (d, J = 7.7 Hz, 1H), 
7.38 – 7.15 (m, 10H), 7.17 (d, J = 8.4 Hz, 1H), 5.03 (s, 2H), 4.53 – 4.39 (m, 3H), 3.14 (dd, J = 
14.0, 9.5 Hz, 1H), 2.86 (dd, J = 14.0, 9.7 Hz, 1H), 1.81 – 1.55 (m, 6H), 1.02 – 0.88 (m, 12H). 
13C NMR (400 MHz, CDCl3) δ/ppm: 207.36, 175.61, 172.14, 171.46, 156.17, 135.98, 129.30, 
128.67, 128.57, 128.28, 128.04, 127.10, 67.24, 60.44, 56.00, 51.88, 51.15, 40.80, 38.16, 24.87, 
24.56, 22.81, 22.74, 22.05, 21.86, 20.64, 14.20. 
 ESI-Q-TOF: [M+Na]+ Calcd: 548.63, found: 548.74.  
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3.115. Synthesis of N-carbobenzoxy-L-phenylalanyl- L-leucyl- L-leucyl-L-
phenylalanyl- L-leucyl- L-leucine methyl ester (88) 
 
 
The product was obtained according to General procedure G starting from 86 (2.00 g, 4.9 mmol) 
and 87 (2.86 g, 5.4 mmol), EDC×HCl (1.42 g, 7.4 mmol) and HOBt (1.00 g, 7.4 mmol), TEA 
(3.45 mL 24.7 mmol) and DMF as solvent (40 mL).  
After precipitation product 88 was isolated as white powder (3.60 g, 3.9 mmol, 79 %). 
Rf: 0.89 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 7.38 – 7.19 (m, 15H), 5.07 (dd, J = 29.4, 12.6 Hz, 
2H), 4.61 (dd, J = 9.7, 4.6 Hz, 1H), 4.46 (dd, J = 9.8, 5.1 Hz, 2H), 4.40 (dd, J = 8.7, 5.2 Hz, 
1H), 4.25 (ddd, J = 15.0, 9.6, 5.1 Hz, 2H), 3.71 (s, 3H), 3.23 (dd, J = 14.2, 4.6 Hz, 1H), 3.13 
(dd, J = 14.0, 5.1 Hz, 1H), 2.97 (dt, J = 14.0, 8.2 Hz, 2H), 1.82 – 1.39 (m, 12H), 1.01 – 0.88 
(m, 24H). 
13C NMR (400 MHz, MeOD) δ/ppm: 175.39, 174.98, 174.71, 173.37, 138.62, 138.26, 130.45, 
130.40, 129.62, 129.57, 129.15, 128.77, 127.99, 127.84, 67.87, 58.60, 56.27, 54.34, 54.29, 
54.19, 53.23, 52.73, 52.28, 46.19, 45.74, 41.97, 41.39, 41.34, 38.69, 38.26, 30.77, 25.88, 25.87, 
25.84, 25.78, 23.75, 23.56, 23.50, 22.22, 22.06, 21.99, 21.90. 
ESI-Q-TOF: [M+Na]+- Calcd: 936.24, found: 936.35. 
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3.116. Synthesis of L-phenylalanyl- L-leucyl- L-leucyl-L-phenylalanyl- L-
leucyl- L-leucine methyl ester (89) 
 
 
Peptide 88 (3.60 g, 3.9 mmol) was dissolved in EtOH (200 mL) and 10wt. % Pd/C (0.36 g) was 
added. In a way described in General procedure for a cleavage of CbZ protecting group product 
89 (2.85 g, 3.7 mmol, 94 %) was obtained as a white powder and used in the next step without 
further purification. 
Rf: 0.35 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 7.39 – 7.15 (m, 10H), 4.63 (dd, J = 8.9, 5.0 Hz, 1H), 
4.47 (t, J = 5.0 Hz, 2H), 4.31 (dt, J = 15.0, 7.3 Hz, 2H), 3.72 (s, 3H), 3.64 (dd, J = 7.2, 5.2 Hz, 
1H), 3.21 (dd, J = 14.3, 5.1 Hz, 1H), 3.05 – 3.00 (m, 2H), 2.84 (dd, J = 13.5, 7.7 Hz, 1H), 1.81 
– 1.44 (m, 12H), 1.04 – 0.84 (m, 24H). 
13C NMR (400 MHz, MeOD) δ/ppm: 176.88, 176.72, 175.09, 174.70, 174.67, 174.65, 174.47, 
173.24, 173.09, 138.62, 138.52, 130.64, 130.39, 129.72, 129.58, 127.97, 127.87, 61.64, 57.39, 
55.95, 53.84, 53.65, 53.11, 52.74, 52.53, 52.26, 42.07, 41.98, 41.93, 41.67, 41.42, 38.35, 25.93, 
25.91, 25.88, 25.79, 23.69, 23.57, 23.52, 23.45, 22.24, 22.20, 22.16, 22.13, 21.95, 20.96, 14.57. 
ESI-Q-TOF: [M-H] - Calcd: 778.20, found: 778.35. 
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3.117. Synthesis of L-phenylalanyl- L-leucyl- L-leucyl-L-phenylalanyl- L-
leucyl- L-leucine (90) 
 
 
The product was obtained through General procedure D using compound 89 (2.85 g, 3.7 mmol), 
LiOH×H2O (0.31 g, 7.4 mmol) and MeOH (18 mL) / H2O (6 mL). 
Solution was neutralized using HCl (0.1 M), solvent was removed under reduced pressure; the 
crude product was dissolved in cold MeOH (10 mL) and LiCl was filtered out through a sintered 
funnel. Solvent was removed under reduced pressure to give product 90 as an white powder 
(2.60 g, 3.4 mmol, 92%). 
Rf: 0.24 (5% MeOH/DCM). 
1H NMR (400 MHz, MeOD- d4) δ/ppm: 7.40 – 7.09 (m, 10H), 4.67 (dd, J = 9.9, 4.6 Hz, 1H), 
4.46 (dd, J = 9.3, 5.4 Hz, 1H), 4.34 – 4.23 (m, 3H), 3.67 (dd, J = 7.6, 4.9 Hz, 1H), 3.27 (dd, J 
= 14.3, 4.5 Hz, 1H), 3.08 – 3.04 (m, 2H), 2.86 (dd, J = 13.6, 7.6 Hz, 1H), 1.79 – 1.40 (m, 12H), 
1.02 – 0.81 (m, 24H). 
13C NMR (400 MHz, MeOD) δ/ppm: 180.49, 177.17, 175.09, 174.68, 173.55, 173.37, 138.76, 
138.67, 130.65, 130.43, 129.63, 129.55, 127.92, 127.82, 127.74, 57.47, 55.93, 54.98, 53.74, 
53.69, 53.65, 53.52, 42.07, 41.98, 41.95, 41.88, 41.70, 38.39, 30.83, 26.16, 25.88, 24.33, 23.97, 
23.85 , 23.59, 23.49, 22.63, 22.21, 22.16, 22.12, 22.00. 
 ESI-Q-TOF: [M-H]- Calcd: 764.09, found: 764.10.  
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§ 4. RESULTS AND DISCUSSION 
4.1. SYNTHESIS AND CYCLIZATION OF TETRA-HEXALYSINE 
4.1.1. Fmoc synthetic strategy 
 
As a first attempt to synthesize cyclic products L4-L6, it was decided to use orthogonal Fmoc-
Boc protecting groups (Scheme 13). The first step was the synthesis of activated succinimidyl 
ester starting from Fmoc-Lys(Boc)-COOH using NHS and DCC as the condensing agents. 
Activation of the carboxyl group is a key step in the peptide synthesis. The carboxylic group 
can be activated in situ or an activated ester can be prepared and isolated as is the case here 
reported. It is necessary for the activation step to be sufficiently rapid and to preserve the optical 
purity of the starting compound. After activation of a starting amino acid, crude succinimidyl 
ester 1 was obtained and was not purified but was used as it is in further synthesis. Confirmation 
of the formation of the activated compound 1 is the disappearance of the corresponding 
carboxyl group signal in 1H NMR in DMSO-d6 and a singlet appearance at 2.82 ppm that 
belongs to the succinimidyl ester. Activated ester 1 was converted into dipeptide 3 by reaction 
with the corresponding unprotected amino acid in a mildly basic conditions in THF as a solvent. 
The formation of the dipeptide 3 was confirmed by the disappearance of the succinimide signal 
in the NMR spectra and the emergence of one signal at 3.96-3.90 ppm in the 1H NMR spectrum 
corresponding to the a second CH group and a singlet at around 1.35 ppm that corresponds to 
another Boc group. Mass analysis also confirmed formation of the desired product. These 
reactions were repeated until the formation of the compound 7. Since the isolation of the 
compound 7 was difficult, the overall yield of this synthetic route was very low (5.6 %) and the 
removal of Fmoc in solution rather problematic, we decided to try another synthetic strategy in 
order to synthesise the desired precursors.  
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Scheme 13. Synthesis of a compound 7. Overall yield 5.6 %. 
 
In fact, the use of octanthiol and DBU as a catalyst was not successful. By changing reaction 
conditions i.e. using Et2NH it was possible to remove Fmoc in 85% yield, but purification and 
isolation of the products were quite complicated.113 
 
4.1.2. CbZ - OtBu synthetic strategy 
 
The second strategy was to protect lysine using other two orthogonal protecting groups: CbZ 
and Boc (Scheme 14). Activation of a carboxyl group was done as before by converting it in 
succinimidyl ester. Succesful synthesis of a precursor 8 was confirmed by 1H NMR spectra 
(singlet integrating 4H at 2.81 ppm corresponding to CH2 of succinimidyl group). The next step 
was the condensation with the second amino acid protected on C-terminus as tert-butyl ester. 
NMR and mass analysis confermed formation of the compound 9. Since the synthesis this time 
was done from C- to N-terminus, in the next step it was neccesary to remove the CbZ protecting 
group by standard hydrogenolysis in the presence of Pd/C as a catalyst. The resulting product 
10 was coupled with ester 8 to give a fully protected tripepeptide 11 (singlets at 1.38 and 1.36 
ppm corresponding to three Boc groups and at 1.29-1.20 ppm for a tert-butyl ester in the 1H 
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NMR spectrum). Removal of CbZ by hydrogenolysis and further condensation with the 
succinimidyl ester afforded the tetrapeptide 13.  
 
Scheme 14: Synthesis of a tetrapeptide 13. Overall yield: 48.8 %. 
 
For a synthesis of compounds L4-L6 it was necessary to prepare precursors having free N- and 
C-termini but protected on the side chains, i.e. in the previously described synthetic strategy to 
selectively remove tert-butyl ester in presence of a Boc protecting group.  
To this aim, before starting the synthesis, we used a peptide containing these protecting groups, 
previously synthesized by our research group, as the model compound (Scheme 15).  
 
 
 
Scheme 15. Selective removal of a tert-butyl ester.  
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We tried two different synthetic pathways described in the literature, using both basic 
conditions and Lewis acid. Reaction with KOH wasn't successful while reaction with CeCl3 
resulted in the formation of the desired product 15. But when the same reaction conditions were 
repeated using tripeptide 11 as the substrate (Scheme 16), reaction yield was only 20 % and 
contemporary removal of one or more Boc groups was observed. Thus, the synthetic strategy 
for the preparation of linear precursors was changed again. However, tetrapeptide 13 was used 
as it was converted into the capped tetrapeptide 20 used later for a coupling with calixarenes. 
 
 
Scheme 16. Synthesis of a compound 16. Yield: 20 %. 
 
In order to obtain product 20, CbZ protecting group was succesfully removed from compound 
13 by catalytic hydrogenolysis to give 14 which was used without purification. In the next step 
acetyl group was introduced as a protecting group since it is hard to remove and it is stable in 
the conditions used for the coupling with calixarenes. Then, Boc protecting groups were 
removed by treatment of 18 with TFA to obtain a product (19) with free amino groups on side 
chains able to react with carboxyl groups of calixarene. Since TFA is a strong organic acid, in 
this reaction also tert-butyl ester was hydrolysed. The last step was introduction of methyl ester 
to protect C-terminus to obtain compound 20 (Scheme 17). 
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Scheme 17. Synthesis of a compound 20. Overall yield: 47.7 % 
 
 
4.1.3. CbZ – OMe synthetic strategy 
 
After two unsuccesful trials, we decided to use three-dimensional orthogonal protection scheme 
to build the linear peptides, then to deprotect the N- and C-termini and to cyclize them in a 
head-to-tail fashion obtaining final products L4-L6. Specifically, we planned to protect the first 
amino acid as CbZ – Boc on amino groups and the second as Boc on the side chain and as 
methyl ester on the carboxyl group. The first step was the preparation of the latter. L-lysine was 
converted into methyl ester (Scheme 18) through acyl chloride in quantitative yield. Singlet at 
3.74 ppm in 1H NMR spectra confirmed the formation of this product. 
 
 
Scheme 18. Synthesis of amino acid 22. Overall yield: 63.2 % 
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The second step was selective protection of only side chain amino group. Since NH2ε (pKa 
10.67) is more basic than NH2α (pKa 9.16) and less sterically hindered, it generally reacts faster. 
Yield (63 %) was lowered by contemporary formation of the di-protected lysine methyl ester 
22b as by-product (18 %). 
 
 
 
A singlet at 1.37 ppm that integrate ~ 9 in 1H NMR spectrum of product 22 corresponds to the 
CH3 of a Boc protecting group showing the good outcome of the reaction. 1H NMR spectra of 
product 22 and byproduct 22b were compared in Figure 22 to prove that was selectively 
protected only NH2 of the side-chain. 
 
 
Figure 22. 1H NMR comparison between product 22 and byproduct 22b. 
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CH2ε peaks of 22 and 22b have the same chemical shift (2.88 ppm), while signal of CHα of 22 
is at higher fields (3.27 ppm) compared to CHα of byproduct 22b (3.90 ppm). NHε-Boc of both 
compounds at 6.76 ppm are shown as triplets corresponding to an NH coupled to a CH2. NHα-
Boc of byproduct 22b instead is coupled with a CHα and it is a doublet at lower fields (7.19 
ppm). 
Synthesis of target molecule 23 was accomplished by reaction of hydrocloride salt of compound 
22 with commercially available CbZ-Lys(Boc)-COOH, in the presence of HBTU and 
EDC×HCl as condensation reagents and TEA as a base in DMF (Scheme 19). To obtain 24 it 
was neccesary to remove CbZ protection as already described. Repeating these two reactions, 
fully protected tetrapeptide 27 was obtained with an overall yield of 72.1 %. 
 
 
Scheme 19. Synthesis of tetrapeptide 27. Overall yield: 72.1 %. 
 
 
Tetrapeptide 27 was used as a precursor of other two products 29 and 31 (Scheme 20). For the 
synthesis of product 29, the methyl ester of 27 was hydrolyzed in basic conditions (LiOH in 
MeOH-water, 3:1) and the resulting product 28 was subjected to hydrogenolysis to give 29. 
From the other side, removal of CbZ protection from 27 to give 30, followed by coupling with 
H-Lys(Boc)-OMe led to the protected pentapeptide 31 whose structure was confirmed by NMR 
and mass analysis.  
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Scheme 20. Synthesis of products 29 and 31. Overall yields: 99.0 % and 87.0 % respectively. 
 
In the same way the pentalysine 33 and the hexalysine 35 were synthesized from precursor 31 
in 97.0 % and 77.2 %, respectively (Scheme 21). NMR and mass analysis were performed to 
confirm their structures. 
 
 
Scheme 21. Synthesis of compounds 33 and 35. Overall yields: 97.0 % and 77.2 % respectively. 
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Removal of protecting groups from N- and C-termini of the hexapeptide 35 afforded 37 in a 
very good yield (95%) (Scheme 22). 
 
 
Scheme 22. Synthesis of a compound 37. Overall yield: 95.0 %. 
 
4.1.4. Cyclization 
 
After preparation of linear precursors, the next step was head-to-tail cyclization. We followed 
a procedure described by Ye and co-workers29 in which DEPBT is used as the coupling reagent 
in DMF as a solvent, TEA as the base and LiCl or NaCl as a source of metal cations that should 
promote cyclization step. The proposed mechanism is shown in Scheme 23. According to the 
mechanism, the cation coordinate the activated C-terminal carboxyl group of the linear peptide 
and make it closer to the N-terminal amino group facilitating the subsequent ring closure. 
 
Scheme 23. Metal assisted head-to-tail cyclisation mechanism. 
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With a goal to determine the equilibrium constants of reactions of linear peptides with Na+, 
microcalorimetric titrations were performed using the methyl esters of linear tetra-, penta- and 
hexapeptides as ligands and sodium perchlorate (NaClO4) as a salt. Titrations were carried out 
at 25 °C by adding a salt solution in N,N-dimethylformamide to the ligand solution. The 
measured heats are reported in Figures 23-28. 
 
Figure 23. Dependence of successive enthalpy change on n(Na+) / n(H2N-Lys(Boc)4-OMe) in the 
microcalorimetric titration of linear H2N-Lys(Boc)4-OMe (c = 4.597·10-3 mol dm-3) with NaClO4 (c = 
0.098 mol dm-3) in N, N-dimethylformamide in the presence of TBAClO4 (c = 5,010·10-2 mol dm-3) at θ 
= 25 ° C. 
 
 
Figure 24. Microcalorimetric titration of linear H2N-Lys(Boc)4-OMe with TBAClO4 (c = 0.250 mol dm-3) 
in N,N-dimethylformamide at θ = 25 ° C. 
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Figure 25. Dependence of successive enthalpy change on n(Na+) / n(H2N-Lys(Boc)5-OMe) in the 
microcalorimetric titration of linear H2N-Lys(Boc)5-OMe (c = 4.948·10-3 mol dm-3) with NaClO4 (c = 
0.102 mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5,002·10-2 mol dm-3) at θ = 
25 ° C. 
 
 
Figure 26. Microcalorimetric titration of linear H2N-Lys(Boc)5-OMe (c = 4.944·10-3 mol dm-3) with 
TBAClO4 (c = 0.249 mol dm-3) in N, N-dimethylformamide at θ = 25 ° C. 
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Figure 27. Dependence of successive enthalpy change on n(Na+) / n(H2N-Lys(Boc)6-OMe) in the 
microcalorimetric titration of linear H2N-Lys(Boc)6-OMe (c = 4.979·10-3 mol dm-3) with NaTPB (c = 
0.102 mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5,002·10-2 mol dm-3) at θ = 
25 ° C. 
 
 
Figure 28. Microcalorimetric titration of linear H2N-Lys(Boc)6-OMe (c = 5,155·10-3 mol dm-3) with 
TBAClO4 (c = 0.249 mol dm-3) in N,N-dimethylformamide at θ = 25 ° C. 
 
Analysis of microcalorimetric data clearly indicated that there is no binding between linear 
peptides and Na+. As a consequence, the mechanism described before of Na-induced cyclization 
is not completely correct. Since the anion recognition capacity of peptides has been reported62-
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65, a possible role of chloride ion to promote cyclization could be envisaged. With the goal to 
understand the reaction mechanism we carried out a series of experiments in which 
tetraethylammonium chloride, containing a very large cation, was used as the salt in the 
titrations 
The dependence of ΔH on the amount of salt added is shown in Figures 29-31. In Table 1 the 
thermodynamic parameters of the complexation reaction are reported. 
An inert electrolyte, tetrabutylammonium perchlorate, was added to the system in order to 
reduce the heats of dissolution. The evidence of the inert behavior of perchlorate ion comes 
from the microcalorimetric titrations of linear peptides with perchlorate ion (Figures 24, 26, 
and 28). In these titrations the measured successive enthalpy changes were negligible and inapt 
for stability constant determination. 
 
 
Figure 29. Dependence of successive enthalpy change on n(Cl-) / n(H2N-Lys(Boc)5-OMe) in the 
microcalorimetric titration of linear H2N-Lys(Boc)4-OMe (c = 4.597·10-3 mol dm-3) with TEACl (c = 0.095 
mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5.010·10-2 mol dm-3) at θ = 25 ° 
C. ■ measured values, — calculated values. 
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Figure 30. Dependence of successive enthalpy change on n(Cl-) / n(H2N-Lys(Boc)5-OMe) in the 
microcalorimetric titration of linear H2N-Lys(Boc)5-OMe (c = 4.902·10-3 mol dm-3) with TEACl (c = 0.103 
mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 4.980·10-2 mol dm-3) at θ = 25 ° 
C. ■ measured values, — calculated values. 
 
 
Figure 31. Dependence of successive enthalpy change on n(Cl-) / n(H2N-Lys(Boc)6-OMe) in the 
microcalorimetric titration of linear H2N-Lys(Boc)6-OMe (c = 4,979·10-3 mol dm-3) with TEACl (c = 0.991 
mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5,002·10-2 mol dm-3) at θ = 25 ° 
C. ■ measured values, — calculated values. 
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Table 1: Thermodynamic parameters of complexation reactions of linear tetra-, penta- and hexalysine 
with chloride anion in N,N-dimethylformamide at 25 °C obtained by microcalorimetric titrations. 
solvent peptide log K  
(ΔrGƟ ± SE) 
/ kJ mol-1 
(ΔrHƟ ± SE) 
/ kJ mol-1 
(ΔrSƟ ± SE) 
/ kJ mol-1 
DMF 
H2N-(LysBoc)4-OMe 1,51 ± 0,01 -8,61 ± 0,05 2,50 ± 0,09 37,3 ± 0,2 
H2N-(LysBoc)5-OMe 1,47 ± 0,07 -8,4 ± 0,4 4,4 ± 0,9 43 ± 2 
H2N-(LysBoc)6-OMe 1,68 ± 0,03 -9,6 ± 0,2 2,8 ± 0,3 41,7 ± 0,4 
SE = standard error of the mean (N = 3) 
These data, clearly indicating a binding affinity of the linear peptides toward chloride ions, were 
confirmed by 1H NMR titrations of ligands with NaTPB and TEACl salts in deuterated N,N-
dimethylformamide. In Figures 32 and 33 the 1H NMR spectra (-hydrogen region) of linear 
pentapeptide in the presence of increasing amount of salts are shown. 
 In the titration with NaTPB only small shifts of -hydrogen signals were observed; by contrast, 
in the titration with TEACl much more significant shifts occured. This was in agreement with 
a preferred binding of chloride by the ligands investigated. 
 
Figure 32. 1H NMR titration of H2N-Lys(Boc)5-OMe (c = 1,08·10-3 mol dm-3) with NaTPB (c = 0,19952 
mol dm-3) in deuterated N,N-dimethylformamide at ϑ = 25 °C.  
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Figure 33. 1H NMR titration of H2N-Lys(Boc)5-OMe (c = 1,08·10-3 mol dm-3) with TEACl (c = 8,075·10-2 
mol dm-3) in deuterated N,N-dimethylformamide at ϑ = 25 °C. 
 
 
The results of molecular dynamics simulations, performed on tetra-, penta- and hexalysine, are 
consistent with microcalorimetric and NMR titrations, indicating that anions, not cations, can 
help linear precursors to adopt favourable conformation and bring two termini closer. Figure 
34 show structures of stable complexes of linear peptides with Cl-. 
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Figure 34. MDs simulations of a complexes of H2N-Lys(Boc)4-OMe, H2N-Lys(Boc)5-OMe and H2N-
Lys(Boc)6-OMe with Cl- in N,N-dimethylformamide. 
 
 
When the same simulations were carried out with complexes of Na+ with linear peptides only 
the complex dissociation was observed. Thus MDs simulations can be used to predict which 
ion forms the most stable complex with a linear precursor and is able to conformationally pre-
organize its reactive ends bringing them close to each other, a position suitable for the ring 
closure. Such pre-arrangement results in a fewer by-products from intermolecular processes 
and higher reaction yields. This is a very important result since cyclization step usually has a 
very low yield. Based on this finding, it is reasonable to conclude that the most likely 
mechanism for ion assisted peptide macrocyclization is that shown in Scheme 24. 
 
NH
 
Scheme 24. Proposed mechanism of the ion assisted macrocyclization of peptides. 
 
With these results in hands, synthesis of cyclic peptides L4, L5 and L6 was repeated by treating 
the linear precursors 29, 33 and 37 with the coupling reagent DEPBT in the presence of both 
NaTPB and TEACl salts to enhance the head-to-tail cyclization, under high dilution conditions 
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for 3-5 days at room temperature (Scheme 25). The obtained results, reported in Table 2, were 
in line with our expectations. Yield in the cyclisation of tetrapeptide 29 increased from 8% (in 
the presence of NaTPB) to 47% when TEACl was used as the salt. For pentapeptide 33 
difference was a little bit smaller: 26 % in the reaction with NaTPB vs 43 % with TEACl; for 
the cyclization of hexapeptide 37 we obtained 10 % yield in the reaction with NaTPB and 17 
% in a reaction with TEACl. Yields in the reactions with LiCl and NaCl were in the middle 
respect to those with NaTPB and TEACl probably due to the competition between anion and 
cation in coordination to the peptide chain. 
 
 
 
             
Scheme 26. Ion-assisted cyclisation of linear precursors.  
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Table 2. Outcome of the macrocyclization reaction in the presence of different salts. 
Linear precursor 
Yield of cyclic peptides in the presence of   
NaTPB TEACl LiCl NaCl 
29 8 % 47 % 21 % ---------- 
33 26 % 43 % ------------ 35 % 
37 10 % 17 % ------------ 15 % 
 
4.1.5. Anion binding studies 
 
To evaluate the binding properties of cyclic penta- and hexalysine (L5 and L6) toward several 
anions (Cl-, Br-, I-, NO3-, AcO-, HSO4-, H2PO4-) in acetonitrile (MeCN) microcalorimetric and 
1H NMR titrations were performed. ESI–MS spectra of ligand-anion solutions were recorded 
in order to identify the stoichiometry of the formed cyclopeptide-anion complexes as well. 
 
4.1.5.1. Cyclic pentalysine 
a) Calorimetric measurements 
 
Stasbility constants of the complexes of L5 with the Cl- (Figure 35), Br- (Figure 36), NO3- 
(Figure 38), OAc- , HSO4- (Figure 40) and H2PO4– (Figure 41) in acetonitrile were determined 
by microcalorimetric titrations. Ligand L5 forms complexes of 1:1 stoichiometry with Cl–, I– 
and NO3– anions. In the titrations with bromide and hydrogensulfate anions in addition to the 
formation of the complexes with 1:1 cyclopeptide/anion stoichiometry, the formation of 2:1 
complexes was also observed. In the titrations with I- (Figure 37) no signifacant enthalpy 
changes were observed, although the NMR measurements indicated the binding of the anion in 
the solution. These data are a clear indicator that the binding process is almost isoenthalpic. 
With that assumption, standard entropy of complexation was calculated directly from the 
binding constant obtained by 1H NMR measurements (Table 3).  
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Figure 35. a) Microcalorimetric titration of c[Lys(Boc)5] (c = 5,137 · 10-4 mol dm-3) with TEACl (c = 
4,925 · 10-3 mol dm-3) in acetonitrile at θ = 25 ° C. b) Dependence of successive enthalpy change on 
n(Cl-) / n(c[Lys(Boc)5]) ratio. ■ measured values,—calculated values. 
 
 
 
Figure 36. a) Microcalorimetric titration of c[Lys(Boc)5] (c = 5,137 · 10-4 mol dm-3) with TBABr (c = 
4,920 · 10-3 mol dm-3) in acetonitrile at θ = 25 ° C. b) Dependence of successive enthalpy change on 
n(Br-)/n(c[Lys(Boc)5]) ratio. ■ measured values, —calculated values 
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Figure 37. a) Microcalorimetric titration of c[Lys(Boc)5] (c = 5,355 · 10-4 mol dm-3) with TBAI (c = 4,444 
· 10-3 mol dm-3) in acetonitrile at θ = 25 ° C. b) Dependence of successive enthalpy change on n(I-) / 
n(c[Lys(Boc)5]) ratio. ■ measured values. 
 
 
Figure 38. a) Microcalorimetric titration of c[Lys(Boc)5] (c = 5,355 · 10-4 mol dm-3) with TBANO3 (c = 
3,499 · 10-3 mol dm-3) in acetonitrile at θ = 25 ° C. b) Dependence of successive enthalpy change on 
n(NO3-) / n(c[Lys(Boc)5]) ratio. ■ measured values,—calculated values. 
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Figure 39. a) Microcalorimetric titration of c[Lys(Boc)5] (c = 5,113 · 10-4 mol dm-3) with TBAOAc(c = 
5,730 · 10-3 mol dm-3) in acetonitrile at θ = 25 ° C. b) Dependence of successive enthalpy change on 
n(OAc-) / n(c[Lys(Boc)5]) ratio. ■ measured values,—calculated values. 
 
 
 
Figure 40. a) Microcalorimetric titration of c[Lys(Boc)5] (c = 5,110 · 10-4 mol dm-3) with TBAHSO4 (c = 
5,070 · 10-3 mol dm-3) in acetonitrile at θ = 25 ° C. b) Dependence of successive enthalpy change on 
n(HSO4-) / n(c[Lys(Boc)5]) ratio. ■ measured values,—calculated values. 
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The ITC isotherm obtained by titrating L5 with TBAH2PO4 in acetonitrile (Figure 41) is of 
characteristic shape for strong binding event and has an inflection point at the value of n(H2PO4–
)/n(L5) ratio being ≈ 2. This is a clear indicator for the formation of L5·(H2PO4)22– complex.  
 
 
Figure 41. a) Microcalorimetric titration of c[Lys(Boc)5] (c = 4,827 · 10-4 mol dm-3) with TBAH2PO4 (c = 
9,498 · 10-3 mol dm-3) in acetonitrile at θ = 25 ° C. b) Dependence of successive enthalpy change on 
n(H2PO4-) / n(c[Lys(Boc)5]) ratio. ■ measured values,—calculated values. 
 
Ligands L5 in acetonitrile forms the most stable 1:1 complex with the chloride anion, followed 
by hydrogensulfate and bromide anions, dihydrogenphosphate, and finally with iodide and 
nitrate ions (Table 5). The binding of halide anions is almost solely entropy driven which can 
be attributed to the desolvation of the anion upon complexation. This is most evident in the case 
of the formation of the complexes with bromide and iodide anions. On the other hand, the 
binding of structural oxoanions has a more pronounced enthalpic contribution to the standard 
reaction Gibbs energy, with the exception for the formation of L5-nitrate complex (Table 5). In 
the case of H2PO4– anion, the formation of 1:1 complex is accompanied by a favourable 
enthalpy change while the complexation entropy is unfavourable. The formation of the 1:2 
complex has a similar cumulative entropy change indicating that the complexation of the second 
anion by 1:1 complex is isoentropic. Successive equilibrium constants for the formation of both 
1:1 and 1:2 complex were determined from the titrations data, being log K1 = 4,04 for the 
formation of 1:1 complex and log K2 = 4.57 for the 1:2 complex. It should be noted that the 
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second constant is larger than first one, indicating the cooperative binding of the second 
dihydrogenphosphate anion. In the model used for the titration data processing, the dimerization 
of H2PO4– was taken into account.117  
 
 
b) NMR measurements  
 
Addition of 1 equivalent of TEACl to a solution of L5 in deuterated acetonitrile induced a 
downfield shift of NH amide signals by ≈ 1 ppm and of α-CH signals by ≈ 0.3 ppm while no 
shift was observed for NH-Boc signals (Figure 42). This indicates a very strong binding of Cl- 
by NH amide group while NH-Boc does not contribute to the interaction, which is in agreement 
with results obtained by MD simulations (Figure 56). Further addition of TEACl did not cause 
shift of signals. A very rough estimation of the maximum value of the stability constant of the 
1: 1 complexes that can be reliably determined by NMR is 104. The stability constant for 
chloride binding is log K1 = 5.72 and therefore could not be determined by NMR titrations. 
 
 
Figure 42. 1H NMR titration of c[Lys(Boc)]5 (c = 0,003 mol dm-3) with TEACl (c = 0,01 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
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Analogously to titration with TEACl, by adding TBABr (Figure 43), TBAI (Figure 44) and 
TBANO3 (Figure 45) to a solution of L5 in deuterated acetonitrile a downfield shifts of NH 
amide signals (≈ 0.65, ≈ 0.35 and 0.25  ppm, respectively) of α-CH signals (≈ 0.3 ppm) was 
observed, whereas no shift of NH-Boc signals occured. This confirms that interaction of the 
cyclopeptide with halide ions involves NH groups of the peptide backbone, whereas NH-Boc 
does not contribute to complex formation.  
 
Figure 43. 1H NMR titration of c[Lys(Boc)]5 (c = 0,003 mol dm-3) with TBABr (c = 8,79 · 10-3 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
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Figure 44. 1H NMR titration of c[Lys(Boc)]5 (c = 0,003 mol dm-3) with TBAI (c = 0,021 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
 
 
Figure 45. 1H NMR titration of c[Lys(Boc)]5 (c = 0,003 mol dm-3) with TBANO3 (c = 0,047 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
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By contrast, addition of TBAOAc (1 eq.), TBAHSO4 (1.3 eq.) and TBAH2PO4 (1.3 eq.) to a 
solution of L5 in deuterated acetonitrile (Figures 46-48) causes the appearance of a new set of 
signals growing in intensity, while simultanously resonances of the free ligand decrease and 
broaden. This indicates that the formation of the complex is slow on the NMR time scale. Both 
NH amide signals and α-CH signals exhibited a downfield shift, which is very significant in the 
case of H2PO4 (about 2 ppm). Moreover, signals of NH-Boc groups also appeared slightly 
downfield shifted indicating that they contribute to AcO-, HSO4- and H2PO4- anions 
complexation. 
  
 
Figure 46. 1H NMR titration of c[Lys(Boc)]5 (c = 0,003 mol dm-3) with TBAOAc (c = 0,01mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
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Figure 47. 1H NMR titration of c[Lys(Boc)]5 (c = 0,003 mol dm-3) with TBAHSO4 (c = 0,011 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
 
 
Figure 48. 1H NMR titration of c[Lys(Boc)]5 (c = 0,003 mol dm-3) with TBAH2PO4 (c = 0,011 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
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c) ESI titrations 
 
The ESI mass spectra (negative mode) of L5 in acetonitrile containing 0.5, 1 and 2 equivalents 
of TEACl, TBABr, TBAI, TBANO3 and TBAOAc show two main peaks (Figures 49-53). One 
signal belongs to the 1:1 complex of L5 with corresponding anion and the other one to the L5 
complex with formic acid. No evidence for presence of higher complexes could be detected.  
 
 
Figure 49. ESI MS spectrum (negative mode) of L5 after addition of 1 equivalent of TEACl. Signals 
assigned to 1:1 complex L5·Cl- and complex with formic acid are shown. 
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Figure 50. ESI MS spectrum (negative mode) of L5 after addition of 1 equivalent of TBABr. Signals 
assigned to complex with formic acid and 1:1 complex L5·Br- are shown. 
 
 
Figure 51. ESI MS spectrum (negative mode) of L5 after addition of 1 equivalent of TBAI. Signals 
assigned to a complex with formic acid and 1:1 complex L5·I- are shown. 
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Figure 52. ESI MS spectrum (negative mode) of L5 after addition of 0.5 equivalents of TBANO3. Signals 
assigned to a complex with formic acid and 1:1 complex L5·NO3- are shown. 
 
 
Figure 53. ESI MS spectrum (negative mode) of L5 after addition of 2 equivalents of TBAOAc. Signals 
assigned to a complex with formic acid and 1:1 complex L5·OAc- are shown. 
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The ESI mass spectra (negative mode) containing TBAHSO4 show five signals. Two signals 
belong to the single and doubly charged 1:1 complex L5·HSO4-, one to the L5 complex with 
formic acid, one to the doubly charged 2:1 complex L5·HSO4- and the fifth one to the 1:1 
complex with one TBA cation (Figure 54). 
 
 
Figure 54. ESI MS spectrum (negative mode) of L5 after addition of 1 equivalent of TBAHSO4. Signals 
assigned to a doubly charged 1:1 complex L5·HSO4-, doubly charged 2:1 complex L5·HSO4-, 1:1 
complex L5·HSO4-are shown. 
 
 
Similarly, spectra after addion of TBAH2PO4 show three signals: complex with formic acid, 
1:1 complex L5·H2PO4- and doubly charged 2:1 complex L5·H2PO4- (Figure 55). 
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Figure 55. ESI MS spectrum (negative mode) of L5 after addition of 1 equivalent of TBAH2PO4. Signals 
assigned to a complex with formic acid and 1:1 complex L5·H2PO4-are shown. 
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Table 3. L5-anion complexes in ESI-MS spectrum (negative mode). 
 Ion (ESI-) m/z 
No salt [M+FA]- 1185.1 
Cl- [M+Cl]- 1175.2 
Br- [M+Br]- 1218.9 
I- [M+I]- 1267.2 
NO3- [M+NO3]- 1203.3 
OAc- [M+OAc]- 1201.9 
HSO4- [M+HSO4-1]2- 
[2M+HSO4-1]2- 
 [M+HSO4]- 
 [M+HSO4]- TBA+ 
617.9 
1188.9 
1237.2 
1479.3 
H2PO4- [2M+H2PO4-1]2- 
[M+H2PO4]- 
1189.5 
1238.2 
 
d) Molecular dynamics simulations 
 
The structure of L5-anion 1:1 complexes (Figures 56-59) were obtained by molecular dynamics 
simulations in acetonitrile with explicit solvent molecules. In the MD simulations studied 
anions were bound by all five amide protons of L5 (Table 4) and in some cases with the protons 
from the NH Boc groups (AcO-, HSO4- and H2PO4-). These results are backed by NMR spectra 
of the complexes from which the participation of NH Boc groups in the anion binding can be 
clearly deduced (Figures 46-48). Structures and stabilities of complexes with higher 
stoichiometries are under further investigation.  
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Table 4: The average number of bonds formed between protons of L5 and complexed anion in 
acetonitrile obtained by MD simulations. 
 N(amide-anion bonds) N(carbamate-anion bonds) 
Cl- 5.0 0.1 
Br- 5.0 0.1 
I- 5.0 0.5 
NO3- 7.4 1.4 
OAc- 7.32 0.85 
HSO4- 7.2 2.4 
H2PO4- 7.4 2.4 
 
  
           
 
Figure 56. Structures of a complexes of c[Lys(Boc)]5 with Cl- (left) and Br- (right) obtained by MDs 
simulations in acetonitrile at 25 °C. 
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Figure 57. Structures of a complexes of c[Lys(Boc)]5 with I- (left) and NO3- (right) obtained by MDs 
simulations in acetonitrile at 25 °C. 
 
 
 
 
Figure 58. Structures of a complexes of c[Lys(Boc)]5 with AcO- (left) and HSO4- (right) obtained by MDs 
simulations in acetonitrile at 25 °C. 
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Figure 59. Structures of a complexes of c[Lys(Boc)]5 with H2PO4- obtained by MDs simulations in 
acetonitrile at 25 °C. 
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Table 5. Thermodynamic parameters for complexation reaction of cyclic pentalysine L5 with different 
anions in acetonitrile at 25 ° C. 
solvent anion log βna ± SE 
(ΔrGƟ ± SE) 
/ kJ mol-1 
(ΔrHƟ ± SE) 
/ kJ mol-1 
(ΔrSƟ ± SE) 
/ J mol-1 K-1 
 
MeCN 
Cl- 
5,72 ± 0,02b (1:1) -32,7 ± 0,1 -8,6 ± 0,1 80,6 ± 0,3 
> 4c (1:1)    
Br- 
4,95 ± 0,05 (1:1) -28,3 ± 0,3 -4,2 ± 0,1 80,8 ± 0,3 
9,05 ± 0,07 (1:2) -51,6 ± 0,4 -3,98 ± 0,06 159,7 ± 0,4 
> 4c (1:1)    
I- 
- d -16,55 ± 0,04 ≈ 0 55,5 ± 0,1 
2,90 ± 0,02c (1:1)    
NO3- 
2,79 ± 0,01b (1:1) -15,86 ± 0,08 -6,0 ± 0,2 33 ± 1 
3,05 ± 0,03c (1:1)  -17,4 ± 0,2   
H2PO4- 
4,04 ± 0,02c (1:1) -23,03 ± 0,09 -49,7 ± 0,9 -89,5 ± 0,9 
8,607 ± 0,005f (1:2) -49,13 ± 0,03 -75,9 ± 0,2 -89,8 ± 0,2 
> 4b (1:1)    
HSO4- 
4,98b (1:1) -28,42 -15,43 43,6 
8,24b (2:1)  -47,03 -29,22 59,7 
> 4c (1:1)    
CH3COO- 
In progress     
    
a Cumulative stability constants of 1:1 and 1:2 (ligand:anion) complexes. b Determined by microcalorimetric 
measurments, c Determined by 1H NMR titrations, d Isenthalpic process,  
SE = standard error of the mean (N = 3) 
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4.1.5.2. Cyclic hexalysine  
 
Very similar results were obtained when the binding of cyclic hexalysine L6 to the anions was 
investigated by 1H NMR and ESI titrations. Microcalorimetric titrations are still in progress.  
 
a) NMR titrations 
Addition of TEACl to a solution of L6 in deuterated acetonitrile produced downfield shifts of 
NH amide and α-CH signals while no shift was observed for NH-Boc signals (Figure 60). As 
confirmed by MD simulations (Figure 74), NH Boc does not participate in anion binding. 
Calculated binding constant amounts log K1 = 3.41. The analysis of titrations with TBABr and 
TBAI resulted in binding constants which amount log K1 = 2.79 and log K1 = 1.54, respectively 
(Figures 61 and 62). It is worth to note that similar results were obtained also for pentapeptide, 
but binding constants were higher which means that pentapeptide binds more strongly these 
anions. 
 
 
Figure 61. 1H NMR titration of c[Lys(Boc)]6 (c = 9,90 · 10-4 mol dm-3) with TEACl (c = 0,01 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C.  
§ 4. Results and discussion 188 
Nikolina Vidović PhD thesis 
 
Figure 62. 1H NMR titration of c[Lys(Boc)]6 (c = 9,90 · 10-4 mol dm-3) with TBABr (c = 0,02 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C. 
 
 
Figure 63. 1H NMR titration of c[Lys(Boc)]6 (c = 9,90 · 10-4 mol dm-3) with TBAI (c = 0,0498 mol dm-3) in 
deuterated acetonitrile at ϑ = 25 °C.  
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NMR spectra recorded after the addition of TBAOAc (3.9 eq.), TBAHSO4 (2.8 eq.), and 
TBAH2PO4 (2.2 eq.) to a solution of L6 in deuterated acetonitrile show downfield shift of NH 
amide signals, NH-Boc signals and α-CH signals (Figures 64-66). That indicates a binding of 
all anions by NH amide group but with a contribution of also NH-Boc. In addition, in the case 
of TBAH2PO4 the appearance of a new set of signals can be noted. Binding constant calculated 
from the titration data corresponding to TBAOAc amounts to log K > 4 and indicate a very 
strong binding of this anion. Actually, the strongest binding of hexapeptide is with acetate 
anion, unlike pentapeptide which binds Cl- more strongly. From these results we can conclude 
that peptides with larger binding site (like hexapeptide) bind more efficiently larger anions. 
  
 
Figure 64. 1H NMR titration of c[Lys(Boc)]6 (c = 9,90 · 10-4 mol dm-3) with TBAOAc (c = 0,0105 mol dm-
3) in deuterated acetonitrile at ϑ = 25 °C. 
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Figure 65. 1H NMR titration of c[Lys(Boc)]6 (c = 9,90 · 10-4 mol dm-3) with TBAHSO4 (c = 0,0102 mol dm-
3) in deuterated acetonitrile at ϑ = 25 °C. 
 
 
Figure 66. 1H NMR titration of c[Lys(Boc)]6 (c = 9,90 · 10-4 mol dm-3) with TBAH2PO4 (c = 9,96 · 10-3 mol 
dm-3) in deuterated acetonitrile at ϑ = 25 °C.  
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b) ESI titrstions 
In ESI mass spectrum (negative mode), after addition of TEACl, two signals could be detected; 
one can be atributed to the L6 complex with formic acid (Figure 67) and the other one to the 
1:1 complex L6·Cl- (Figure 68). Similar results were obtained using TBABr and TBAI (Figures 
69-70). 
 
 
 
Figure 67. ESI MS spectrum (negative mode) of L6 ater addition of 0.5 equivalents of TEACl. Signal 
assigned to a complex with formic acid is shown. 
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Figure 68. ESI MS spectrum (negative mode) of L6 ater addition of 1 and 2 equivalents of TEACl. Signal 
assigned to a 1:1 complex L6·Cl- is shown. 
 
 
Figure 69. ESI MS spectrum (negative mode) of L6 ater addition of 0.5 equivalents of TBABr. Signals 
assigned to a complex with formic acid and 1:1 complex L6·Br- are shown. 
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Figure 70. ESI MS spectrum (negative mode) of L6 ater addition of 1 equivalent of TBAI. Signals 
assigned to a complex with formic acid and 1:1 complex L6·I- are shown. 
 
 
The ESI mass spectrum (negative mode) of L6 in acetonitrile containing TBAOAc, show two 
main signals that can be attributed to a deprotonated ligand and complex with formic acid. Only 
small signals that belong to the 1:1 complex L6·OAc-and L6·2OAc- can be detected (Figure 
71). In the case of TBAHSO4, four signals can be noted (Figure 72); two of them belong to the 
single and double charged 1:1 complex L6·HSO4-, one to the doubly charged 2:1 complex 
2L6·HSO4- and the fourth one to the 1:1 complex with one TBA cation. ESI spectra with 
TBAH2PO4 show the analogous signals as with HSO4 with addition of a signal that can be 
attributed to the double charged 2:2 complex L6·H2PO4- with TBA cation (Figure 73). 
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Figure 71. ESI MS spectrum (negative mode) of L6 ater addition of 1 equivalent of TBAOAc. Signals 
assigned to a deprotonated ligand, complex with formic acid, 1:1 complex L6·OAc- and 1:2 complex 
L6·OAc- are shown. 
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Figure 72. ESI MS spectrum (negative mode) of L6 ater addition of 1 equivalent of TBAHSO4.Signals 
assigned to a doubly charged 1:1 complex L6·HSO4-, doubly charged 2:1 complex L6·HSO4-, 1:1 
complex L6·HSO4- and 1:1 complex L6·HSO4- with TBA cation are shown. 
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Figure 73. ESI MS spectrum (negative mode)  of L6 ater addition of 1 equivalent of TBAH2PO4.Signals 
assigned to a doubly charged 1:1 complex L6·H2PO4-, doubly charged 2:1 complex L6·H2PO4-, 1:1 
complex L6·H2PO4-, 1:1 complex L6·H2PO4- with TBA cation and doubly charged 2:2 complex L6·H2PO4- 
with TBA cation. 
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Table 6. L6-anion complexes in ESI-MS spectrum (negative mode). 
 Ion (ESI-) m/z 
No salt [M+FA]- 1413.3 
Cl- [M+Cl]- 1403.3 
Br- [M+Br]- 1449.3 
I- [M+I]- 1495.2 
NO3- [M+NO3]- 1430.3 
OAc- [M+OAc]- 
[M+2OAc]- 
1426.9 
1492.1 
HSO4- [M+HSO4-1]2- 
[2M+HSO4-1]2- 
 [M+HSO4]- 
 [M+HSO4]- TBA+ 
732.1 
1416.9 
1465.3 
1706.4 
H2PO4- [M+H2PO4-1]2- 
[2M+H2PO4-1]2- 
[M+H2PO4]-  
[M+H2PO4]- TBA+ 
[[M+H2PO4]2 TBA]2- 
732.1 
1416.7 
1465.3 
1708.4 
1804.4 
 
 
c) Molecular dynamics simulations 
Molecular dynamics simulation of 1:1 complexes of L6 with anions were also performed 
(Figures 74-76). Similar as for the pentapeptide, the formation of complexes of 1:1 
stoichiometry was confirmed which correlates well with the results of NMR titrations. 
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Monoatomic anions are preferably coordinated by amide protons of L6 while in the 
coordination sphere of the larger cations the participation of carbamatic groups is observed 
(Table 7). It should be noted the average number of bonds between L6 and halogen anions is 
smaller than in the corresponding complexes of L5 ligand. That can at least partially explain 
the reduced stability of halogen anion L6 complexes compared to the ones of L5. The MD 
simulations of complexes with higher stoichiometries are planned to be performed in future 
investigations. 
 
Table 7: The average number of bonds formed between protons of L6 and complexed anion in 
acetonitrile obtained by MD simulations. 
 N(amide-anion bonds) N(carbamate-anion bonds) 
Cl- 4.9 0.1 
Br- 4.6 0.2 
I- 3.0 0.2 
NO3- 7.9 1.3 
OAc- 9.1 0.7 
HSO4- 8.5 1.4 
 
 
 
Figure 74. Structures of a complexes of c[Lys(Boc)]6 with Cl- (left) and Br- (right) obtained by MDs 
simulations in acetonitrile at 25 °C. 
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Figure 75. Structures of a complexes of c[Lys(Boc)]6 with I- (left) and OAc- (right) obtained by MDs 
simulations in acetonitrile at 25 °C. 
 
 
              
Figure 76. Structures of a complexes of c[Lys(Boc)]6 with HSO4- (left) and H2PO4- (right) obtained by 
MDs simulations in acetonitrile at 25 °C. 
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4.1.6. Synthesis of a peptidocalix[4]arenes 
 
With the aim to synthesize a novel class of anion recepetors, namely calixarene homo-
cyclopeptide derivatives, we needed to set-up a simple and efficient method to directly 
conjugate cyclopeptides L4-L6 to calixarenes through the amino acid side chains. Specifically, 
the p-tert-butyl-lower-rim-functionalized calix[4]arenes C1, previously synthesized at 
University of Zagreb, was activated both to the acyl chloride C2 by reaction with thionyl 
chloride and to the succinimidyl ester by reaction with NHS/DCC. By coupling C2 with Fmoc-
Lys(NH2)-COOMe, used as the model compound, in the presence of DIPEA as a base in DCM 
as a solvent we obtained the tetralysine-calix[4]arene derivative C4 (Scheme 27) in 59% yield. 
 
Scheme 27. Synthesis of a compounds C2, C3 and C4.  
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Unfortunately, any attempt to conjugate the capped linear tetrapeptide 20 to the calix[4]arene 
derivative C1 under the same experimental conditions was unsuccessfull. Also reaction of 20 
with the activated tetraester C3 didn't lead to the desired product C5 (Scheme 28). 
 
 
Scheme 28. Synthesis of a compound C5. 
 
 
As an alternative approach, we explored the possibility to use the tetralysine derivative C4 as 
the precursor of C5, i.e. to obtain the cyclic tetrapeptide C5 by reaction of amino and carboxyl 
groups of the lysines already conjugated to calixarene. In this way calixarene could serve as a 
template for the cyclization reaction.  
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Scheme 29. Synthesis of a compound C6. 
 
The first step was the removal of Fmoc protecting group from C4 N-terminus (Scheme 29). 
Then, we tried to get peptide bonds through intramolecular aminolysis of methyl esters by 
heating the precursor C6 under reflux in EtOH and diethylaniline (Scheme 30), but in both cases 
the reaction was not succsesful.  
In the last few years mechanochemistry, i.e., chemical transformations initiated or sustained by 
mechanical force, has become a very attractive field. This approach reduce significantly use of 
organic solvents and it is a very useful for a reagents with reduced solubility. Mechanochemical 
reactions are carried out in sealed vessels or jars of materials like stainless steel, carbide, agate, 
etc. Since procedures for amide bond formation by mechanocemical milling has been reported 
in the literature118,119 we decided to try this alternative route. Specifically, precursor C6 was 
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milled for 2 hours with NaCl to obtain diluted conditions (Scheme 30). Even this reaction didn't 
lead to the desired product. 
 
 
Scheme 30. Attempt of a synthesis of a product C8. 
 
A possible explanation of the unsuccessful outcome of the previous reactions could be the not 
sufficient activation of the carboxylic groups. For this reason, the ester groups of compound C6 
were hydrolyzed with LiOH (Scheme 31) and the resulting product C7 was treated with a very 
strong coupling reagent PyBop both in solution (DMF) in the presence of DIPEA and by milling 
in the presence of NaHCO3 as a base and NaCl to obtain diluted conditions (Scheme 32). 
In both cases, no formation of the cyclic peptidocalixarene C8 was observed. 
Work is in progress to find the proper conditions for the conjugation reaction.  
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Scheme 31. Hydrolysis of the methyl ester. 
 
 
Scheme 32. An attempt of a synthesis of C8.  
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4.2. AMINOALANINE 
4.2.1. Synthesis of aminoalanine 
 
As a first approach to prepare poly-β-aminoalanines we decide to use the synthesized 
polyserines (see chapter 4.3) as staring material. Unfortunately, any attempt to convert the side-
chain-OH groups of the into NH2 (using TsCl/NaN3, MsCl/NaN3, DPPA/NaN3) was 
unsuccessful. 
Probably the presence of inter- or intramolecular hydrogen bonds makes the hydroxyl group 
less reactive inhibiting the formation of the desired products. 
β-amino-L-alanine is commercially available but it is prohibitively expensive (CbZ-β-amino-
L-alanine(Boc)-COOH (40b): 500 mg, 132 €, Sigma Aldrich).  
A number of synthesis of β-amino-L-alanine derivatives are reported in the literature.120-122 
Among them we selected the route based on the Hofmann rearrangement of protected 
asparagine mediated by iodosobenzene diacetate (PIDA). 
PIDA is a hypervalent iodine chemical reagent used as an oxidizing agent in organic chemistry. 
Usually, (bis(trifluoroacetoxy)iodo)benzene (PIFA) is used in this kind of reaction, but PIDA 
offers some advantages: it is possible to conduct the reaction under less acidic conditions and 
it is possible to avoid basic catalysis with pyridine. Additionally, reaction is faster and there is 
no formation of urea. For this reason, it is easier to isolate pure product. Since PIDA is 
commercially available and cheap reagent, this reaction is widely used in academic and 
industrial fields.  
 
 
Scheme 33. Synthesis of a compound 40. Overall yield: 50 %. 
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Fmoc-L-Asn-COOH was subjected to a Hoffmann rearrangement with PIDA (1.1 eq) in a 
mixture of in ethyl acetate, acetonitrile, and water (39/39/22 v/v/v) to give β-amino-L-alanine 
derivative 38 (Scheme 33). The formation of the product was confirmed by the significant 
upfield shift of protons bound to β-carbon going from starting materiam to 38. 
The next step was the introduction of Boc group on the side chain to give 39 in quantitative 
yield as confirmed 1H NMR spectrum showing the presence of the diagnostic peak relative to 
the 9 methyl protons of the tert-butyl group as well as of triplet at 6.8 ppm to NHBoc.  
Removal of Fmoc protecting group with diethylamine afforded 40a in pure form as indicated 
by 1H NMR (no peaks in the resonance area of the aromatic protons) and MS analysis. 
 
 
4.2.2. Synthesis of tetra- β-amino-L-alanine 
 
Fully protected tetra-β-amino-L-alanine 45 was synthesized (Scheme 34) in the same way as 
described in the chapter 4.1.3 for polylysines using CbZ-β-amino-L-alanine(Boc)-COOH (40b) 
prepared from 40a, as a starting material. The intermediate formation of dimers (41 and 42) and 
trimers (43 and 44) was confirmed by NMR and mass analysis. 
 
 
Scheme 34. Synthesis of a compound 45. Overall yield: 74.3 %. 
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Compound 45 was subjected to the hydrolysis of the methyl ester using, as previously 
described, LiOH as a base (Scheme 35). Unexpectedly, under these reaction conditions, 
hydrolysis of the benzyl carbamate and formation of the carbamic acid 46b occur. 46b was 
found to be unusually stable as it did not decarboxylate even by heating under the reflux of 
methanol, toluene or water (acid solution) (Scheme 36).  
 
 
Scheme 35. Synthesis of a compound 46. 
 
 
Me
OH
 
Scheme 36. Unsuccessful attempts to synthesize compound 47. 
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Results of MDs simulations suggest stabilization of this product by intramolecular hydrogen 
bonds between the carbamate and CO and NH groups of Boc as well as NH group of the peptide 
backbone (Figure 77). 
 
Figure 77. Structure of a compound 46b obtained by MDs simulations in N,N-dimethylformamide at 
25 °C. 
 
4.3. SERINE 
 
With the aim to prepare cyclic peptides functionalized on the side chain with OH groups, we 
planned the synthesis of polyserine derivatives. 
This task was found to be more difficult than expected. Most of the planned reactions were 
unsuccessful and this forced us to change several times the synthetic route. 
We succeeded in preparing tetra-, penta-, and hexaserine (66, 70 and 74, respectively), linear 
precursors of the corresponding cyclic peptides, as reported in the Schemes 38, 39 and 43. 
In the case of tetra- and pentaserine, a linear approach analogous to that used for polylysine and 
poly-β-aminoalanine, was followed (Scheme 37). 
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Scheme 37. Synthesis of a compound 63. Overall yield: 33.2 %. 
 
Specifically, reaction of CbzNH-Ser(tBu)-COOH and H2N-Ser(tBu)-COOMe in the presence 
of HOBt and EDC as coupling reagents, TEA as a base in DMF, afforded dipeptide 59 (92 % 
yield) which was CbZ deprotected by hydrogenolysis and coupled with another unit of CbZ-
Ser(tBu)-COOH.  Deprotection of the resulting tripeptide 61 and a further coupling led to fully 
protected tetraserine 63 in 55 % yield. 
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Scheme 38. Synthesis of a compounds 66 and 68. Overall yields: 71.2 % and 52.3 % respectively. 
 
Starting from 63, the linear tetrapeptide 66, deprotected at both N-and C-termini, could be 
prepared (Scheme 38) by hydrogenolys followed by removal of methyl ester with LiOH. It is 
worth noting that, by changing the order of reactions it was not possible to obtain 66 in that the 
hydrogenolysis of 65 led to the formation of a stable carbamic acid 66b (Figure 78). Any attempt 
to decarboxylate product 66b in neutral, basic or mild acidic conditions at 50 °C didn’t lead to 
the desired product. 
Using the N-terminus deprotected tetrapeptide 67, the fully protected pentaserine 68 was 
prepared by coupling with CbZ-Ser(tBu)-COOH.   
 
 
 
 
Figure 78. Structure of a by-product 66b.  
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Removal of both N- and C-termini protection from 68 led to the pentapeptide 70 which was 
used later in the cyclization reaction (Scheme 39). Its structure was confirmed by MS and NMR 
analysis.  
 
 
Scheme 39. Synthesis of a compound 70. Overall yield: 73.5 %. 
 
Considering two facts a) significant amounts of linear precursors needed for cyclization 
reactions: 
b) the significant decreasing of yield with increasing  of the length of the peptide chain  
we decide to move from a linear to a convergent approach for the preparation of the hexapeptide 
74 according to the following strategy of assembly of intermediate segments: condensation of 
two dipeptides to give a tetrapeptide which is then coupled with another dipeptide segment 
(Scheme 40). 
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Scheme 40. Convergent synthesis of 74. 
 
Deprotection of dipeptide 59 from either –OMe or –CbZ to give 60 and 71 proceeded without 
particular issues as previously described (Scheme 41). 1H NMR and mass spectrometry both 
confirmed the structure of products. 
 
 
 
Scheme 41. Deprotection of either methyl ester and CbZ protecting group. 
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Dipetides 60 and 71 were coupled under the usual experimental conditions to give 63 that after 
deprotection of methyl ester was in turn coupled with 60 to afford the fully protected linear 
hexaserine (72) (Scheme 42) in an overall yield of 8%.  
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Scheme 42. Synthesis of a compound 72. Overall yield: 8 %. 
 
The dramatic decrease of yield is certainly attributable to the formation of a by-product 52b 
arising from the intramolecular condensation of the amine at one terminus and the ester at the 
other one in 60. The basic conditions enhance this tendency to a rapid cyclization driven by the 
stability of the resulting six membered ring of the diketopiperazine 52b.  
 
§ 4. Results and discussion 214 
Nikolina Vidović PhD thesis 
Cleavage of methyl ester and CbZ in 72 led to the precursor 74 which was characterized by 
NMR and mass spectrometry. 
 
 
 
Scheme 43. Cleavage of OMe and CbZ protecting groups and decarboxylation. 
It is worth noting that also during the removal of CbZ in 73, the formation of an intermediate 
carbamic acid 74b was observed, presumably due to stabilization by intramolecular hydrogen 
bonds. Decarboxylation of product 74b was however successful operating at reflux of toluene 
overnight and hexaserine 74 was obtained in 85% yield (Scheme 43). 
 
4.3.1. Cyclization 
 
A number of different coupling reagents (PfOH, EDC or DPPA) and experimental conditions 
were tested to perform head-to-tail cyclization of linear precursors 66, 70, and 74.  
Frequently TLC analysis during the monitoring of the reactions showed the presences of 
activated intermediates. However, cyclization reaction didn’t proceed and only starting material 
was found upon the addition of water and the extraction with EtOAc. 
Analogously to the case of poly-lysines, successful cyclization of 66, 70, and 74 was obtained 
using the Ye and co-workers procedure, i.e. DMF as the solvent, DEPBT as the coupling 
reagent, TEA as the base in the presence of LiCl or NaCl. 
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Cyclo[Ser(tBu)]4 (S4), cyclo[Ser(tBu)]5 (S5) and cyclo[Ser(tBu)]6(S6) were isolated in 10 %, 
21 %, and 15 % yield, respectively (Scheme 44) and characterized by NMR ad MS analysis. 
 
 
 
Scheme 44. Products of head-to-tail cyclization.  
 
ESI-Q-TOF mass spectrometry confirmed the good outcome of the cyclization as reported in 
Figure 79.  
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Figure 79. ESI-Q-TOF of products S4, S5 and S6. 
 
1H NMR spectrum of cyclo[Ser(tBu)]5 displayed a strong dependence on solvents used for 
analysis. In deuterated chloroform at RT all signals appeared very broad (Figure 80). 
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Figure 80. 1H NMR spectra of a compound S5 in CDCl3. 
 
In deuterated methanol (Figure 81), a significant sharpening of all signals was observed. It is 
worth noting that 5 doublets integrating each 1H, one for each NH group, were observed in the 
range 7.4-8.7 ppm, indicating that no exchange with the solvent occurs. In addition 4 multiplets, 
3 of which integrating 1H and the last one 2H, are present in the range typical of the -
hydrogens and 5 broad singlets, each integrating 9H, corresponding to the five tBu groups, in 
the range 1.15-1.4 ppm. 
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Figure 81. 1H NMR spectra of compound S5 in CD3OD. 
 
 
Comparison of 1H NMR spectra of compound S5 in CD3OD recorded at various temperatures 
in the range -70 °C to 50 °C are shown in Figures 82 and 83. 
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Figure 82. Temperature dependence of the 1H NMR spectrum of compound S5 in CD3OD (alpha 
region).  
 
 
Figure 83. Temperature dependence of the 1H NMR spectrum of compound S5 in CD3OD (tBu region).  
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As Addendum to the above reported preparation of cyclic poly-serines, it has to be mentioned 
that we tried a number of alternative synthetic routes to these compounds, in particular the one 
based on the use of [L-Serine]2 methyl ester as starting material in the conditions of Beck and 
co-workers.27 
These authors reported that a facile synthesis of 12-, 14-.16- and 18-membered cyclic 
tetrapeptide can be through a transition metal assisted cyclodimerization of nonactivated 
dipeptide ester precursors (Scheme 45). 
 
Scheme 45. Synthesis of cyclic tetrapeptide by transition metal-mediated cyclodimerization of 
unactivated dipetide esters.9 
 
Unfortunately, any attempt to perform the same reaction using [L-Serine]2 methyl ester as 
starting material didn’t lead to the desired cyclic product (Scheme 46). 
 
Scheme 46. Cyclisation of dipeptide methyl ester. 
 
Preparation of compound 52 was not straightforward and different routes were followed to 
prepare it (Schemes 47, 48 and 49). 
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a) 
 
Scheme 47. Synthesis of compound 52.  
 
Fmoc-L-Serine-(O-tBu)-Serine was converted into succinimidyl ester 48 that in a reaction with 
Ser gave a dipeptide 49. Methyl ester 50 was then obtained following an already described 
procedure. Removal of tBu protecting groups led to the product 51. Cleavage of Fmoc 
protecting group from compound 51 didn’t led to the desired product 52. Instead, 
diketopiperazine 52b was obtained. 
b)  
 
 
Scheme 48. Synthesis of compound 52. Overall yield: 58.2 %. 
Since previously described synthesis was unsuccessful, we tried to invert the order of reactions 
i.e. first removal of tBu ether to 49 and then of Fmoc to give compound 54. Finally, methyl 
ester was introduced leading to the desired precursor 52 in 58,2% overall yield (Scheme 48). 
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c) 
 
Scheme 49. Synthesis of compound 52. Overall yield: 38.1 %. 
Boc-Ser-COOH was converted into the succinimidyl ester 55 that in a coupling reaction with 
NH2-Ser(tBu)-COOtBu gave dipeptide 56. Protecting groups were then removed to give 
diserine 54 which was protected as methyl ester 52 in 38.1 % overall yield (Scheme 49). 
 
4.4. H2N-(Leu)5-COOH and H2N-Phe-Leu-Leu-Phe-Leu-Leu-COOH 
 
To confirm the role of chloride anion in assisting macrocyclization of peptides, two additional 
linear precursors were prepared: pentaleucine 84 and the hexapeptide 90 (Phe-Leu-Leu-Phe-
Leu-Leu).  
The first step in the synthesis of the linear precursor 84 was the conversion of carboxylic group 
of dileucine into methyl ester 79 with a yield of 84.2 % (Scheme 50). 
 
Scheme 50. Synthesis of compound 79. Yield: 84.2 %.  
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Then the same procedure already described for the synthesis of linear precursors protected as 
methyl esters and CbZ was followed and the desired product 84 was obtained in an overall yield 
of 64.1 % (Scheme 51).  
Scheme 51. Synthesis of compound 84. Overall yield: 64.1 %. 
 
To prepare hexapeptide 90, dipeptide 79 was condensed with CbZ-Phe-COOH to give the fully 
protected tripeptide 85 (Scheme 52). 85 was then converted into two compounds: 86 by removal 
of CbZ protecting group and 87 by hydrolysis of methyl ester.  
Condensing these two tripeptides the fully protected hexapeptide 88 was obtained. Its 
deprotection from both CbZ and OMe to give sequentially 89 and 90 proceeded without 
particular issues as previously described (Scheme 52). 
 
 
Scheme 52. Synthesis of compound 90. Overall yield: 55.1 %.  
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The binding of peptides methyl esters 83 and 89 with Na+ and Cl- ions was studied by means 
of microcalorimetric titrations using NaClO4 and TEACl salts. Titrations were carried out at 25 
°C by adding a salt solution in N,N-dimethylformamide to the ligand solution. The measured 
heats for titration with Na+ cation are reported in Figures 84-87. 
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Figure 84. Dependence of successive enthalpy change on n(Na+) / n(H2N-(Leu)5-OMe) in the 
microcalorimetric titration of linear H2N-(Leu)5-OMe (c = 5,117 · 10-3 mol dm-3) with NaClO4 (c =0,095 
mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5,020·10-2 mol dm-3) at θ = 25 ° 
C. 
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Figure 85. Microcalorimetric titration of linear (H2N-(Leu)5-OMe) with TBAClO4 (c = 4,824 mol dm-3) in 
N,N-dimethylformamide at θ = 25 ° C. 
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Figure 86. Dependence of successive enthalpy change on n(Na+) / n(H2N-(Phe-Leu-Leu)2-OMe) in the 
microcalorimetric titration of linear H2N-(Leu)5-OMe (c = 4,445 · 10-3 mol dm-3) with NaClO4 (c = 0,095· 
10-2 mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5,020·10-2 mol dm-3) at θ = 
25 ° C. 
  
§ 4. Results and discussion 226 
Nikolina Vidović PhD thesis 
0 4 8 12
-0.1
0.0
0.1
0.2
0.3
 (
 H
) /
 m
J
n (TBAClO4) / n (H2N-(PheLeuLeu)2-OMe)
 
Figure 87. Microcalorimetric titration of linear (H2N-(Phe-Leu-Leu)2-OMe) with TBAClO4 (c = 0,250 mol 
dm-3) in N,N-dimethylformamide at θ = 25 ° C. 
 
Analysis of microcalorimetric data indicated that there was no binding between linear peptides 
and Na+.  
On the contrary, microcalorimetric measurments clearly showed that compounds 83 and 89 
bind chloride ions (Figures 88 and 89). By processing the corresponding titration data, the 
thermodynamic quantities listed in Table 6 were calculated.  
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Figure 88. Dependence of successive enthalpy change on n(Cl-) / n(H2N-(Leu)5-OMe) in the 
microcalorimetric titration of linear H2N-(Leu)5-OMe (c = 5.117·10-3 mol dm-3) with TEACl (c = 0.096 
mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5,020·10-2 mol dm-3) at θ = 25 ° 
C. ■ measured values, — calculated values. 
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Figure 89. Dependence of successive enthalpy change on n(Cl-) / n(H2N-(Phe-Leu-Leu)2-OMe) in the 
microcalorimetric titration of linear H2N-(Phe-Leu-Leu)2-OMe (c = 4,445·10-3 mol dm-3) with TEACl (c = 
0.097 mol dm-3) in N,N-dimethylformamide in the presence of TBAClO4 (c = 5,020·10-2 mol dm-3) at θ = 
25 ° C. ■ measured values, — calculated values. 
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Table 6. Thermodynamic parameters of complexation reactions of 83 and 89 with chloride anion in N,N-
dimethylformamide at 25 ° C obtained by microcalorimetric titrations. 
solvent peptide log K1 ± SE 
(ΔrGƟ ± SE) 
/ kJ mol-1 
(ΔrHƟ ± SE) 
/ kJ mol-1 
(ΔrSƟ ± SE) 
/ J K-1 mol-1 
DMF H2N-(Leu)5-OMe 1,46 ± 0,01 -8,33 ± 0,05 6,2 ± 0,1 48,7 ± 0,3 
 H2N-(PheLeuLeu)2-OMe 2,06 ± 0,03 -11,8 ± 0,2 1,9 ± 0,2 46,0 ± 0,1 
SE = standard error of the mean (N = 3) 
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§ 5. CONCLUSIONS 
In conclusion, in the course of this PhD thesis a number of novel synthetic cyclopeptides have 
been prepared by head-to-tail coupling-based lactamization and their complexation abilities 
have been investigated through an integrated approach which includes thermodynamic, 
computational and NMR studies. 
Specifically: 
1. Linear homopeptides containing three different side-chain functionalized amino acids, 
namely lysine, serine and aminoalanine, were prepared by solution phase peptide synthesis in 
a moderate to good yields and in amounts up to 3 g. An orthogonal protection scheme was 
adopted involving the use of the following protecting groups: methyl ester for carboxyl group, 
CbZ for N-terminus, Boc and tert-butyl ether for the side chains. EDC/HBTU and HOBt were 
used as coupling reagents in DMF as a solvent and TEA as a base.  
All products were purified by flash column chromatography and characterized by 1H NMR, 13C 
NMR spectroscopy and ESI-Q-TOF mass spectrometry. 
 
2. Macrocyclization reactions were carried out on completely protected peptide precursors 
under high dilution conditions in the presence of salts (NaCl, LiCl, NaTPB and TEACl) to 
promote the head-to-tail condensation and DEPBT as the condensing reagent in order to have 
a strongly activated acyl component.  
Microcalorimetric titrations using H2N-[Lys(Boc)]4-OMe, H2N-[Lys(Boc)]5-OMe and H2N-
[Lys(Boc)]6-OMe as ligands and NaClO4 and TEACl as salts indicated a very weak binding of 
the peptides with Na+ and, on the contrary, a strong binding with Cl-. The binding constants for 
the complexation of chloride ions were evaluated to be Log K=1.51, Log K=1.47 and Log 
K=1.68, for tetra-, penta- and hexapeptide, respectively. These findings suggest that the 
mechanism commonly accepted for the so called metal-ion assisted cyclization has to be revised 
indicating that coordination of chloride (and not alkali metals) with amidic groups along the 
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chain is the factor that predominantly brings N- and C-termini closer, forcing them to react. 
Accordingly, the highest cyclization yields were obtained when TEACl was used as the salt to 
bring the reactive functionalities in close proximity. Finally, MD simulations show the 
formation of stable complexes of linear peptides with Cl- while in complexes with sodium 
dissociation of the cation occurs. 
 
3. Binding proprieties of cyclic pentalysine toward different anions were investigated by means 
of microcalorimetric titrations in CH3CN. In complexation reactions with halides (Cl-, Br-, I-) 
as well as with NO3-, inflection was observed at a ratio n(A-)/n(L) ≈ 1 which indicates that the 
stoichiometry of the resulting complex is 1:1. In contrast, with H2PO4- we observed inflection 
at the ratio n(L)/n(A-) ≈ 2 i.e. two ligands are needed to coordinate one H2PO4- anion. 
Calorimetric titrations showed also that the most efficient binding of cyclopentalysine is with 
Cl- with the binding constant of Log K=5.72 while that of cyclohexalysine is with OAc- (Log 
K > 4, obtained by NMR titration). In general, cyclic pentapeptide binds stronger all 
investigated anions than cyclic hexapeptide. 
Complexation reactions of cyclic penta- and hexalysine were also investigated by 1H NMR and 
ESI-MS titrations. The results obtained by these two methods are in excellent agreement to each 
other as well as with results arising from microcalorimetric titrations of pentapeptide. 
 
Cyclic homoserine derivatives were also prepared as well as linear H2N-(Leu)5-COOH and 
H2N-Phe-Leu-Leu-Phe-Leu-Leu-COOH to confirm the role of chloride anion in assisting 
macrocyclization of peptides. 
 
With the ultimate goal to prepare a novel class of anion receptors, namely calixarene homo-
cyclopeptide derivatives, work is in progress to set-up a simple and efficient method to directly 
conjugate the prepared homocyclopeptides to calixarenes by exploiting side chain functional 
groups. 
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§ 6. ABBREVATIONS 
Boc: tert-butoxycarbonyl  
Boc2O: Di-tert-butyl dicarbonate 
Cbz: carboxybenzyl  
DBU: 1,8-Diazabicyclo(5.4.0)undec-7-ene 
DCC: N,N'-dicicloesilcarbodiimmide 
DCM: dichloromethane 
DCU: Dicyclohexylurea 
DEA: Diethylamine 
DEPBT: 3-(Diethoxyphosphoryloxy)-1,2,3-benzotriazin-4(3H)-one 
DIPEA: N,N-diisopropylamine  
DMF: dimethylformamide  
DMSO: dimethylsulphoxyde 
DPPA: Diphenylphosphoryl azide 
EDC: 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide  
EtOAc: ethyl acetate 
EtOEt: diethyl ether 
EtOH: ethanol 
Fmoc: fluorenylmethyloxycarbonyl  
HBTU: O-benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate  
HOBt: hydroxybenzotriazole  
MeOH: methanol 
MeONa: Sodium methoxide 
MsCl: Methanesulfonyl chloride 
NaTPB: sodium tetraphenyl borate 
NHS: N-hydroxysuccinimide 
OMe: Methyl ester  
OSu: Succinimidyl ester 
OtBu: Tert-butyl ester 
PfOH: 2,3,4,5,6-Pentafluorophenol 
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Ser: Serine 
SPPS: Solid-phase peptide synthesis 
tBu: Tert-butyl ether 
TEA: triethylammine 
TEACl: tetraethylammonium chloride 
TFA: trufluoroacetic acid 
THF: Tetrahydrofuran 
TsCl: 4-Toluenesulfonyl chloride 
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